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Abstract 
 ii 
Studies in health care professional (HCPs) have demonstrated a high prevalence 
of dehydration, which has been linked with morphological brain changes as well 
as cognitive impairment in other groups. Moreover, many age-related 
pathophysiological changes result in increased susceptibility to fluid and 
electrolyte imbalance, rendering older adults vulnerable to dehydration which 
may be associated with poor outcome.   
This thesis investigates the prevalence of dehydration and impact on cognitive 
function amongst HCPs. It also investigates the prevalence of dehydration in 
hospitalised older adults and the association between dehydration, acute kidney 
injury (AKI) and clinical outcome.  
Hydration status and cognition were objectively assessed in nurses and doctors 
working on emergency medical and surgical wards. This study demonstrated that 
a significant proportion of HCPs were dehydrated at the start and end of their 
shifts and many were oliguric. The prevalence of dehydration varied with level of 
experience and speciality and was associated with short-term memory 
impairment.  
Using serum osmolality, the key regulated variable in fluid homeostasis as a 
measure of hydration status in hospitalised older adults, prospective assessment 
of 200 patients demonstrated that over a third had hyperosmolar dehydration 
(HD) at admission, two-thirds of which were dehydrated 48 hours later. 
Dehydration at admission was independently associated with a six-fold increase 
 iii 
in 30-day mortality. Subsequent retrospective assessment of 32,980 hospitalised 
older adults demonstrated that dehydration was diagnosed clinically in 8.9% of 
patients and was independently associated with a two fold increase in mortality. 
Nearly half of those dehydrated had a concomitant diagnosis of AKI and the 
median length of hospital stay (LOS) was nearly three times greater than those 
without the condition.  
Despite the widespread use of serum osmolality in human physiology studies, it is 
rarely used clinically to assess hydration. Analysis of published equations 
estimating osmolality, demonstrated that an equation by Khajuria and Krahn was 
90% sensitivity and 97% specificity at diagnosing hyperosmolar dehydration. 
Using this equation, we demonstrated that 27.2% of 6632 older adults had HD at 
admission to hospital and the risk of developing AKI 12-24 hours after admission 
in these patients was five times those euhydrated at admission. Moreover, the 
30-day mortality was nearly twice that of euhydrated patients, independent of 
key confounders. The median LOS in dehydrated patients was almost double. 
This work has highlighted the need to educate both patients and HCPs on the 
importance of hydration. Further work is required to prospectively assess the use 
of serum osmolality as a predictor of dehydration, AKI and outcomes. Given that 
hydration and nutrition are the hallmarks of compassionate care, there is clear 
room for improvement with findings from this thesis suggesting the need for 
further investigation and intervention in both community and hospital settings. 
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 Introduction 1.
  
 2 
1.1 Fluid homeostasis in the healthy adult 
Water is the most abundant compound in the body. It is a regulator of the 
internal environment and is essential for optimal cellular function. Total body 
water (TBW) makes up approximately 60% of body mass in healthy young adults 
of stable weight, divided into the intracellular (ICF) and extracellular fluid 
compartment (ECF) (Edelman and Leibman, 1959, Rush et al., 2009). These 
compartments are separated by the cell membrane that is permeable to water 
but not solutes. The ICF compartment accounts for approximately 40% of the 
total body mass and the ECF compartment approximately 20% of the total body 
mass. The ECF compartment is further divided into intravascular space containing 
circulatory blood volume (approximately 5% of TBW) and the extravascular space, 
which includes interstitial fluid (approximately 15% of the TBW) (Figure 1). 
Interstitial fluid surrounds cells and includes other pockets of fluid such as that 
within connective tissues as well as cerebrospinal fluid and fluid within the 
gastrointestinal tract (Cheek, 1961).  
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Figure 1: Schematic representation of fluid compartments and body water 
distribution. Total body water (TBW) makes up approximately 60% of total body 
mass (TBM) in healthy young adults of stable weight. This is divided into the 
intracellular (ICF), approximately 27 litres, 40% of the TBM and the extracellular 
fluid compartment (ECF), approximately 15 litres, 20% of the TBM. These 
compartments are separated by the cell membrane that is permeable to water 
but not solutes. The ECF compartment is further divided into intravascular fluid 
approximately 3.5 litres and extravascular fluid approximately 11.5 litres. 
Total Body Water  
60% of body mass (42L) 
 
Extracellular fluid   Intracellular fluid 
   35% of TBW (15L)      65% of TBW (27L) 
Intravascular 
25% of ECF (3.5L) 
 
Extravascular 
75% of ECF (11.5L) 
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The volume of TBW fluctuates on a daily basis by up to 5% in healthy weight 
stable adults as a result of food and fluid consumption as well as climate and 
physical activity (Rush et al., 2009, Rush et al., 2010). Variations in TBW have also 
been reported with gender, age and race, often attributed to differences in body 
composition (Rush et al., 2010, Rush et al., 2009, Baumgartner et al., 1995, 
Chumlea et al., 2001, Jiang et al., 1991, Watson et al., 1980, Cohn et al., 1985, 
Kyle et al., 2001). The FELS longitudinal study (Chumlea et al., 1999), reported 
that the mean TBW in men aged 20 to 29 years was approximately 42 litres 
compared with 31 litres in women of the same age group, using deuterium as a 
measure of TBW. Sequential decline in mean TBW was also reported in 
association with increased age (Chumlea et al., 1999, Steele et al., 1950, Norris et 
al., 1963, Watson et al., 1980, Baumgartner et al., 1995, Cohn et al., 1985). This is 
likely a result of the overall reduction in the proportion of fat free mass (FFM) 
and is associated with increased body fat which is relatively anhydrous, therefore 
leading to a reduction in TBW (Kyle et al., 2001)-(Hume, 1971). Race related 
differences in TBW have also been reported (Townsend et al., 1983, Schutte et 
al., 1984, Jiang et al., 1991), with the mean TBW in African-American men being 
approximately five litres more than age-matched Caucasian males (Chumlea et 
al., 2001). Similar findings were also reported between age-matched Caucasian 
and African-American women (Chumlea et al., 2001). These differences in TBW 
are thought to be related to higher proportions of FFM in the African-American 
subjects (Townsend et al., 1983, Schutte et al., 1984, Chumlea et al., 2001).  
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 Fluid movements across compartments 1.1.1
The distribution of TBW across the compartments will vary depending on the 
balance of osmotic, oncotic and hydrostatic forces. The osmotic pressure is the 
pressure required to oppose the movement of water by osmosis across the cell 
membrane. This is proportional to the number of particles in the solution (Landau 
et al., 1970) and is created by the presence of high concentrations of solutes, 
most commonly sodium and potassium on one side of a membrane. The cell 
membrane is impermeable to solute but allows the free movement of water 
which will then move by osmosis across the membrane into the area with a high 
solute concentration until a balance or steady state has been reached.  
The oncotic pressure is exerted by complex molecules such as proteins which are 
usually located within the intravascular space and cannot easily cross competent 
capillary walls (Evans, 2002, Adamson et al., 2004). These large proteins act to 
draw water into the intravascular space and oppose the hydrostatic pressure that 
exists within the vessel acting to force water out of the intravascular space 
(Adamson et al., 2004). The intravascular hydrostatic pressure increases with 
blood pressure (BP) and is influenced by cardiac output and vascular tone (Gertz 
et al., 1966). The balance between the intravascular oncotic and hydrostatic 
pressure exert the greatest influence on the net movement of water across the 
capillary bed as described in Starling’s equation (Woodcock and Woodcock, 
2012). Interstitial hydrostatic pressure which increases with volume and is 
affected by tissue compliance can also effect the direction of fluid shift. 
 6 
Encapsulated organs such as the kidneys tend to have low interstitial tissue 
compliance compared with non-encapsulated organs such as the skin. 
Consequently, small changes in interstitial volume within the kidneys results in 
significant interstitial hydrostatic pressure increase and therefore, greater 
influence on the net movement of fluid between the compartments. 
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Figure 2: Schematic representation of the forces influencing the movement of fluid 
between compartments. The distribution of TBW across the compartments will vary 
depending on the balance of osmotic, oncotic and hydrostatic forces. The osmotic 
pressure is the pressure required to oppose the movement of water by osmosis 
across the cell membrane. The balance between the intravascular oncotic and 
hydrostatic pressure exert the greatest influence on the net movement of water 
across the capillary bed as described in Starling’s equation. Interstitial hydrostatic 
pressure which increases with volume and is affected by tissue compliance can also 
affect the direction of fluid shift. 
Cell 
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1.2  Regulation of fluid balance 
Fluid balance is regulated tightly by neurohormonal mechanisms that result in 
conservation of salt and water as well as the activation of the thirst mechanism 
that stimulates ingestion of fluid. Osmoreceptors and baroreceptors are the 
regulators of fluid homeostasis, key to maintaining intravascular fluid volume and 
organ perfusion.  
 Osmoregulation  1.2.1
Osmoregulation is key to maintaining adequate cell volume, sensitive to as little 
as a 1% change in serum osmolality (Fitzsimons, 1963). This sensitivity to change 
in osmolality helps avoid large fluctuations in cell volume, which can be 
detrimental to cell function and can result in cell rupture. Osmoregulation is 
mediated by changes in water balance detected by osmoreceptors located within 
the vascular organ of the laminar terminalis (OVLT) in the hypothalamus, which 
sits outside the blood brain barrier (Thrasher et al., 1982). Increase in plasma 
osmolality results in osmoreceptor activation, which stimulates the release of 
antidiuretic hormone (ADH) from the posterior pituitary (Stocker et al., 2006, 
Benarroch, 2005, Robertson et al., 1976, Mckinley et al., 1992). ADH acts directly 
on receptors located on the basolateral membrane of the principal cells of the 
renal collecting tubules to increase the number of aquaporin channels (Figure 3) 
(Robertson et al., 1976, Birnbaumer, 2000). Aquaporin channels allow selective 
 9 
water reabsorption (Birnbaumer, 2000, Harris et al., 1994), resulting in low urine 
volume and concentrated urine.  
Increase in plasma osmolality by 1 to 2% also stimulates thirst, with animal 
models demonstrating that a further increase in plasma osmolality is associated 
with a proportional increase in water consumption (Fitzsimons, 1963).  
Other osmoreceptors outside the hypothalamus have also been identified 
including the hepatoportal osmoreceptors (Ishiki et al., 1991). Although their 
exact role is yet to be fully defined, animal models support their involvement in 
controlling and mediating the thirst response to plasma hyperosmolality (Ishiki et 
al., 1991).  
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Figure 3: Summary of processes that results from serum hyperosmolality. Water 
loss dehydration can causes an increase in plasma osmolality resulting in 
hypothalamic osmoreceptor activation, which stimulates the thirst response as 
well as the release of antidiuretic hormone (ADH) from the posterior pituitary. 
ADH acts directly to increase the number of aquaporin channels in the distal 
convoluted tubules and cortical collecting ducts, allowing selective water 
reabsorption. Other osmoreceptors outside the hypothalamus have also been 
identified including the hepatoportal osmoreceptors thought to mediate the 
thirst response following fluid ingestion. 
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 Baroreceptor activation 1.2.2
Baroreceptors are distributed throughout the circulatory system and detect 
changes in volume. The baroreceptor sensory endings are located within the 
tunica adventitia of the vessel and measure change in stretch and luminal 
pressure that accompanies changes in circulatory volume. Low pressure 
baroreceptors are found in the great veins as well as the right atrium (Zoller et 
al., 1972, Abboud et al., 1979). High pressure baroreceptors are located in many 
of the arteries with the greatest density found in the carotid body and the aortic 
arch. They are also found in the kidney, located in the juxtaglomerular apparatus 
of the afferent arterioles and the macula densa.  
Baroreceptor neural activity has an inhibitory effect on efferent sympathetic 
nerve activity. Efferent baroreceptor nerves are continuously firing; when volume 
depletion is detected, baroreceptor activity decreases. This in turn reduces the 
inhibitory effects on the sympathetic centres in the brain stem (Guyenet, 2006, 
Dampney et al., 2002, Strack et al., 1989). The result is a neurohormonal 
response mediated by autonomic and sympathetic nervous system and activation 
of the renin angiotensin aldosterone system (RAAS) (Koganezawa et al., 2008). 
This triggers ADH secretion from the posterior pituitary, activation of the thirst 
centre, salt and water retention as well as an increase in heart rate and vascular 
tone (Figure 4) (Johns et al., 2011, DiBona and Kopp, 1997, DiBona, 1994, Janig 
and Habler, 2003). However, a substantial fall in intravascular volume by 
approximately 10% is required before baroreceptors are activated (Dunn et al., 
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1973), and although less sensitive than the osmoreceptors, the hypovolaemic 
response mediated by baroreceptors results in a much greater surge of ADH.  
 Activation of the renin angiotensin aldosterone system 1.2.3
Stimulation of the RAAS occurs indirectly through baroreflex via the sympathetic 
afferent nerves, but also directly through the renal baroreceptors. The 
juxtaglomerular cells release renin when a reduction in arterial pressure is 
detected. Renin converts angiotensinogen into angiotensin I which is converted 
by angiotensin converting enzyme (ACE) into angiotensin II. Angiotensin II leads 
to central stimulation of the sympathetic nervous system and arterial 
vasoconstriction resulting in increased BP. Angiotensin II also triggers 
adrenocorticotrophic hormone (ACTH) release from the anterior pituitary and 
therefore stimulating the release of glucocorticoids (Gaillard et al., 1981). ADH 
secretion is also stimulated by angiotensin II, resulting in water reabsorption from 
the collecting tubules. Angiotensin II also acts directly on the proximal tubules of 
the kidney resulting in sodium and water retention. Furthermore, it acts on the 
adrenal cortex to stimulate the production and release of aldosterone, from the 
zona glomerulosa. Aldosterone, a mineralocorticoid acts mainly on the distal 
convoluted tubule and the principle cells of the cortical collecting tubules in the 
distal nephron increasing permeability of the luminal membrane to sodium. It 
also promotes sodium-hydrogen exchange and activation of the sodium 
potassium ATPase pump on the basolateral membrane, thus increasing the 
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extracellular sodium concentration and the excretion of potassium leading to 
increased extracellular fluid and TBW (Linas et al., 1979, Bauer et al., 1979).  
1.2.3.1 The thirst response 
Hypovolaemia is also known to stimulate the thirst response mediated through 
the baroreflex, however, the exact mechanism is yet to be fully defined. In animal 
models where intravascular hypovolaemia was induced by administering 
extravascular colloids, water consumption was proportional to volume loss, 
thought to be mediated through activation of the RAAS (Stricker, 1983, Stricker, 
1968, Stricker, 1981, Stricker and Jalowiec, 1970, Gauer and Henry, 1963, 
Stricker, 1966, Kozlowski et al., 1968, Fitzsimons, 1961). Animal models have also 
demonstrated that angiotensin II acted as a dipsogenic hormone mainly with 
small circulatory volume loss (Johnson et al., 1981). However, hypovolaemia 
appears to be a weak stimulant of thirst given that a 2% to 3% dilution of plasma 
osmolality has been shown in rats to abolish water intake with 35% plasma-
volume deficits (Stricker, 1969). It is important to note, when plasma 
hyperosmolality and hypovolaemia coexist there is an additive effect on water 
intake (Corbit, 1968, Stricker and Verbalis, 1986). However, in the presence of 
arterial hypertension, inhibitory effect on water intake was observed in animal 
models, even in the presence of plasma hyperosmolality or hypovolaemia 
(Kirchheim, 1976, Stocker et al., 1999).  
 14 
 
Figure 4: Schematic representation of processes involved in volume regulation in 
healthy adults. Baroreceptor neural activity decreases when volume depletion is 
detected. This in turn reduces the inhibitory effects on the sympathetic centres in 
the brain stem and results in a neurohormonal response mediated by the autonomic 
and sympathetic nervous system as well as activation of the renin angiotensin 
aldosterone system. Renin converts angiotensinogen into angiotensin I which is then 
converted by angiotensin converting enzyme into angiotensin II. Angiotensin II leads 
to central stimulation of the sympathetic nervous system and arterial 
vasoconstriction as well as stimulation of the thirst response. Angiotensin II also 
triggers adrenocorticotrophic hormone release from the anterior pituitary and 
therefore stimulating the release of mineralocorticoids. Furthermore, it acts on the 
adrenal cortex to stimulate the production and release of aldosterone which acts to 
increase sodium reabsorption. Antidiuretic hormone (ADH) secretion from the 
posterior pituitary is also stimulated by angiotensin II, resulting in water 
reabsorption. 
Angiotensin I 
Angiotensinogen  
Angiotensin II  
Reduced baroreceptor activity 
Angiotensin converting 
enzyme  
 
Sympathetic nerve 
activity 
Water retention 
ADH secretion  
 
Renin release  
Salt & water 
retention  
 
Aldosterone 
Vasoconstriction 
Thirst response 
Adrenocorticoids 
 15 
1.3 The pathophysiology of fluid and electrolyte balance in 
older adults 
The number of adults aged 65 years and over has increased significantly across 
the developed world; a likely result of advances in medical care. Between 1999 to 
2000 and 2009 to 2010, there was a 66% rise in hospital stay across England in 
the over 75-year age group (HSCIC, 2012). The UK government estimates that the 
number of people aged 65 years and over will double by the year 2050, with an 
associated increase in public cost burden (Cracknell, 2010).  
Older adults are susceptible to dehydration and electrolyte abnormalities. The 
causes are multifactorial, ranging from physical disability restricting access to 
adequate fluid intake to iatrogenic causes including polypharmacy and the 
unmonitored use of diuretics and other drugs (Allison and Lobo, 2004). Physical 
disability can limit older adults access to water (Gaspar, 1999), whilst 
incontinence-associated embarrassment may lead older adults to restrict their 
oral fluid intake. Furthermore, those from lower socioeconomic backgrounds, 
living alone, with pre-existing comorbidities, or receiving multiple drugs are more 
susceptible to dehydration and electrolyte disturbances. They are also at 
increased risk of associated morbidity and mortality (Foroni et al., 2007). Poor 
patient education has also been reported to lead to high rates of dehydration-
related hospital readmissions after discharge, particularly in surgical patients 
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(Hari and Rosenzweig, 2012, Khan et al., 2012, Messaris et al., 2012). Dehydration 
has been shown to be the main reason for readmission following formation of a 
defunctioning ileostomy, with those on diuretics being at increased risk (Messaris 
et al., 2012). Higher mortality rates have been noted at one year associated with 
those readmitted to hospital after surgery for hip fracture, a significant 
proportion of which were related to dehydration (Khan et al., 2012).  
The ageing process is associated with physiological changes in water balance. 
TBW is reduced by 10-15%, owing to reduced lean body mass, leading to an 
increased extracellular to intracellular water ratio (Kyle et al., 2001, Baumgartner 
et al., 1995, Watson et al., 1980, Steele et al., 1950, Cohn et al., 1985, Chumlea et 
al., 1999). This, coupled with reduced glomerular filtration rate and a reduced 
ability to concentrate urine, can predispose older adults to dehydration as well as 
fluid retention and iatrogenic overload (Allison and Lobo, 2004, Lindeman et al., 
1985), further increasing their vulnerability during periods of physiological stress 
associated with illness or the perioperative period. 
 Renal senescence 1.3.1
Renal senescence reflects irreversible structural and functional changes 
associated with the ageing kidney (Melk, 2003). Amongst other changes, there is 
a loss of renal mass due to glomerular sclerosis and glomerular loss (Lindeman et 
al., 1985, Nyengaard and Bendtsen, 1992, Epstein, 1996). This impairs the ability 
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to retain sodium, and therefore water, thus predisposing the patient to 
dysnatraemia and hypovolaemia (Hawkins, 2003). In addition, the ability to 
secrete potassium and excrete hydrogen is also impaired (Musso et al., 2006, 
Frassetto and Sebastian, 1996, Berkemeyer et al., 2008). The creatinine clearance 
in the aged kidney is also reduced. Reduction in the mean creatinine clearance 
was reported in two-thirds of the population studied in the Baltimore 
Longitudinal Study of Aging, with an estimated reduction in estimated glomerular 
filtration rate (eGFR) by 50-63% from the age of 30 to 80 years (Lindeman et al., 
1985). Furthermore, reduced tubular function and the medullary concentration 
gradient are also impaired in an aged kidney, diminishing the ability of the kidney 
to concentrate urine. Age-related reduction in renal blood flow has also been 
reported; this contributes to loss of nephrons as a result of ischaemia (Lindeman 
et al., 1985, Messerli et al., 1983, Hollenberg et al., 1974, Beck, 2000). These 
changes impair the ability of the kidney to control water and electrolyte balance, 
predisposing to dehydration and electrolyte abnormalities, particularly in 
situations of physiological stress.  
 Hormonal changes and ageing 1.3.2
Hormonal changes that affect fluid and electrolyte homeostasis have been 
reported in older adults. There is an age-related reduction in the serum 
concentrations of renin and aldosterone as a result of increased atrial natriuretic 
peptide (ANP) activity, usually released in response to increased BP and right 
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atrial filling. This, coupled with age-related reduction in tubular response to 
aldosterone, predisposes to dehydration and electrolyte abnormalities (Beck, 
2000, Kenny et al., 1987). Serum ANP concentrations were shown to be nearly 
five-times greater in older adults than in the young (Ohashi et al., 1987). ANP 
inhibits renin secretion from the juxtaglomerular cells, therefore limiting the 
conversion of angiotensinogen to angiotensin I, and inhibiting the RAAS (Figure 5) 
(Kurtz et al., 1986). These changes result in a decreased ability to retain sodium in 
a hypovolaemic state and a reduced ability to excrete potassium (Ling et al., 
1990, Musso et al., 2006), making it difficult to adapt to extracellular fluid 
depletion and sodium loss.  
It is also important to consider the role of ADH in older adults, where there is 
conflicting evidence suggesting increased as well as decreased serum 
concentrations. The normal diurnal variation results in increased plasma 
concentrations of ADH at night, but in older adults this is attenuated contributing 
to the high prevalence of nocturia (Asplund and Aberg, 1991). This, along with 
reduced renal sensitivity to ADH, limits the ability to respond to extracellular fluid 
depletion (Beck, 2000, Stachenfeld et al., 1996, Phillips et al., 1984a). 
Furthermore, decreased plasma ADH concentrations have been reported in 
patients with Alzheimer’s disease, limiting the ability to conserve water (Albert et 
al., 1989).  
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Figure 5: Age-related changes in the hormonal control of fluid and electrolyte 
homeostasis. There is an age-related reduction in the serum concentrations of renin 
and aldosterone as a result of increased atrial natriuretic peptide (ANP) activity. ANP 
inhibits renin secretion from the juxtaglomerular cells, therefore, limiting the 
conversion of angiotensinogen to angiotensin I, ultimately resulting in reduced 
angiotensin II, therefore inhibiting the renin angiotensin aldosterone system (RAAS). 
Consequences of this include; reduced aldosterone, impaired thirst response, reduced 
antidiuretic hormone. These changes result in a decreased ability to retain sodium and 
water making it difficult to adapt to extracellular fluid depletion and sodium loss. 
 
 20 
1.3.2.1 The thirst response in older adults 
The thirst response is blunted in older adults resulting in a persistent 
hyperosmolar state (McAloon Dyke et al., 1997, Phillips et al., 1991, Phillips et al., 
1984a, Silver and Morley, 1992, Stachenfeld et al., 1997, Mack et al., 1994), 
which is exacerbated by the reduced concentrating ability of the kidney. In a 
double-blinded crossover study investigating the thirst response in older men, 
healthy men aged 65-78 and 25-32 years were infused with isotonic, 0.154 M 
(0.9%) saline or hypertonic, 0.855 M (5% saline) two weeks apart (Phillips et al., 
1991). The authors reported less volume expansion in older adult subjects 
following hypertonic saline than in the younger subjects. Moreover, older adults 
felt less thirsty and consumed less water than the younger subjects during the 
hypertonic state, thus demonstrating the increased thirst threshold in older 
adults (Phillips et al., 1991). Another study showed that older men had a blunted 
thirst response following 24 hours without fluids compared with younger men 
(Phillips et al., 1993). The mechanism responsible for this is yet to be defined, but 
may be a result of blunted osmotic and baroreceptor sensitivity, particularly in 
the left atrium (Kenney and Chiu, 2001, Stachenfeld et al., 1997) or possibly 
inhibition of the RAAS as a result of the raised concentrations of ANP (Burrell et 
al., 1991). It is important to note however, that the amount of fluid consumed on 
a daily basis is not entirely physiologically driven, but is dependent on 
consumption that is driven by social factors, habit and other influences, such as 
the fluid intake with meals (Kenney and Chiu, 2001, Phillips et al., 1984b). 
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Therefore, the healthy independent older person is generally able to maintain 
adequate fluid balance through spontaneous consumption of fluids but may 
become vulnerable to dehydration in a state of physiological stress. 
 Electrolyte abnormalities in older adults  1.3.3
Electrolyte abnormalities, particularly dysnatraemia, should be considered in the 
context of water balance. Hypertonic dehydration occurs when proportionally 
more water than sodium is lost from the ECF compartment. This may occur as a 
result of age-related thirst impairment and would manifest as serum sodium 
concentration of greater than 145 mmol/l in the context of dehydration. 
Hypotonic dehydration on the other hand occurs when the portion of sodium lost 
is greater than water, resulting in a serum sodium concentration of less than 135 
mmol/l, and may occur with the use of diuretics. Isotonic dehydration results 
from proportionate loss of water and sodium and results in normal serum sodium 
concentrations. This may occur as a result of diarrhoea, where there is salt and 
water loss in similar proportions. 
1.3.3.1  Dysnatraemia in older adults  
Dysnatraemia is the most common electrolyte abnormality in older adults, with 
age being an independent risk factor (Hawkins, 2003). Clinical manifestations of 
dysnatraemia vary depending on the severity, with fatigue, seizure and coma 
being recognised complications. Dysnatraemia, particularly hypernatraemia, is 
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also linked with increased mortality rates of up to 70% in severe cases (Alshayeb 
et al., 2011, Snyder et al., 1987), associated with a seven-fold increase in 
mortality compared with that of age-matched hospitalised patients (Snyder et al., 
1987).  
Hyponatraemia, on the other hand, is more common in older adults than 
hypernatraemia and is an independent risk factor for bone fractures (Gankam 
Kengne et al., 2008, Zilberberg et al., 2008, Kinsella et al., 2010). This may be a 
result of reduced bone mineral density and increased risk of osteoporosis 
(Barsony et al., 2009). Moreover, hyponatraemia is associated with a 2.1-fold 
increase in mortality in mild cases and 4.6-fold increase in severe cases in 
patients admitted for orthopaedic surgery (Waikar et al., 2009, Zilberberg et al., 
2008).  
 It is important to note that a significant proportion of dysnatraemia in older 
adults occurs as a result of concurrent disease such as the syndrome of 
inappropriate ADH secretion (SIADH) and hyperglycaemia (Anderson et al., 1985). 
Older adults require longer to excrete salt loads due to the age-related reduction 
in eGFR and they are more likely to become overloaded when challenged with a 
sodium load. The kidney is also unable to cope with the excess chloride load even 
in physiologically normal subjects (Chowdhury et al., 2012). Therefore, diuretic 
use as well as excessive administration of intravenous hypotonic fluids can result 
in hyponatraemia.  
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1.3.3.2  Hyperkalaemia in older adults  
Age-related renal changes make older adults vulnerable to other electrolyte 
abnormalities, in particular hyperkalaemia, resulting from impaired ability to 
secrete potassium and excrete acid, a consequence of age-related decline in 
distal renal tubular function (Musso et al., 2006, Frassetto and Sebastian, 1996, 
Berkemeyer et al., 2008, Biswas and Mulkerrin, 1997). Reduced aldosterone 
response to a potassium infusion was also demonstrated in healthy older adult 
volunteers when compared with younger controls (Mulkerrin et al., 1995). 
Furthermore, the age-related blunting of the renin-aldosterone response to an 
acute rise in serum potassium further increases the susceptibility to 
hyperkalaemia (Clark et al., 1992). Other mechanisms have also been suggested 
to contribute to hyperkalaemia. Transtubular potassium concentration gradient, 
an index of potassium secretory activity in the distal tubule, was shown to be 
lower in healthy older adult subjects than in the young (Musso et al., 2006).  
  The impact of prescribing on fluid and electrolyte regulation 1.3.4
in older adults 
The predisposition of older adults to electrolyte abnormalities is further 
increased by the underlying co-morbidities that often coexist and can often be 
precipitated by polypharmacy. Some drugs also interfere with thermoregulation 
and predispose to dehydration, (Table 1) (Cuddy, 2004). Widespread 
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unmonitored use of medications such as angiotensin-converting enzyme 
inhibitors (ACE-I), diuretics and non-steroidal anti-inflammatory drugs (NSAIDs) 
are significant risk factors for dehydration and electrolyte abnormalities. ACE-I 
prevent the conversion of angiotensin I to angiotensin II, thereby reduce 
aldosterone secretion. NSAIDs inhibit prostaglandin synthesis, associated with 
reduced renin and aldosterone, thus predisposing to hyperkalaemia (Biswas and 
Mulkerrin, 1997, Nadler et al., 1986).  
Table 1: Commonly prescribed drugs that affect thermoregulation. 
 Levothyroxine 
 Selective serotonin reuptake inhibitors 
 Atypical antipsychotics e.g. olanzapine 
 Tricyclic antidepressants 
 Carbamazepine 
 Anticholinergics  
 Antihistamines 
 
 Hydration and cellular function 1.3.5
The maintenance of adequate cell hydration is essential to cell function and 
survival because it has profound effects on cell volume. Loss or gain of even a 
small percentage of cellular water interferes with key metabolic processes and 
affects the integrity of the cellular architecture as well as membrane integrity 
mediated by changes in cell volume (Baskett, 1990, Raj, 2006, Razminia et al., 
2004). Cell swelling is a necessity for stimulation of key cellular functions such as 
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proliferation (Convertino et al., 2006), whilst cell shrinkage is key to apoptotic cell 
death (Jacob et al., 1997).  
Cell swelling stimulates protein and glycogen synthesis, and cell shrinkage 
stimulates proteolysis and glycogen breakdown, with both pathways leading to 
the production of osmotically more active substances (Haussinger et al., 1993). 
There is also evidence supporting the effects of cell volume on gene and protein 
expression, such as the heat shock protein expression and ADH stimulated by cell 
shrinkage (Baskett, 1990). Maintenance of fluid and electrolyte balance is, 
therefore, essential to healthy living, no more so than in periods of ill-health. 
Dehydration, overhydration and salt and water overload have been associated 
with morbidity and mortality, with older adults at increased risk (Warren et al., 
1994, Wilkinson K, 2010, El-Sharkawy et al., 2014).  
 Acute and chronic effects of hydration status on health 1.3.6
There is a growing body of evidence supporting the link between the state of fluid 
imbalance and disease including urological, gastrointestinal, circulatory and 
neurological disorders. However, the evidence is largely associative and lacks 
consistency with limited number of randomised trials.  
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1.3.6.1 Dehydration 
A state of dehydration occurs with excess loss of total body water and is often 
associated with electrolyte abnormalities, particularly dysnatremias. Hypertonic 
dehydration occurs when proportionally more water than sodium is lost from the 
extracellular fluid compartment. This may occur as a result of age-related thirst 
impairment, which is seen in older adults. Hypotonic dehydration, on the other 
hand, occurs when the proportion of sodium lost is greater than the proportion 
of water lost. This may occur with the use of diuretics or in patients with burns. 
Isotonic dehydration results from proportionate loss of water and sodium, and 
results in normal serum sodium concentrations. This may occur as a result of 
diarrhea, where there is salt and water loss in equivalent proportions. Common 
causes of isotonic, hypotonic, and hypertonic dehydration are listed in Table 2. 
The evidence linking dehydration and health disorders are summarised in Table 
3a, 3b and 3c.   
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Table 2: Summary of the conditions linked with hypotonic, isotonic and 
hypertonic dehydration and associated level of evidence. 
Dehydration 
Isotonic Hypotonic Hypertonic 
Burns 
Vomiting* 
Diarrhoea* 
Ascites 
Vomiting* 
Diarrhoea* 
Enterocutaneous fistula* 
Adrenocortical 
deficiency 
Renal failure 
Cerebral salt wasting 
Hyperglycaemia 
Osmotic diuretics 
Mannitol* 
Inadequate water intake 
Sweating 
Diabetes insipidus 
Polyuric phase post-acute 
tubular necrosis 
Osmotic diuretics 
Mannitol* 
Loop diuretics 
Enterocutaneous fistula* 
Osmotic laxatives 
*
Depending on electrolytes lost.   
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Table 3a: Summary of the evidence linking dehydration to health disorders. 
Conditions Summary of findings 
Level of 
evidence 
Urological 
Urinary tract 
infections (UTI) 
Inconsistent findings, however, evidence largely 
favours the positive effects of ‘adequate’ fluid 
intake on UTIs.  
IIb 
Urolithiasis 
Evidence largely from epidemiological studies 
and RCTs reporting beneficial effects of 
increased fluid consumption in preventing 
urolithiasis recurrence.  
Ib 
Acute kidney 
injury 
Limited evidence, one observational study. 
However, many experts believe severe 
dehydration can cause acute kidney injury. 
IV 
Chronic kidney 
disease 
One population based cross-sectional study 
showing reduced risk of developing chronic 
kidney diseases associated with increased fluid 
consumption. 
IV 
 
Bladder cancer 
Conflicting evidence on the link between chronic 
dehydration and bladder cancer. 
III 
Gastrointestinal 
Functional 
constipation 
Some evidence linking dehydration as a cause of 
functional constipation. The strongest evidence 
favours increased fluid consumption to treat 
constipation during a state of dehydration and as 
an adjunct to high fibre diet. 
III 
Colorectal cancer 
Evidence largely from retrospective case control 
studies showing an inverse relationship between 
increased water consumption and colorectal 
cancer. The beneficial effects are greater for 
distal tumours. 
III 
 
Level of evidence (based on the Oxford Centre for Evidence Based Medicine Level of 
evidence guide (Phillips et al., 2009) - Ia – systematic reviews (SR) of RCTs with 
homogeneity. Ib- Individual RCT with narrow confidence interval and >80% follow 
up. IIa- systematic reviews of cohort studies with homogeneity. IIb- low quality 
RCTs and large cohort studies. III- SR of case control studies with homogeneity or 
individual case control studies. IV- case series and poor cohort and case control 
studies. V- Expert opinion. 
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Table 3b: Summary of the evidence linking dehydration to health disorders. 
Conditions Summary of findings 
Level of 
evidence 
                       Circulatory  
 
Deep vein 
thrombosis (DVT) 
Limited number of studies. Serum 
hyperosmolality associated with increased risk of 
DVT in hospitalised patients with stroke. 
III 
Cerebral infarct 
Limited evidence directly linking dehydration as 
a cause of cerebral infarct. However, some 
evidence linking serum hyperosmolality to poor 
outcome following stroke. 
III 
Coronary heart 
disease (CHD) 
Strongest evidence from a large prospective 
cohort study which reported that increased 
water consumption was inversely associated 
with reduced risk of fatal CHD events.  
IIb 
Orthostatic 
hypotension 
Good evidence linking dehydration and 
orthostatic hypotension particular in severe 
cases that result in significant hypovolaemia. 
IIb 
Mitral valve 
prolapse (MVP) 
Limited evidence showing that acute mild 
dehydration induced MVP in healthy subjects 
and resolved with rehydration.  
III 
Neurological 
Delirium 
Evidence linking dehydration to cognitive 
impairment is inconsistent. An inverse 
relationship has been reported between 
increased water consumption and delirium in 
long term care residence.  
III 
Headache 
No direct link between dehydration as a cause of 
headache. Evidence supports increased water 
consumption helps limit the intensity of 
migraine. 
IIb 
 
Level of evidence (based on the Oxford Centre for Evidence Based Medicine Level of 
evidence guide (Phillips et al., 2009) - Ia – systematic reviews (SR) of RCTs with 
homogeneity. Ib- Individual RCT with narrow confidence interval and >80% follow 
up. IIa- systematic reviews of cohort studies with homogeneity. IIb- low quality 
RCTs and large cohort studies. III- SR of case control studies with homogeneity or 
individual case control studies. IV- case series and poor cohort and case control 
studies. V- Expert opinion. 
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Table 3c: Summary of the evidence linking dehydration to health disorders. 
Conditions Summary of findings 
Level of 
evidence 
Metabolic  
Diabetes mellitus 
Evidence from a cohort study suggests an inverse 
relationship between increased water 
consumption and type II diabetes. Strongest 
evidence supports the link between dehydration 
and poor outcome with diabetic ketoacidosis. 
III 
Obesity 
Inconsistent evidence linking increased water 
consumption in relation to meals to treat 
obesity. Some evidence supports the effects of 
cold water consumption on increased basal 
metabolic rate. 
III 
Pregnancy and labour  
Oligohydramnios 
Good evidence from multiple RCTs and 
systematic reviews concluding that dehydration 
results in a reduced amniotic fluid index which 
increases with rehydration. 
Ib 
Labour 
Good evidence from multiple RCTs and 
systematic reviews concluding that 250ml/hr of 
intravenous fluid results in reduced frequency of 
prolonged labour in fasted women. However, 
when patients eat and drink liberally no clear 
differences were observed.  
IIb 
Other conditions 
Respiratory 
disorders 
Dehydration in the airways may result in 
bronchoconstriction and inspiration of 
humidified air is beneficial in obstructive airway 
disease. However, no link between total body 
fluid balance and bronchoconstriction.  
III 
Dental disorders, 
hypertension, 
gallstones and 
breast cancer 
Limited evidence concluding that dehydration  
may be associated with: dental disorders, 
hypertension, gallstones and breast cancer 
IV 
 
Level of evidence (based on the Oxford Centre for Evidence Based Medicine Level of 
evidence guide (Phillips et al., 2009) - Ia – systematic reviews (SR) of RCTs with 
homogeneity. Ib- Individual RCT with narrow confidence interval and >80% follow up. IIa- 
systematic reviews of cohort studies with homogeneity. IIb- low quality RCTs and large 
cohort studies. III- SR of case control studies with homogeneity or individual case control 
studies. IV- case series and poor cohort and case control studies. V- Expert opinion. 
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1.4 Dehydration and kidney function 
Adequate kidney function and filtration are maintained through tightly controlled 
homeostatic mechanisms.  Dehydration when severe can result in hypovolaemia 
and therefore, hypoperfusion, which can result in renal cell injury and death. This 
results in decreased urine output and the accumulation of urea and creatinine, 
the syndrome of AKI. Many definitions and classifications of AKI exist, the most 
popular of which were the Risk, Injury, Failure, Loss of kidney function, and End-
stage kidney disease (RIFLE) and Acute Kidney Injury Network (AKIN) 
classifications (Table 4) (Lopes, 2013). More recently the Kidney Disease 
Improving Global Outcomes (KDIGO) guidelines have been adopted as the 
international standard by which AKI is defined and managed (Khawaja, 2012).  
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Table 4: Acute kidney injury (AKI) stage and severity definitions according to 
Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease (RIFLE), 
Acute Kidney Injury Network (AKIN) and Kidney Disease Improving Global 
Outcomes (KDIGO) classifications. 
 Stage/Severity Serum creatinine criteria Urine output 
R
IF
LE
 c
la
ss
if
ic
at
io
n
 
Risk 
Increase in SCr by 1.5-fold or 
decrease in GFR >25% 
<0.5 ml/kg/hour for 
6 hours 
Injury 
Increase in SCr by 2-fold or 
decrease in GFR >50% 
<0.5 ml/kg/hour for 
12 hours 
Failure 
Increase in SCr by 3-fold or 
decrease in GFR >75% or if 
baseline SCr ≥353.6 μmol/l, 
increase >44.2 μmol/l 
<0.3 ml/kg/hour for 
24 h or anuria for 12 
hours 
Loss of kidney 
function 
Complete loss of kidney function 
for >4 weeks 
- 
End-stage kidney 
disease 
End stage kidney disease for >3 
months 
- 
A
K
IN
 c
la
ss
if
ic
at
io
n
 
1 
Increase in SCr ≥26.4 μmol/l or 
Increase in SCr ≥150% to 200% 
(1.5- to 2-fold) 
<0.5 ml/kg/hour for 
> 6 hours 
2 
Increase in SCr >200% to 300% 
(>2- to 3-fold) 
<0.5 ml/kg/hour for 
>12 hours 
3* 
Increase in SCr >300% (>3-fold) 
or if baseline SCr ≥353.6 μmol/l, 
increase ≥44.2 μmol/l 
<0.3 ml/kg/hour for 
≥24 hours or anuria 
for ≥12 hours 
K
D
IG
O
 c
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ss
if
ic
at
io
n
 
1 
Increase in SCr ≥26.5 μmol/l or 
Increase in SCr by 1.5 to 1.9-fold 
<0.5 ml/kg/hour for 
> 6 hours 
2 Increase in SCr 2- to 2.9-fold 
<0.5 ml/kg/hour for 
>12 hours 
3 
Increase in SCr 3-fold or increase 
in SCr to ≥353.6 μmol/l or 
initiation of renal replacement 
therapy 
<0.3 ml/kg/hour for 
≥24 hours or anuria 
for ≥12 hours 
GFR, glomerular filtration rate; SCr, serum creatinine. 
*
Stage 3 also includes patients that are 
requiring renal replacement therapy, independent of the stage of kidney injury. AKIN and 
guidelines require abrupt change within 48 hours and should be considered after adequate 
resuscitation and excluding easily reversible causes of reduced urine output, such as obstruction 
(AKIN). Whilst RIFLE guidelines require changes in serum creatinine from baseline over 1 to 7 days 
(Bellomo, 2004). KIDGO guidelines require increase in SCr ≥26.5 μmol/l within 48 hours of baseline 
or by 1.5-fold within 7 days of baseline (KDIGO, 2012) 
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Whilst most agree that severe dehydration that results in hypovolaemia is a 
significant risk factor for AKI, there is disagreement as to the effect of less severe 
dehydration on kidney function. However, there is evidence linking mild 
dehydration to kidney impairment. Dehydration resulting in increased serum 
osmolality by as little as 1% stimulates the release of ADH, increasing water 
reabsorption in the kidney. ADH also results in peripheral vasoconstriction and 
renal blood flow redistribution which may lead to progression of existing chronic 
kidney disease (CKD), a progressive condition that leads to fibrosis and scarring of 
the kidney (Bolignano et al., 2010). It is also proposed that maintaining a state of 
euhydration reduces plasma ADH and therefore protects against renal damage. 
Studies looking into the role of increased fluid intake and CKD are inconsistent. 
Some researchers have also reported a protective role of increased urine output 
on the rate of decline in estimated glomerular filtration rate (Clark et al., 2011). 
Strippoli et al., 2011 also demonstrated an inverse relationship between water 
intake and the risk of developing CKD, with those consuming 3.2 l of fluid a day 
being at lower risk than those who consumed 1.8 l/day (odds ratio [OR], 0.5; 95% 
confidence interval [CI], 0.32–0.77). However, other researchers have reported 
increased renal function loss with increased urine volume production in 
individuals with established CKD (Herber et al., 2003, Torres et al., 2009). 
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In the case of AKI, there are no studies that have investigated the effects of 
dehydration that is not associated with hypovolaemia, on kidney function in the 
acute phase.   
1.5 Dehydration and cognitive function 
Studies investigating the effects of hydration on mood have reported adverse 
effects associated with dehydration. Mild dehydration of as little as 1.4% of body 
weight can result in degraded mood, increased perception of task difficulty, and 
reduced ability to concentrate (Armstrong et al., 2012, Wilson and Morley, 2003, 
Shirreffs et al., 2004). Increased subjective feelings of fatigue, headache, tension, 
anxiety and deterioration in cognitive performance, including short-term memory 
impairment, have also been associated with modest restriction of fluid intake 
(Cian et al., 2000, Shirreffs et al., 2004). Dehydration may also result in increased 
errors of visual vigilance as well as reduced latency of visual working memory 
response (Ganio et al., 2011). Dehydration when severe can lead to 
hypovolaemia and in extreme cases, cerebral hypo-perfusion. Parallels can be 
drawn with the clinical features associated with haemorrhagic hypovolemic 
shock, where intravascular volume loss of 800 to 1500 ml can result in anxiety or 
aggression, and >2000 ml intravascular volume loss can result in confusion and 
loss of consciousness (Baskett, 1990). However, dehydration of this severity and 
magnitude is uncommon and the link between more mild dehydration and 
cognitive impairment is far from conclusive (Beecher and Simeone, 1947).  
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Hyperosmolality associated with dehydration has also been shown to result in 
morphological changes within the brain as a result of water movement out of 
cells down an osmotic gradient (Clark et al., 2012, Lane et al., 2002). Studies have 
reported increased ventricular volume, inversely proportional to changes in body 
weight associated with acute dehydration (Kempton et al., 2009, Dickson et al., 
2005), which were reversible with rehydration (Laederach-Hofmann et al., 1999).  
These changes did not impact on cognition using the Tower of London task, 
although, functional brain changes were demonstrated in subjects dehydrated by 
2% of body weight (Kempton et al., 2009). These changes were comparable to 
morphological brain changes reported in patients with early Alzheimer’s disease 
associated with mild cognitive impairment (Hocking et al., 2001).  
Several studies have investigated the effect of rehydration on cognitive function, 
demonstrating improvement in subjective alertness following rehydration of 
dehydrated subjects (Neave et al., 2001), with the degree of improvement 
related to the severity of the thirst perception (Rogers et al., 2001). Studies in 
children have also supported these findings, showing significant differences in 
cognitive performance in well-hydrated children that drink supplementary water, 
in particular short-term memory and visual attention showed significant 
improvements (Edmonds and Burford, 2009).  
In older adults, cognitive impairment is a risk factor for dehydration (Mentes, 
2006, El-Sharkawy et al., 2014, El-Sharkawy et al., 2015a). People with dementia 
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can forget to drink which may lead to dehydration and further cognitive decline. 
However, there are few clinical studies that investigate the impact of dehydration 
in this group despite the potential for increased risk. Dehydration has been 
reported to cause delirium, a state of acute confusion (Seymour et al., 1980, 
Voyer et al., 2009) which is reversed by water consumption in long-term care 
residents (Voyer et al., 2009). However, this association between dehydration 
and delirium reversibility was not shown in cancer patients (Lawlor et al., 2000). 
In keeping with some of the evidence, national guidelines recommend adequate 
hydration in patients with delirium. 
1.6 Diagnosing dehydration  
Clinical detection of electrolyte abnormalities and dehydration is challenging, 
particularly in older adults, partly due to difficulties in recognising the clinical 
signs and symptoms of dehydration. This, coupled with limited knowledge by 
frontline staff and the difficulty in monitoring and managing fluid balance are also 
contributing factors (Woodrow, 2002), which can result in morbidity and even 
mortality.  
 Clinical and bedside tools 1.6.1
Clinical skills, the ability to elicit clinically relevant information from talking to and 
examining patients is arguably one of the most important and valued bedside 
tools available. These tools have been utilised for centuries as an effective way to 
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diagnose and monitor patients and disease. However, inter-observer variations 
are inevitable as many clinical signs are poorly defined and a number of variations 
exist in the methods of assessment and quantification. In addition, inadequate 
techniques and clinician bias, where a clinician may interpret the presence of a 
sign to fit clinical suspicion based on expectation rather than fact, are not 
uncommon. 
1.6.1.1 Clinical history 
The clinical history is of particular relevance when considering acute changes in 
fluid status, allowing the clinician to stratify some of the risk factors that may 
affect fluid status, for example, a patient prescribed diuretics is at increased risk 
of dehydration if they develop diarrhoea and vomiting. 
The accuracy of the medical history however, can be limited by various factors 
including patient understanding of the question as well as clinician interpretation 
of the answer. Some patients are not always aware of their medical history or 
medication intake whilst others may not be able to understand or communicate 
answers to key questions. Furthermore, the medical history even if 
comprehensive and accurate does not easily allow the quantification of the fluid 
status beyond the state of dehydration or fluid overload. Other limitations 
include lack of specificity for example, the sensation of thirst may be a feature of 
dehydration, however, the ageing process is associated with a blunted thirst 
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response and hence thirst may be a late feature of dehydration in older adults 
(Phillips et al., 1984a, Phillips et al., 1984b).  
1.6.1.2 Clinical examination 
Clinical examination complements the clinical history and provides non-invasive, 
reproducible and sometimes quantifiable parameters that can allow effective 
assessment as well as monitoring of hydration status and fluid balance. 
Moreover, it provides the tools which can be used to assess the impact of fluid 
status on various organs. However, changes in fluid balance that result in 
clinically detectable signs often suggest significant changes in volume status.  
1.6.1.2.1 Pulse rate 
Increased pulse rate (PR), tachycardia [PR >100 beats per minute (bpm)] can 
occur as a result of hypovolaemia. In isolation tachycardia is a non-specific 
measurement that can occur physiologically such as with exercise. However, in 
the context of volume loss/dehydration tachycardia may indicate hypovolaemia, 
equivalent to 15% blood loss (Baskett, 1990). Postural tachycardia, an increase in 
PR from supine to a standing state may be an earlier manifestation of 
hypovolaemia (Raj, 2006). In healthy individuals, there is a physiological response 
that results in increased cardiac output, heart rate and vascular resistance that 
compensates for a shift of up to 600 ml of blood to the lower limbs on standing 
(Smit et al., 1999). These compensatory mechanisms maintain the systolic BP; 
although, an increase in PR by >30 bpm is thought to be pathological (Raj, 2006). 
 39 
However, postural tachycardia may be a manifestation of autonomic 
dysregulation, common in the older adult population as well as those with 
diabetes, and may give a false change in PR despite normal volume status 
(Laederach-Hofmann et al., 1999). 
Using PR to assess and monitor hydration status is limited because most of the 
current evidence is derived from studies investigating acute haemorrhage. 
Therefore, it may not accurately translate to dehydration-induced volume loss. 
Moreover, it is a late feature of dehydration as significant volume loss is required 
before a change is detected. Furthermore, it may be blunted or inhibited by drugs 
such as beta blockers. It is important to note that tachycardia is not specific to 
hypovolaemia as it often occurs as a result of physiological stress, a manifestation 
of many disease processes. Cardiogenic shock following fluid overload can also 
cause tachycardia and hypotension. If this is treated as hypovolaemic shock, it 
may be detrimental and in severe cases can be fatal. 
1.6.1.2.2 Blood pressure  
As with PR, BP measurements also form part of clinical guidelines that are used to 
diagnose, quantify and monitor hypovolaemia. However, this clinical 
measurement needs to be considered in the clinical context (Baskett, 1990).  
BP can be used to calculate the pulse pressure, a measure of the pressure 
difference between the systolic and diastolic pressure (Convertino et al., 2006), a 
more sensitive marker of hypovolaemia than systolic or diastolic BP alone. The 
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mean arterial pressure (MAP), considered to be a measure of the organ perfusion 
pressure, can also be estimated from systolic and diastolic pressure measures 
2×(𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑖𝑐 + 𝑠𝑦𝑠𝑡𝑜𝑙𝑖𝑐 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒)
3
 (Razminia et al., 2004). However, a 15% drop in 
circulatory volume is required before any clinically meaningful differences are 
detected (Baskett, 1990).  
Orthostatic hypotension (OH) is a measure of supine and standing BP, and is 
arguably the most sensitive BP measure of changes in volume status. However, 
orthostatic changes in BP occur with autonomic dysfunction, and it is not always 
possible to measure OH as some patients are not able to stand. Significant drops 
in systolic BP have also been reported in healthy young volunteers (McGee et al., 
1999).  
Limitations affecting the accuracy of BP to assess hydration status are similar to 
those reported with PR. In addition, the accuracy of BP readings may be affected 
by diseased arteries and is also operator dependent (Lane et al., 2002, Clark et 
al., 2012). Measurements done by different people using opposite arms may 
report significant discrepancies in readings, reported to be up to 10 mmHg 
between both arms in normal healthy subjects (Lane et al., 2002). Furthermore, 
commonly used ambulatory BP monitors report inaccurate BP readings in the 
context of pulse abnormalities such as atrial fibrillation (Stergiou et al., 2013, 
Stergiou et al., 2012, Cheng et al., 2013).  
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1.6.1.2.3 Capillary refill time  
Capillary refill time (CRT) is a measure of the time taken for the colour of the skin 
to return to normal after pressure is applied for five seconds to cause blanching. 
This is often performed on the patient’s finger (peripheral CRT) or chest (central 
CRT) at heart level and at room temperature. CRT depends on the assumption 
that perfusion in the distal capillary bed will be impaired with hypovolaemia and 
therefore result in prolonged CRT (Anderson et al., 2008). Although initially CRT 
was classified as normal, slowing and very sluggish (Beecher and Simeone, 1947), 
modern interpretations of this clinical examination tool advise that two seconds 
is the upper limit of normal for CRT. There is some evidence supporting the 
accuracy of CRT to assess for hypovolaemia (Saavedra et al., 1991), however, the 
clinical evidence supporting this cut off for CRT is debated in the literature. 
Furthermore, CRT is affected by many environmental and patient factors 
including; low room temperature and lighting (Gorelick et al., 1993) and 
increased age results in increased CRT with wide variations reported including an 
increase of 3.3% in CRT per decade (Frank, 2006, Schriger and Baraff, 1988, 
Anderson et al., 2008). However, in recent years the development of electronic 
probes to digitally measure CRT using photoplethysmographic (PPG) sensors have 
demonstrated promising results, although such devices are not yet fully clinically 
integrated (Shavit et al., 2006, Lima and Bakker, 2005). 
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1.6.1.3  Changes in body mass  
Acute changes in body mass over a short period of time are thought to represent 
changes in fluid balance given that one millilitre of water equates to one gram in 
weight, and that acute changes in TBM usually represent changes in fluid status 
as no other body constituent is lost at such a rate. Serial body mass 
measurements can be an easy, safe and clinically effective way of measuring 
changes in fluid balance and as such is often used as a gold standard in many 
studies investigating hydration. A randomised double-blinded trial investigated 
two different commonly used intravenous fluids in healthy male volunteers 
(Chowdhury et al., 2012). Weight measurements and serum biochemistry were 
measured at regular intervals over a period of four hours after they were infused 
with 1.5 l of the fluids over one hour period. The authors reported a clear 
increase in weight by approximately 1.5 kg just after the infusion with an 
associated increase in blood volume and extracellular fluid (Chowdhury et al., 
2012). Furthermore, they demonstrated a reduction in weight over the 
observation period which corresponded with reduction in blood volume and 
extracellular fluid (Chowdhury et al., 2012).  
However, the use of changes in body mass to assess and monitor hydration status 
are limited by the fact that it only measures overall balance and not inter-
compartmental shifts and large volumes of ECF may be pooled in the gut and 
therefore be functionally inert. Moreover, when measuring changes in body mass 
over days one must account for the daily fluctuations of approximately 0.5 kg 
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(Cheuvront et al., 2004). Nonetheless, when assessing the clinical effectiveness of 
a treatment for fluid overload, a general trend showing reduction in weight that 
correlates with improving symptoms is sufficient. Serial measures of body weight 
and changes in body mass requires identical conditions each time a patient is 
weighed and may be affected by the clothes a patient is wearing, time in relation 
to meals as well as bowel and bladder functions. Therefore, it can be difficult to 
accurately measure in a busy and stressful clinical environment. Other factors 
that impact on the feasibility and accuracy of using changes in body mass to 
assess fluid balance include lack of infrastructure and tools to weigh immobile 
and critically ill patients. 
1.6.1.3.1 Other clinical manifestations of hydration status 
Dry mucous membranes, sunken eyes, and reduced skin turgor are widely 
reported in association with dehydration (McGee et al., 1999). Skin turgor is often 
used as a useful clinical aid to help diagnose dehydration. It involves grasping the 
skin for approximately three seconds, usually on the back of the hand or forearm 
and assessing the elasticity of the skin by measuring how quickly it returns to 
normal (Chassagne et al., 2006). However, this has proven to be an inaccurate 
measure particularly in the elderly due to age-related changes in skin structure 
such as loss of elastin (Shuster et al., 1975). Similarly, other age-related changes 
such as loss of fat (Larrabee Jr and Caro, 1984) and mouth breathing make 
sunken eyes and dry mucous membranes an unreliable measure of hydration in 
the elderly.  
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Axillary sweat measurements have also been used to assess hydration status with 
varying success in clinical studies. Dry axilla was reported to be 50% sensitive and 
82% specific with a diagnostic likelihood ratio of 2.8 at diagnosing dehydration 
(Eaton et al., 1994). However, this is a very difficult measure to do accurately in 
routine clinical practice. 
Passive leg raise is another method that can be used to assess for volume 
depletion. This method involves raising the legs of a supine patient to 45° with 
some evidence to suggest that starting the procedure from a semi-recumbent 
position before laying the patient supine, then raising the legs is more sensitive at 
detecting hypovolaemia. This increases the volume of blood return to the heart, 
effectively resulting in transient increase in the preload whilst the legs are 
elevated and has been reported to be equivalent to 300 ml intravenous fluid 
challenge with colloids (Rutlen et al., 1981, Wong et al., 1988, Boulain et al., 
2002). Cardiac output or stroke volume is measured usually using an oesophageal 
Doppler probe just before and then just after the manoeuvre with an increase in 
more than 10-15% thought to be significant (De Backer, 2006). A hypovolaemic 
patient would be positioned on the steep part of Starling’s curve and the passive 
leg raise would result in increased preload which results in increased cardiac 
output as has been described by Frank Starling. However, in a euvolemic patient 
or indeed one that is fluid overloaded the patient would be positioned on the flat 
part of Starling’s curve and therefore further increase in preload is not associated 
with an increase in cardiac output. Knowing this is of clinical importance in order 
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to avoid administering fluids to patients who are already overloaded, particularly 
those with pre-existing cardiac or respiratory impairment. However, this test is 
not readily available as it requires access to expensive devices to measure cardiac 
output. Furthermore, it is contraindicated in patients with head injury as it may 
raise the intracranial pressure and can also be difficult to perform in the 
perioperative period. Other similar methods that monitor changes in stroke 
volume with respiration operate using the same underlying principle. However, 
they cannot be used in patients who are spontaneously breathing (not 
mechanically ventilated) and those with arrhythmias (Monnet and Teboul, 2008, 
Monnet et al., 2005).  
 Urine measures of hydration 1.6.2
1.6.2.1 Urine output 
Urine output is considered by many to be one of the most accurate measures of 
fluid balance particularly over a 24-hour period, dependent on normal renal 
function. Low urine output can be an early sign of dehydration, however, in 
severe cases may result in oliguria (hourly urine output <0.5 ml/kg/hr), a 
recognised feature of AKI (Bellomo et al., 2012, Cuhaci, 2009). The most common 
cause of oliguria is renal hypo-perfusion that results from a pre-renal pathology 
as a consequence of hypovolaemia (Cerda, 2011). However, urine output does 
not always reflect hydration status as physiological oliguria may occur in the 
immediate postoperative stage in normovolaemic patients and polyuria may 
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occur post AKI (Short and Cumming, 1999). The sensitivity and specificity or urine 
output may be affected by diuretic use. Moreover, the absorption of water 
following the rapid ingestion of large volumes stimulates the production of large 
quantities of dilute urine even before equilibrium between the intra and 
extracellular compartments has occurred (Maresh, 1998). This occurs as a result 
of protective mechanisms against fluid overload, even in a state of dehydration. 
This mechanism means that urine volume and other urine markers of hydration 
might not always be representative of the hydration status (Maresh, 1998, Kovacs 
et al., 1999, Popowski et al., 2001). Furthermore, the accuracy and reproducibility 
of urine output as a measure of hydration status is challenging in the clinical 
setting due to difficulties collecting and measuring urine output in patients who 
are not catheterised and those that suffer from incontinence or cognitive 
impairment. In addition, inherent errors in recording and calculating urine output 
in a busy clinical environment are not uncommon. 
Other urinary parameters such as urine colour have been used with varying 
degrees of accuracy, where light coloured urine indicates a hydrated state and 
dark coloured urine represents a dehydrated state, owing to the differences in 
water excreted relative to solutes (Kovacs et al., 1999, Armstrong et al., 1994). 
However, urine colour may be influenced by the volume of fluid consumed rather 
than the state of hydration. Additionally, some drugs such as rifampicin cause 
urine discolouration (orange-coloured urine) and may falsely suggest 
dehydration. 
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1.6.2.2 Urinary osmolality  
Urine osmolality reflects the solute to water concentration in the urine and is 
measured using a freezing point depression. Osmometers measure the amount of 
osmoles of solute particles per kilogram of solution, where a solution with more 
solute has a lower freezing point than a less concentrated solution (Sweeney and 
Beuchat, 1993). Dehydration results in water reabsorption from the collecting 
tubules through aquaporin channels and hence, increased urine osmolality. 
However, urine osmolality is dependent on normal kidney function and is 
affected by factors that influence renal solute excretion or water reabsorption, 
such as in the case of SIADH which results in increased aquaporin channels and 
water reabsorption thus resulting in concentrated urine. Conversely, low urine 
osmolality may result as a consequence of low urinary sodium excretion due to 
renal hypo-perfusion and activation of the RAAS, serum hyponatraemia or injury 
(Goh, 2004).  
It is also important to consider that urine osmolality often represents the 
osmolality of all urine stored in the bladder between the last void and when the 
sample was taken and thus may not be an accurate measure of the hydration 
status at the time of measurement. Urine osmolality may also be influenced by 
large variations in dietary salt and water consumption (Armstrong et al., 2007, 
Manz et al., 2003)  
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1.6.2.3 Urinary specific gravity 
Urine specific gravity (SG) is a measure of urine density relative to pure water and 
increases urine solute concentration, similar to urine osmolality. Urine SG can be 
easily measured at the bedside using a hand held refractometer or urine dipstick 
testing, although studies have reported varying degrees of correlation with urine 
osmolality (Voinescu et al., 2002). The accuracy of urine SG is affected by factors 
that affect urine osmolality, but also depends on the method used to measure it. 
Measurements with a refractometer have proven to be more accurate than 
dipstick testing which can be more subjective (Kovacs et al., 1999, Stuempfle and 
Drury, 2003).  
 Serum biomarkers 1.6.3
Serum biomarkers and in particular osmolality are considered amongst the most 
reliable methods of assessing hydration status (Cheuvront and Sawka, 2005, 
Sawka et al., 2005, Bhalla et al., 2000, Sollanek et al., 2011, Cheuvront et al., 
2013, Cheuvront et al., 2010, Stookey et al., 2005). Furthermore, they also 
provide a reliable measure of changes in kidney function which can occur in the 
context of severe dehydration that results in hypovolaemia and renal 
hypoperfusion. However, it is important to note that there are many other causes 
of AKI (Table 5). 
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Table 5: Common causes of acute kidney injury 
 
Currently, many clinicians rely on changes in serum urea and creatinine 
independently and in combination (urea:creatinine ratio) to aid the assessment 
of hydration status and fluid balance. However, changes in creatinine and urea 
are not sensitive to small changes in hydration status, and are features of AKI 
(Sandhofer et al., 2002, Khwaja, 2012). Moreover, there is evidence suggesting 
that changes in creatinine may lag several days behind actual changes in GFR 
(Moran and Myers, 1985, Star, 1998). In addition, creatinine production and 
excretion is affected by various factors such as age, muscle mass and medication, 
resulting in under or over estimation of kidney function. Raised creatinine 
Prerenal causes (Hypoperfusion) 
- Volume loss e.g. dehydration, haemorrhage  
- Drugs e.g. diuretics, angiotensin-converting enzyme inhibitors  
- Circulatory failure e.g. shock, cardiac arrhythmia, arterial 
stenosis/occlusion  
- Sepsis 
Intrinsic causes (tissue injury) 
- Infection 
- Drugs e.g. non-steroidal anti-inflammatory drugs 
- Autoimmune disease e.g. vasculitis  
- Ischaemia e.g. acute tubular necrosis post hypoperfusion 
- Prolonged prerenal cause 
Post renal (obstruction) 
- Renal tract calculus 
- Malignancy e.g. renal tract, pelvic (extrinsic compression) 
- Fibrosis e.g. post radiotherapy  
- Stricture e.g. urethral stricture post infection or surgery  
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following trauma or rhabdomyolysis does not necessarily indicate renal 
impairment and CKD can result in overestimation of kidney function due 
increased tubular secretion of creatinine (Lopes et al., 2012). Conversely, a small, 
underweight older patient may have a creatinine value within normal laboratory 
range but this does not rule out dehydration and associated kidney impairment, 
as an increase in serum creatinine by more than 26 µmol/l within 48 hours may 
be suggestive of AKI even if the creatinine value is within normal laboratory limits 
(Cuhaci, 2009). 
Serum urea concentrations can also be affected by many factors such as a high 
protein meals, GI bleed or even sepsis.  
Serum osmolality is the measure of osmolality in the ECF measured by freezing 
point depression and is the key regulated variable in fluid balance (Fitzsimons, 
1963, Thrasher et al., 1982, Stocker et al., 2006, Benarroch, 2005, Robertson et 
al., 1976, Mckinley et al., 1992). For a given solution such as plasma or other 
body fluids, osmolality (mOsmol/kg), is the number of osmotically active solutes 
per kilogram contributing to the solution’s osmotic pressure.  
An increase of as little as 1% in serum osmolality triggers physiological changes 
that result in the release of ADH and activation of the thirst centre (Fitzsimons, 
1963). Osmolarity, a calculated estimate of osmolality (mmol/l or mOsmol/l), is 
less than osmolality (mOsmol/kg), because the total solvent mass used in the 
expression of osmolarity excludes the mass of any solutes present.  
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Osmolality is considered by many to be the gold standard measure of hydration 
where serum osmolality of 297 mOsmol/kg was shown to be 90% sensitive and 
100% specific in young adults dehydrated in a hot environment to between 2% 
and 7% of body weight (Cheuvront et al., 2010). It can be used to assess 
hydration status at a set point as well as monitor hydration over time at any given 
time interval. Although, some argue that serum osmolality does not always 
accurately reflect TBW due to its tight regulation. This is because most of the 
supporting evidence is derived from controlled laboratory conditions and 
therefore may not be accurate in the clinical setting (Armstrong, 2007). 
Furthermore, in healthy young adults, serum osmolality may not correlate to 
their hydration status due to tightly regulated internal mechanisms (Armstrong, 
2007, Shirreffs, 2003). However, age-related pathophysiological changes in older 
adults impair their ability to maintain normal osmolality when dehydrated (El-
Sharkawy et al., 2014) 
 Despite the widespread use of serum osmolality to assess hydration status in a 
variety of human physiological research settings, it has not been fully adopted in 
the clinical setting. This is likely due to a combination of limited awareness, 
financial constraints as well as the lack of evidence demonstrating its 
effectiveness in the clinical setting.  
Haematological markers such as haemoglobin, haematocrit and plasma viscosity 
are used in clinical practice as a guide when assessing fluid status. However, 
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these can be affected by many disease processes such as anaemia, polycythaemia 
or inflammation and are notoriously unreliable.  
  Dilutional methods  1.6.4
Dilutional techniques have traditionally been viewed as the ‘gold standard’ 
method of measuring extracellular and TBW. These techniques are based on the 
assumption that stable isotopes such as deuterium oxide are distributed equally 
across all fluid compartments. Dilutional methods usually involve intravenous 
administration or oral ingestion of a tracer substance after collection of baseline 
serum or urine samples. Repeated sampling of the serum and urine is then 
performed after the administrated substance has distributed throughout the fluid 
compartment which usually occurs within four hours. Knowing the quantity of the 
administered substance, the baseline measurements and repeated 
measurements allow the calculation of dilution and therefore the distribution, 
which directly relates to the size of the fluid compartment. Deuterium and 
deuterium oxide are amongst the most commonly used stable isotopes of 
hydrogen used to measure TBW. Bromide ingested orally or administered 
intravenously, is the most commonly used method of measuring the volume of 
the ECF compartment. ICF volume can then be calculated by subtracting the ECF 
volume from the TBW. However, this technique is based on the assumption that 
deuterium distributes equally throughout all the compartments. This has not 
been verified, as direct sampling of all the fluid compartments is not possible.  
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Although these methods have proved to be accurate and reproducible, their use 
is currently limited to laboratory settings. Key to the accuracy of these methods is 
the timing, for example deuterium requires sufficient time to distribute and reach 
equilibrium across all the fluid compartments. Changes in fluid status in clinical 
practice can sometimes be rapid and at times require an immediate intervention. 
This limits the use of these dilutional techniques in a significant proportion of 
clinical scenarios, arguably in situations where accurate assessment of fluid status 
is most needed. Moreover, these techniques are also costly, invasive and time 
consuming and cannot be repeated in patients to monitor treatment progress.  
  Bioelectrical impedance 1.6.5
Multi frequency bioelectrical impedance (BIA) technology utilises a range of 
frequencies from 5 to 500 kHz in order to measure resistance and conductivity of 
the tissue planes. It assumes that the resistivity is constant in the human body 
and that the volume of fluid is homogeneously distributed across uniform cross 
sections like a cylinder (Vaisman et al., 1987, Frank, 2006).  
BIA measurements involve the placement of two electrodes, on the right hand 
and foot while the subject is in a supine position. The electrodes are then 
connected to a small handheld device that transmits a small electrical current at 
various frequencies and measures the resistance and reactance of the current. 
The body composition is then calculated using validated algorithms that have 
been developed using regression equations and measurements from large study 
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populations (Kyle et al., 2004a). Low-frequency currents cannot penetrate the cell 
membrane and therefore are used as a proxy measure of ECF volume. High-
frequency currents on the other hand, cross all compartments including the cell 
membrane and therefore give an estimation of the TBW (Figure 6) (Kyle et al., 
2004a). ICF volume is then calculated based on simple subtraction of ECF volume 
from TBW volume. TBW measured by BIA has been validated using ‘gold 
standard’ dilutional techniques such deuterium and show good correlation. 
Furthermore reference values have been developed for healthy male and female 
volunteers as well as the elderly (Kyle et al., 2004b, Armstrong, 2005).  
Bioelectrical impedance has proven a popular research tool because it is a non-
invasive, safe, quick and relatively inexpensive method of measuring body 
composition. It is also used in clinical practice to measure and monitor fluid 
status in dialysis patients. However, the accuracy and reproducibility is affected 
by several environmental and host factors including ambient temperature, 
electrode placement and the fluid consumed (Table 6).  
A study investigating the physiological effects of saline and dextrose in healthy 
volunteers, demonstrated that despite giving equal volumes of fluid 
intravenously, BIA reported a drop in ECF volume and TBW with intravenous 5% 
dextrose, and an increase in TBW and ECF volume with 0.9% saline infusion 
(Dileep et al., 2001). This is because BIA measurements are independently 
affected by water and electrolytes and therefore may not be a reliable measure 
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(Roos et al., 1992). Furthermore, the arms and legs account for the majority of 
the impedance generated, the trunk only accounts for up to 12% of the 
impedance despite accounting for approximately 50% of the body mass (Kushner, 
1992). Therefore, large changes in water content of the trunk such in the case of 
ascites will not represent a significant change in impedance whereas small 
changes in limb fluid content such as in peripheral oedema, exerts much more 
significant changes. 
These factors individually and in combination limit the clinical application of BIA 
as a reliable tool, given the difficulties in guaranteeing standardised and 
reproducible conditions in routine clinical practice.  
Table 6: Factors that influence bioelectrical impedance accuracy and 
reproducibility 
 Ambient temperature  
 Electrode placement 
 Electrical current flow through the body 
 Resistance by tissue and water 
 Utilised to provide estimates of body water and body composition  
 Electrode site placement 
 Skin temperature and blood flow 
 Peripheral oedema 
 Posture and movement 
 Composition and tonicity of recently ingested fluids 
 Changes in plasma sodium concentration and plasma osmolality 
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Figure 6: Schematic representation of mechanism underlying BIA. High-frequency 
currents pass through all the fluid compartments and give an estimation of the 
TBW. Low-frequency currents cannot penetrate the cell membrane and is used as 
a proxy measure of extracellular water. Intercellular fluid volume is then 
calculated by subtraction of extracellular fluid volume from total body water 
volume.
Low frequency         
current 
 
 
High frequency 
current 
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Figure 7: Figure from Lobo et al., 2001 demonstrating that despite giving equal volumes of saline and dextrose infusions, impedance 
measures implied significant differences in the body fluid volume. Bioelectrical impedance measures demonstrated increase in body 
fluid with saline and reduction with dextrose compared with time 0. Figure reproduced with permission from publishers.
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 Invasive monitoring  1.6.6
Central venous pressure (CVP) monitoring is considered to be a direct measure of 
the BP in the right atrium and vena cava. A probe at the tip of a catheter is 
threaded through to sit in the lower two-thirds of the superior vena cava. CVP 
can be helpful for goal directed fluid therapy where low CVP usually indicates 
hypovolaemia and the response to fluid can be assessed. It is particularly useful in 
patients who are peripherally oedematous and those with heart failure to allow 
better assessment and management of fluid balance. This advanced technique 
requires specialist equipment and experienced clinicians to place and interpret 
the results (Magder, 2006).  
Oesophageal Doppler monitoring uses the technique of goal directed fluid 
therapy and measures the impact of fluid bolus on stroke volume. It is frequently 
used in the intraoperative period to help manage fluid balance by infusion of 250 
to 300 ml of fluid and measuring the impact on stroke volume by measuring 
blood flow in the descending aorta. These waveforms generated are then 
displayed on the monitor which provides measurements for cardiac parameters 
such as flow time, stroke volume, and cardiac index. If this increases by >10% the 
bolus is repeated until there is little change in the stroke volume. Although this 
technique has helped revolutionise intraoperative fluid management, it requires 
expensive technology and a degree of sophisticated technical ability to place the 
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probe and interpret the results (Conway et al., 2002, Abbas and Hill, 2008). 
Moreover, it would be poorly tolerated by patients who are not anaesthetised.  
1.7 Hospital care and hydration 
Physiological stress associated with hospitalisation can result in deterioration in 
fluid imbalance, particularly in vulnerable groups including older adults. Older 
adults are particularly vulnerable to dehydration often due to HCPs experiencing 
difficulty in assessing and recognising dehydration despite numerous available 
tools.  
A report by the Royal College of Nursing in 2007 suggested that 46% of nurses say 
there are not enough staff to ensure patients get the help they need to eat and 
drink (Nursing, 2007). Studies have shown that HCPs, especially nurses and 
healthcare assistants do not have sufficient knowledge surrounding hydration; 
this can be a particular problem when identifying patients at risk (Leach et al., 
2013).  
Patients may also be at higher risk of dehydration due to accessibility of fluids. 
Those with limited to no mobility cannot reach to pour themselves a drink 
regardless of whether there is fresh water on their table. Due to pressure area 
care and the implementation of turn charts, patients are often positioned where 
they may be unable to reach the fluid (Kayser-Jones et al., 1999).  
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1.8 Hydration in health care workers 
Working as frontline medical and nursing staff is highly demading and requires 
optimum physical and mental function in order to perform at the highest 
standards expected of these professionals. Solomon et al., 2010 first investigated 
dehydration in UK doctors and suggested that a significant proportion may be 
dehydrated based on urine output. However, it is important to note that this 
study, published in the Christmas BMJ was aimed at criticising poor research 
design and therefore had significant limitations. 
The effect of dehydration on cognitive function highlights the importance of 
maintaining optimal hydration status as this may affect clinical decision making 
and potentially influence patient outcome. This is of particular relevance in HCPs 
working night shifts which are independently associated with cognitive 
impairment (Dula et al., 2001). The cognitive performance of 16 emergency 
physicians following five, eight- hour night shifts was investigated in a cross-over 
study (Dula et al., 2001). Using the Fluid Scale of the Kaufman Adolescent and 
Adult Intelligence Test, the authors reported a substantial decline in cognitive 
performance. Others have reported similar findings in 13 emergency physicians 
using Southern California Repeatable Episodic Memory Test (REMT), showing that 
significantly fewer words were recalled by the emergency physicians on the REMT 
after both day and night shifts (Machi et al., 2012). Such effects could be 
worsened by dehydration-induced cognitive impairment, a likely risk during busy 
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night shifts which could have serious consequences for both staff and patient 
safety. 
This supports the need to identify and highlight dehydration in medical staff, 
which could allow the development of intervention strategies that may help 
improve working conditions and more importantly enhance patient safety.   
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 Hypothesis  2.
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I hypothesised that a significant proportion of healthcare professionals would be 
dehydrated at the end of their shift and this would impair subjective feelings and 
cognitive function. 
I hypothesised that the prevalence of hyperosmolar dehydration in hospitalised 
older adults would be significantly greater than clinically reported rates and 
would be associated with increased risk of acute kidney injury and poor clinical 
outcome.  
Equations based on biochemistry performed routinely are likely to provide an 
accurate and suitable alternative to measured serum osmolality at predicting 
hyperosmolar dehydration and would be useful as an early predictor of acute 
kidney injury and clinical outcome. 
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 Methodology 3.
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3.1 Approvals from regulatory bodies 
Approvals were obtained for all studies in line with regional and national 
guidelines. Chapter 4 was approved by the Nottingham 1 NHS Research Ethics 
committee, reference 12/EM/0454 and Chapter 5 was approved by the 
Northampton NHS Research Ethics committee, reference 12/EM/0152. Both 
studies were also registered on http://clinicaltrials.gov; reference NCT02230774 
& NCT01703715, respectively.  
Chapters 6-8 comprised of an analysis of a link-anonymised database, therefore 
the need for ethics permission was waived. However, the protocol was registered 
with and approved by the hospital audit office (Registration No. 13-099C). 
3.2 Ethics and Consent  
Informed written consent was obtained prior to recruitment of 
participants/patients to the study in Chapter 4 and 5. Proxy consent was sought 
for patients who lacked capacity in Chapter 4, in line with ethical 
recommendations. Chapters 6-8 comprised of an analysis of a link-anonymised 
retrospective database and the need for patient consent was waived. 
3.3 Eligibility and exclusion criteria 
Eligibility and exclusion criteria are detailed in each chapter. 
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3.4 Collection of blood samples  
Blood was sampled by venepuncture or using a venous cannula (Venflon®, 
Ohmeda, Sweden) into the appropriate Vacutainer® blood collection tube 
(Becton Dickinson & Co, UK).  
Blood sampled (Chapters 4 and 5) was sent and analysed by laboratory 
technicians at Nottingham University Hospital (NUH) NHS Trust clinical pathology 
laboratory accredited by Clinical Pathology Accreditation UK Ltd (reference 
number 2914). Analysis was performed for serum osmolality (by freezing point 
depression), serum concentrations of sodium, potassium, urea and creatinine 
(U&Es), estimated glomerular filtration rate (eGFR), and full blood count (FBC). 
Biochemical and haematological analyses were performed using validated 
methods previously reported, with an inter-assay coefficient variance of 0.6-4% 
(Reid et al., 2003).  
Hyperosmolar dehydration was defined as serum osmolality >300 mOsmol/kg 
and impending dehydration as 295-300 mOsmol/kg (Thomas et al., 2008). AKI 
was defined in accordance with RIFLE and AKIN guidelines widely accepted as the 
diagnostic benchmark at the time of the data collection (Cuhaci, 2009). Diagnosis 
and stage of AKI were retrieved from the hospitals AKI electronic-alert database 
and linked using the patients’ unique hospital number and date of admission 
(Porter et al., 2014). Details of the algorithm used for the alert have been 
published previously (Porter et al., 2014) (Table 7). 
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 Table 7: Details of the algorithm used for the acute kidney injury alert.  
 Stage Change in serum creatinine (SCr) from baseline* 
R
IF
LE
 c
la
ss
if
ic
at
io
n
 
Risk/stage 1 
Increase in SCr by 1.5-fold or decrease in GFR 
>25% 
Injury/stage 2 Increase in SCr by 2-fold or decrease in GFR >50% 
Failure/stage 3 
Increase in SCr by 3-fold or decrease in GFR >75% 
or if baseline SCr ≥353.6 μmol/l, increase >44.2 
μmol/l 
Loss of kidney 
function/stage 3 
Complete loss of kidney function for >4 weeks 
End-stage kidney 
disease/stage 3 
End stage kidney disease for >3 months 
A
K
IN
 
cl
as
si
fi
ca
ti
o
n
 
Stage 1 
Increase in SCr ≥26.4 μmol/l or Increase in SCr 
≥150% to 200% (1.5- to 2-fold) 
Stage 2 Increase in SCr >200% to 300% (>2- to 3-fold) 
Stage 3+ 
Increase in SCr >300% (>3-fold) or if baseline SCr 
≥353.6 μmol/l, increase ≥44.2 μmol/l 
GFR, glomerular filtration rate; SCr, serum creatinine. *Baseline Scr = The lowest serum 
creatinine between 7 to 365 days prior to admission. If unavailable, an estimated 
baseline using the modification of diet in renal disease equation based on- Estimated GFR 
(ml/min/1.73m2) = 186 x (SCr / 88.4)-1.154 x (Age)-0.203 x (0.742 if female) x (1.210 if black). 
+Stage 3 also includes patients that are requiring renal replacement therapy, independent 
of the stage of kidney injury.  
3.5 Collection of urine samples 
Urine was sampled (Chapters 4 and 5) and was analysed for osmolality by 
freezing point depression. Osmolality analysis for Chapter 4 was performed at the 
NUH NHS Trust clinical pathology laboratory by a technician. Osmolality analysis 
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for Chapter 5 was performed at the University of Loughborough Sports Science 
laboratory by a technician. 
3.6 Database data collection 
Prospective data was collected in line with the study protocol for Chapter 4 and 
5. Chapters 6- 8 used a retrospective database collated and populated by NUH 
staff and computer systems. The database was searched by a specialist data 
analyst who retrieved data that related to patients aged ≥65 admitted to medical 
specialties as an emergency between the 1 April 2011 and 31 October 2013.  
The trust changed the way dehydration was coded in March 2011 to comply with 
national guidelines defining dehydration coding and the study start date was 
chosen to ensure consistency.  
Each record represented an individual admission and contained patient 
identifiers and demographic information including: patient age and gender, the 
route and dates of admission. The database also contained up to 25 diagnoses 
related to the admission and comorbidity classified according to the International 
Classification of Disease (ICD-10) (World Health Organization, 2010). In addition, 
it also contained details of the dates of death for patients regardless of whether 
they had died in hospital or in the community up to 29th December 2014. Using 
these data, length of stay (LOS), in-hospital, 30, 90 and 365-day (one-year) post-
admission mortality were calculated. Date of death was retrieved from the 
hospital database and this was used to identify patients who had died as well as 
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time to death. LOS was calculated using date of hospital admission and discharge. 
Patients who died in hospital were excluded from the LOS analysis. 
The hospital’s database is updated and crosschecked with the National Summary 
Care Record system by the Data Quality team on a daily basis to ensure accuracy. 
Primary and secondary diagnoses relating to each admission are coded in 
accordance with the ICD-10 classification and uploaded onto the hospital 
database once patients are discharged from hospital or deceased. Regular 
internal audits are undertaken by a Health and Social Care Information Centre 
(HSCIC) accredited auditor to ensure quality control and external audits were 
undertaken by Caspe Healthcare Knowledge Systems (CHKS) 
(http://www.chks.co.uk) and overseen by Monitor 
(https://www.gov.uk/government/organisations/monitor). Both audits reported 
that the coding for the primary and secondary diagnoses were 96% and 93%-95% 
accurate, respectively. 
 Validation of database 3.6.1
The study team independently audited the accuracy and appropriateness of the 
clinical diagnosis of dehydration in Chapters 6 to 8 by reviewing a sample of 200 
written and electronic notes selected randomly. Further validation of a larger 
cohort was carried out using the serum biochemistry measured during the 
admission. Further biochemical validation was performed using osmolarity 
calculated using the equation developed by (Krahn and Khajuria, 2006), [1.86 x 
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(Na + K) + 1.15 x glucose + urea + 14], which has been shown to be up to 97% 
sensitive and 76% specific at diagnosing dehydration in older adults (Siervo et al., 
2014).  
 Covariates 3.6.2
Covariates including age, gender, comorbidities and illness severity were 
measured and used in statistical models to help account for potential 
confounders that can affect outcome.  
Gender was obtained from the hospitals database, other variables were 
calculated using the information retrieved. Age was calculated by subtracting the 
participant’s date of birth from the date they entered the study for Chapter 4 and 
5, or date of admission to hospital for the retrospective database studies, 
Chapters 6-8. Age was then categorised into four time periods each, 65 to 75, 76 
to 85, 86 to 95 and >95 years. 
To account for comorbidities the Charlson Comorbidity Index (CCI) score was 
calculated for all records utilising the scoring protocol developed by Charlson et 
al., 1987 and adapted to the ICD-10 coding system (Quan et al., 2005). CCI was 
calculated to include all the recorded diagnoses including the primary cause of 
admission which were coded after patients are discharged or deceased. This 
information was collected prospectively in Chapter 5 and was calculated in 
Chapter 6 and 8 using the retrospective database. 
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National Early Warning Score (NEWS) was calculated in accordance with 
published guidelines to account for the severity of illness using observations 
collected at admission (Chapter 5) and for a subset of patients who had 
electronically reported clinical observations at admission (Chapter 8) (Smith et al., 
2013).  
3.7 Statistical analysis  
Data analysis was performed using IBM® SPSS® Statistics version 22 (IBM® 
Corporation, Armonk, NY, USA) in Chapters 4 and 5 and Stata Statistical Software, 
StataCorp. 2013. Release 13. College Station, TX: StataCorp LP for Chapters 6 to 8. 
Continuous data was assessed for normality visually by viewing distribution plots 
and by using the Shapiro-Wilkes test. Normally distributed data was presented 
with means and standard deviations (SD) and Independent Samples t-test was 
used to assess for statistically significant differences. Non parametric data was 
presented as medians and interquartile ranges (Q1, Q3) and the Mann Whitney U 
or the Kruskal Wallis test when used to assess for statistically significant 
differences. Chi squared analysis was used to assess for statistically significant 
differences between categorical variables. P value <0.05 was considered 
statistically significant. 
Mortality analysis was performed for Chapters 5, 6 and 8. Risk estimates for 
mortality were assessed for in-hospital stay, and at 30, 90 days and one year after 
admission. Kaplan-Meier survival plots were generated to schematically 
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represent one-year survival stratified by hydration status. Cox regression 
modelling was used to provide unadjusted and adjusted hazard ratios (HR) as an 
approximation of risk of AKI in Chapter 8. Cox regression modelling was also used 
to assess unadjusted and adjusted hazard ratios (HR) as an approximation of risk 
of mortality in the presence of dehydration, adjustments were made for potential 
confounding factors. Explanatory variables (potential confounders) considered 
were age, gender and comorbidities (CCI) were considered in Chapters 5, 6 and 8. 
Illness severity (NEWS) was considered in Chapters 5 and 8, and frailty (CHSA) 
score and nutritional status (NRS 2002) in Chapter 5. In this analysis age-
unadjusted CCI scores were used in the cox analysis, with age categories 
investigated separately in keeping with previously validated methods (Charlson et 
al., 1987, Murray et al., 2006). 
3.8 Funding 
These studies were supported by funding from the European Hydration Institute, 
who had no role in the design or execution of the studies.   
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4.1 Introduction 
The demands of the medical and nursing professions require staff to work long 
and unsociable hours during both day and night shifts. Frontline staff working on 
medical and surgical admissions wards face daily challenges and require optimum 
physical and mental function in order to perform at the highest standards. Staff 
working in these often hot environments are also amongst the busiest and 
frequently deal with complex, unwell patients making it difficult to take regular 
breaks which may predispose to dehydration (Solomon et al., 2010, Alomar et al., 
2013).  
The available research suggests that physical and mental performance can be 
adversely affected by dehydration. Moreover, there is increasing evidence linking 
dehydration to cardiovascular, respiratory, gastrointestinal and urinary conditions 
(Manz, 2007, El-Sharkawy et al., 2015a). Dehydration of as little as 2% of total 
body weight may be detrimental to physical, visuomotor, psychomotor and 
cognitive performance (Adan, 2012, Grandjean and Grandjean, 2007). However, 
the link between dehydration and cognitive impairment is inconsistent, and some 
studies have failed to report significant impairment in cognition associated with 
dehydration (Lieberman, 2007, Lieberman, 2010).  
There is also evidence highlighting the importance of HCPs wellness to clinical 
care, with clinicians reporting that stress, tiredness and burnout may have 
contributed to the provision of suboptimal care (Firth-Cozens and Greenhalgh, 
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1997, Shanafelt et al., 2002). Others have gone further to suggest that the health 
and fitness of employees should be considered as important as patient care, 
highlighting it as a marker of organisational success and well-being (Alomar et al., 
2013, Wallace et al., 2009, Arnetz, 2005, Linzer et al., 2001). This is supported by 
the link between ill health and sickness absence which is estimated to cost the UK 
economy over £12 billion in 2004 and 168 million lost working days (National 
Patient Saftey Agencey, 2007).  
Previous studies have shown that dehydration is common amongst doctors 
working in intensive care (Solomon et al., 2010) and in emergency department 
staff (Alomar et al., 2013). However, to our knowledge, there are no previous 
studies investigating the prevalence of dehydration nor its link with cognitive 
imparment in nurses and doctors on-call working on acute medical and surgical 
wards. 
The primary aim of this study was to assess the prevalence of dehydration in 
HCPs working on-call on acute medical and surgical wards using objective 
markers of hydration. The secondary aims were to assess the association 
between hydration status and changes in cognitive function and subjective 
feelings.  
4.2 Hypothesis 
We hypothesised that dehydration would be prevalent amongst HCPs, 
particularly at the end of their working shift. Junior staff may be at increased risk 
 76 
due to inexperience in managing time and stress whilst maintaining adequate 
hydration needs. Moreover, we hypothesised that dehydration may adversely 
affect subjective feelings of headache, stress and concentration and may also be 
associated with impaired cognitive function.  
4.3 Methodology 
This prospective cohort study was conducted between March 2013 and April 
2014 at a large university teaching hospital in the UK. All HCPs working on acute 
medical and emergency surgical wards were eligible for inclusion, but were 
excluded if; they were pregnant, unwell in the 6 weeks preceding the study, had 
pre-existing renal disease or taking diuretics or antihypertensive medications.  
Participants arrived on the ward where they were due to work approximately 20 
minutes before commencing their shift and demographics were recorded. 
Following this, they were asked to empty their bladder and provide a 5 ml urine 
sample. Height and weight were then measured and recorded using Seca scales 
959 to the nearest 0.05 kg. A 10 ml blood sample was collected and sent for 
analysis of full blood count, serum osmolality, urea and electrolytes, and blood 
glucose. 
Participants then completed a visual analogue subjective feelings questionnaire 
using an eight-question 100 mm visual analogue scale previously used to assess 
the impact of fluid restriction on subjective feelings (Shirreffs et al., 2004). They 
then undertook a series of computer-based cognitive function tests for 15 
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minutes, as described in Table 8 (Ashbridge et al., 1997, Müller and 
Krummenacher, 2006, Trick et al., 2005, Sternber.S, 1966, Sternberg, 1969, Corsi, 
1972, Kessels et al., 2000, Stroop, 1935, MacLeod, 1991).  
Table 8: Cognitive tests and functions measured 
 
Following the pre-shift assessment, participants worked their normal shift but 
were asked to keep a food and fluid diary, from which fluid intake was estimated. 
Participants were also provided with Salter scales 1066 and asked to measure and 
record the mass of each urine void to the nearest 0.001 kg during the course of 
the day and hourly urine output was calculated (oliguria defined as urine output 
<0.5 ml/kg/hour) (Khwaja, 2012). Blood, urine and cognitive function tests were 
repeated at the end of the shift. Participants who worked both day and night 
shifts were invited to participate in the study for one day and one night shift to 
allow for comparison. Dehydration was defined as urine osmolality >800 
Cognitive test Cognitive functions measured 
Visual search threshold 
test1 
Visual cognition and selective attention 
Stroop colour naming 
interference test2  
Sensitivity to interference and the ability to 
suppress an automatic response, and is a classical 
measure of frontal lobe function 
Sternberg memory 
paradigm3  
Working memory and basic sensorimotor speed 
Corsi-test4  Visuo-spatial short term working memory 
1. (Ashbridge et al., 1997, Müller and Krummenacher, 2006, Trick et al., 2005), 2. 
(Stroop, 1935, MacLeod, 1991), 3. (Sternberg, 1966, Sternberg, 1969), 4. (Corsi, 1972, 
Kessels et al., 2000). 
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mOsmol/kg (Popowski et al., 2001, Shirreffs, 2003, Shirreffs and Maughan, 1998, 
Armstrong et al., 1994).  
4.4 Results 
Of the 92 participants recruited, four dropped out and 88 participants, 
representing 130 shifts, completed the study. Of these, 46 (52%) participated in 
the study for one shift, and 42 (48%) for two shifts. Participant and shift details 
are summarised in Table 9.  
Table 9: Shift and demographic details of the study participants 
 
 
 
 
 
 
 
 
  
Category 
All HCP 
(n=88) 
Nurse  
(n= 40) 
Doctor  
(n= 48) 
Age: mean (SD) 29 (7) 32 (9) 27 (3) 
Gender: n (%) 
Female 60 (68) 35 (88) 25 (52) 
Male 28 (32) 5 (13) 23 (48) 
Job description 
Surgery 38 (43) 20 (23) 18 (21) 
Medicine 50 (59) 20 (23) 30 (34) 
Grade: n (%) 
Junior 
nurse 
32 (36) 32 (80) - 
Senior 
Nurse 
8 (9) 8 (20) - 
Foundation 
Doctor 
28 (32) - 28 (58) 
Speciality 
Doctor 
18 (21) - 20 (42) 
*Type of shift: n (%) 
Day 41 (47) 17 (43) 24 (50) 
Night 47 (53) 23 (59) 24 (50) 
Both 42 (48) 28 (70) 14 (29) 
Hours worked: mean (SD) 12.5 (0.5) 12.5 (0.2) 13.2 (0.4) 
Shift stress: mean (SD) 67 (18) 68 (19) 67 (19) 
Shift intensity: mean (SD) 70 (18) 71 (20) 71 (16) 
Length of breaks [minutes]: mean 
(SD) 
43.7 (31) 43.6 (13.4) 40.5 (31.9) 
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 Prevalence of dehydration amongst health care professionals 4.4.1
Of the 87 participants who had urine osmolality measured at the start of the 
shift, 31 (36%) were dehydrated. Of the 80 who had urine osmolality measured at 
the end of the shift, 36 (45%) were dehydrated (P=0.17). Figure 8 demonstrates 
the change in hydration status from the start to the end of the shift.  
 
Figure 8: Change in hydration status from the start to the end of the shifts 
amongst healthcare professionals. 
Mean (SD) urinary osmolality was significantly greater at the end of the shift 
when compared with the start [720 (282) vs. 622 (297) mOsmol/kg, P=0.031]. 
Change in body weight mirrored change in hydration status over the course of 
the shift (Figure 9). Changes in serum biomarkers are listed in Table 10.  
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Figure 9: Change in weight with change in hydration status between the start and 
end of the shifts amongst healthcare professionals. 
P=0.114 
P=0.180 
P=0.352 
P=0.019 P=0.002 
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Table 10: Serum biomarkers before and after the shifts 
 
Figure 10 compares the differences in fluid consumption with change in hydration 
status over the course of the shift. It demonstrates that those who became 
dehydrated at the end of the shift consumed significantly less fluid than those 
who maintained a euhydrated status at the end of their shifts. Urine output 
followed similar patterns (Figure 11). Subjective feelings at the start and end of 
shifts are reported in Table 11. 
 
 
Start/End of Shift Mean (SD) P value 
Serum osmolality 
(mOsmol/kg) 
Start (n=82) 294 (5) 0.006 
End (n=79) 292 (5) 
Sodium (mmol/l) 
Start (n=85) 140 (2) 0.053 
End (n=81) 139 (2) 
Potassium (mmol/l) 
Start (n=88) 3.9 (1.2) 0.104 
End (n=88) 3.6 (1.5) 
Urea (mmol/l) 
Start (n=85) 4.9 (1.4) 0.820 
End (n=81) 5.0 (1.4) 
Creatinine (mmol/l) 
Start (n=85) 76 (15) 0.485 
End (n=81) 75 (15) 
Urea:creatinine ratio 
Start (n=85) 66 (17) 0.496 
End (n=81) 68 (17) 
Haemoglobin (g/l) 
Start (n=85) 139 (15) 0.008 
End (n=80) 133 (14) 
Haematocrit 
Start (n=85) 0.418 (0.036) 0.001 
End (n=80) 0.400 (0.034) 
Glucose (mmol/l) 
Start (n=83) 5.1 (0.8) 0.006 
End (n=80) 4.8 (0.6) 
Urine osmolality 
(mOsmol/kg) 
Start (n=87) 622 (297) 0.031 
End (n=80) 720 (282) 
 82 
  
P=0.183 
P=0.584 
 
P=0.935 
P=0.260 
 
 
 
 
P=0.042 
Figure 10: Fluid consumed and change in hydration status between the start and end of the 
shifts amongst healthcare professionals. 
 83 
 
 
  
 
 
 
P=0.382 
P=0.002 
P=0.029 P=0.873 
 
P=0.317 
P=0.383 
  
Figure 11: Urine output and change in hydration status between the start and end of the 
shifts amongst healthcare professionals. 
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Table 11: Hydration status and subjective feelings at the start and end of the 
shift, values are in mm on a 0-100 mm scale. 
 
 
Seventy-nine participants recorded their urine output for the duration of the 
shift. Thirty-two (41%) produced <0.5 ml/kg/hour of urine and were therefore 
oliguric (Khwaja, 2012), with significant differences in the total fluid consumed 
and urine output between the groups (Table 12).  
Subjective 
feelings 
Hydration 
status 
Start of shift End of shift 
n 
Mean 
(SD) 
P 
value 
n 
Mean 
(SD) 
P 
value 
Thirst 
Euhydrated 54 35 (25) 
0.030 
39 76 (19) 
0.973 
Dehydrated 31 48 (27) 35 76 (21) 
Hunger 
Euhydrated 54 15 (19) 
0.052 
39 53 (28) 
0.637 
Dehydrated 31 25 (23) 35 56 (28) 
Tired 
Euhydrated 54 36 (19) 
0.036 
39 76 (21) 
0.067 
Dehydrated 31 46 (24) 35 84 (16) 
Alert 
Euhydrated 54 67 (21) 
0.902 
39 45 (20) 
0.912 
Dehydrated 31 67 (19) 35 45 (23) 
Concentration 
Euhydrated 54 70 (21) 
0.753 
39 43 (18) 
0.886 
Dehydrated 31 72 (20) 35 44 (21) 
Stress 
Euhydrated 54 22 (20) 
0.231 
39 40 (26) 
0.354 
Dehydrated 31 27 (10) 35 35 (36) 
Headache 
Euhydrated 54 11 (20) 
0.847 
39 37 (33) 
0.181 
Dehydrated 31 12 (18) 35 47 (29) 
Refreshed 
Euhydrated 53 55 (26) 
0.531 
39 24 (21) 
0.793 
Dehydrated 31 52 (21) 35 23 (18) 
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Table 12: Fluid intake, urine output, oliguria, and change in hydration status 
 
 
4.4.1.1 Day vs. night shifts  
Forty-two participants were involved in the study for one day and one night shift. 
There were no significant differences in the intensity or stress of the shifts (Table 
13). Of the day shifts, 40 (95%) had urine osmolality measured at the start and 37 
(88%) at the end, 16 (40%) were dehydrated at the start and 19 (51%) at the end 
of day shift respectively, P=0.482. Of the night shifts, 39 (93%) had urine 
osmolality measured at the start, and 38 (91%) at the end of the shift. Of these, 
12 (31%) were dehydrated at the start, and 17 (45%) at the end of the night shift 
(P=0.647) respectively. There were no significant differences in change in 
hydration status or oliguria between day and night shifts (Table 14).  
 
Not-oliguric 
n (%) 
Oliguric 
n (%) 
P value 
Fluid consumed (n=79): mean (SD) 868 (358) 669 (362) 0.024 
Urine output (n=79): mean (SD) 815 (428) 316 (142) <0.001 
Euhydrated to euhydrated 
 (n=31): n (%) 
24 (77%) 7 (23%) 
0.043 
Euhydrated to dehydrated  
(n=16): n (%) 
7 (44%) 9 (56%) 
Dehydrated to euhydrated 
 (n=9): n (%) 
5 (56%) 4 (44%) 
Dehydrated to dehydrated  
(n=19): n (%) 
8 (42%) 11 (58%) 
*oliguria, urine output < 0.5mg/kg/hour 
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Table 13: Shift details, fluid consumed and urine output, comparing day and night 
shifts. 
Shift details Mean (SD) P value 
Hours worked: hours 
Day (n=42) 12.8 (0.6) 
0.484 
Night (n=42) 12.7 (0.4) 
Shift stress* 
Day (n=40) 69 (16) 
0.126 
Night (n=36) 68 (19) 
Shift busy* 
Day (n=40) 73 (16) 
0.222 
Night (n=36) 68 (21) 
Overall length of 
breaks: minutes 
Day (n=40) 42 (23) 
0.441 
Night (n=36) 48 (38) 
Total fluid consumed: 
ml 
Day (n=40) 836 (402) 
0.693 
Night (n=37) 875 (455) 
Urine output: ml 
Day (n=40) 635 (510) 
0.138 
Night (n=37) 493 (273) 
*100 mm visual analogue scale 
 
Table 14: Change in hydration status and oliguria - day vs. night shifts 
 
 
Day shift 
(n=40) 
Night shift 
(n=37) 
P value 
Change in hydration 
status 
Euhydrated to 
euhydrated: n (%) 
16 (43%) 15 (40%) 
0.113 
Euhydrated to 
dehydrated: n (%) 
6 (16%) 11 (29%) 
Dehydrated to 
euhydrated: n (%) 
3 (8%) 7 (18%) 
Dehydrated to 
dehydrated: n (%) 
12 (32%) 5 (13%) 
Oliguria 
Not-oliguric*: n 
(%) 
22 (55%) 18 (49%) 
0.577 
Oliguric*: n (%) 18 (45%) 19 (51%) 
*oliguria, urine output < 0.5 ml/kg/hour 
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4.4.1.2 Nurse vs. doctor shifts 
Forty participants, (46%), were nurses and 48 (55%) were doctors. All of the 
nurses had urine osmolality measured at the start and 37 (93%) at the end of the 
shift. Of these, 17 nurses, (43%), were dehydrated at the start of the shift and 16 
(43%) at the end. Forty-seven (98%) of the doctors had urine osmolality 
measured at the start and 43 (90%) at the end. Of these, 14 (30%) were 
dehydrated at the start and 20 (47%) at the end of the shift. There were no 
statistically significant differences between the hydration status of nurses and 
doctors at the start and end of the shift, P=0.770 and P=0.284 respectively.  
Thirty-five (88%) nurses and 44 (92%) doctors measured their fluid intake and 
urine output over the course of the shift. The mean (SD) volume of fluids 
consumed by nurses was 911.3 ml (395.6) vs. 688.4 ml (353.1) for doctors, 
P=0.010. However, there were no differences in the urine output between nurses 
and doctors, 611mls (438.1) vs. 614.6mls (411.2) respectively, P=0.864. 
Furthermore, 17 (48.6%) nurses and 15 (34%) doctors were oliguric, P=0.193.  
There were no significant differences between the hydration status of junior and 
senior nurses at the start or end of the shift, 13 (41%) vs. 3 (38%), P=0.872 and 12 
(41%) vs. 3 (38%), P=0.786, respectively. However, a significantly higher 
proportion of foundation doctors (junior doctors) were dehydrated at the start 
and end of the shift compared with speciality doctors (more senior doctors), 11 
(39%) vs. 4 (21%), P=0.188 and 17 (63%) vs. 4 (25%), P=0.011, respectively. 
 88 
4.4.1.3 Medical vs. surgical shifts 
There were significant differences in the hydration status between specialities 
(Table 11). Surgical nurses consumed the greatest volume of fluid during their 
shifts and produced the most urine, with a mean (SD) of 1083.5 ml (405.9) and 
766.1 ml (598.1) respectively. Doctors working in surgical wards, however, 
consumed the lowest volume of fluid and passed the least urine, mean (SD) of 
641.5ml (423.2) and 472.9ml (266.0) respectively. There were no statistically 
significant differences in the prevalence of oliguria between the groups (Table 
15).  
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Table 15: Change in hydration status and oliguria, comparing surgical and medical 
shifts. 
 
 Dehydration and cognitive function 4.4.2
Cognitive tests revealed trends towards an increase in the number of errors made 
in dehydrated participants, but this was statistically significant only with the 
single number and five-letter Sternberg test (Figures 12, 13 & Table 16). There 
were no significant differences in the time taken to perform the cognitive tests 
(Table 16).  
There were also no significant differences in cognitive scores and hydration status 
during night shifts. However, during day shifts, dehydration was associated with 
increased error at the start and end of the shifts in the three letters Sternberg 
test (Table 17). 
 
Nurse 
P 
value 
Doctor 
P 
value Surgery Medicine Surgery Medicine 
Euhydrated to 
Euhydrated 13 (68%) 3 (17%) 
0.001 
6 (35%) 12 (46%) 
0.486 
Euhydrated to 
Dehydrated 
4 (21%) 2 (11%) 4 (24%) 7 (27%) 
Dehydrated to 
Euhydrated 
2 (11%) 4 (22%) 1 (6%) 3 (12%) 
Dehydrated to 
Dehydrated 0 (0%) 9 (50%) 6 (35%) 4 (15%) 
Oliguric*: 7 (44%) 10 (56%) 
0.429 
6 (35%) 9 (32%) 
0.519 
Not Oliguric* 9 (56%) 8 (44%) 11 (65%) 19 (68%) 
*oliguria, urine output <0.5 ml/kg/hour  
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Table 16: Time to perform cognitive tests and results comparing euhydrated and 
dehydrated states from start and end of shifts 
 
Cognitive test 
Hydration 
status 
Start of the shift* End of the shift+ 
Mean 
(SD) 
P 
value 
Mean 
(SD) 
P 
value 
Ti
m
e 
to
 p
er
fo
rm
 t
e
st
: 
m
in
u
te
s:
 m
ea
n
 
(S
D
) 
Visual Search 
Baseline 
Euhydrated 989 (135) 
0.938 
1010 (153) 
0.995 
Dehydrated 992 (136) 1010 (150) 
Visual Search 
Interference 
Euhydrated 2624 (818) 
0.787 
2694 (897) 
0.744 
Dehydrated 2674 (827) 2634 (650) 
Stroop Simple 
Euhydrated 777 (208) 
0.985 
758 (214) 
0.627 
Dehydrated 776 (243) 735 (200) 
Stroop 
Complex 
Euhydrated 1098 (283) 
0.252 
1135 (342) 
0.844 
Dehydrated 1182 (371) 1151 (343) 
Sternberg one 
number 
Euhydrated 525 (80) 
0.171 
547 (110) 
0.788 
Dehydrated 557 (128) 540 (119) 
Sternberg 
three letter 
Euhydrated 595 (98) 
0.771 
616 (148) 
0.758 
Dehydrated 602 (122) 605 (136) 
Sternberg five 
letter 
Euhydrated 692 (182) 
0.913 
706 (168) 
0.467 
Dehydrated 688 (132) 680 (136) 
N
u
m
b
er
 o
f 
er
ro
rs
: 
m
ed
ia
n
 (
Q
1
, Q
3
) Stroop simple 
[no. errors]: 
median 
(Q1,Q3) 
Euhydrated 0 (0,1) 
0.696 
0 (0,0) 
0.841 
Dehydrated 0 (0,1) 0 (0,0) 
Corsi [no. 
error]: median 
(Q1,Q3) 
Euhydrated 4 (4,5) 
0.639 
5 (4,6) 
0.391 
Dehydrated 4 (4,5) 4 (4,5) 
M
ax
. 
Se
q
u
en
ce
: 
m
ed
ia
n
 
(Q
1
, Q
3
) Corsi [max. 
sequence]: 
median 
(Q1,Q3) 
Euhydrated 7 (6,7) 
0.167 
7 (6,7) 
0.867 
Dehydrated 6 (6,7) 7 (5,7) 
*Start of shift: Euhydrated (n=51), dehydrated (n=31). 
+ End of shift:-Euhydrated (n=40), dehydrated (n=36). 
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P=0. 059 P=0.056 
P=0.359 P= 0.009 
Figure 12: Hydration status and cognitive function at the start of shifts amongst healthcare professionals. (a) Complex Stroop, (b) 
Single letter Sternberg, (c) Three letter Sternberg, (d) Five letter Sternberg.   
a b 
d c 
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P=0.639 P=0.044 
P=0.174 P= 0.431 
a b 
d c 
Figure 13: Hydration status and cognitive function at the end of the shift amongst healthcare professionals. (a) Complex Stroop, 
(b) Single letter Sternberg, (c) Three letter Sternberg, (d) Five letter Sternberg. 
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Table 17: Cognitive function and hydration status before and after day and night shifts. 
Cognitive test 
Day shifts Night shifts 
Euhydrated Dehydrated P value Euhydrated Dehydrated P value 
Stroop simple start [no. errors]: median (Q1,Q3) 0 (0, 0) 1 (0, 1) 0.095 0 (0, 0) 0 (0, 0) 0.575 
Stroop simple end [no. errors]: median (Q1,Q3) 0 (0, 1) 0 (0, 1) 0.298 0 (0, 0) 0 (0, 0) 0.908 
Stroop complex start [no. errors]:  
median (Q1,Q3) 
1 (0, 2) 2 (1, 2) 0.095 1 (0, 2) 2 (0, 4) 0.312 
Stroop complex end [no. errors]:  
median (Q1,Q3) 
2 (1, 3) 1 (1, 3) 0.988 2 (0, 2) 2 (1, 3) 0.706 
Sternberg single no. start [no. errors]:  
median (Q1,Q3) 
0 (0, 0) 0 (0, 1) 0.503 0 (0, 1) 0 (0, 0) 0.256 
Sternberg single no. end [no. errors]:  
median (Q1,Q3) 
0 (0, 0) 0 (0, 0) 0.169 0 (0, 0) 0 (0, 0) 0.685 
Sternberg three letter. start [no. errors]: 
median (Q1,Q3) 
0 (0, 1) 1 (1, 2) 0.021 0 (0, 2) 1 (0, 2) 0.816 
Sternberg three letter. end [no. errors]:  
median (Q1,Q3) 
1 (0, 1) 2 (1, 2) 0.003 1 (1, 1) 1 (0, 2) 0.908 
Sternberg five letter. start [no. errors]:  
median (Q1,Q3) 
1 (0, 1) 2 (0, 3) 0.359 1 (0, 2) 1 (1, 3) 0.699 
Sternberg five letter. end [no. errors]:  
median (Q1,Q3) 
1 (0, 2) 2 (1, 2.5) 0.134 1 (1, 3) 1 (1, 3) 1.000 
Corsi [max. sequence] start: median (Q1,Q3) 7 (6, 7) 7 (6, 7) 0.633 6 (5, 7) 7 (6, 8) 0.142 
Corsi [max. sequence] end: median (Q1,Q3) 6 (6, 8) 7 (7, 8) 0.408 6 (6, 7) 7 (6, 8) 0.199 
Corsi [no. errors] start: median (Q1,Q3) 5 (4, 5) 4 (4, 5) 0.594 5 (4, 5) 4 (4, 5) 0.168 
Corsi [no. errors] end: median (Q1,Q3) 5 (4, 5) 4 (4, 5) 0.599 5 (4, 5) 5 (4, 5) 0.931 
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4.5 Discussion 
The prevalence of dehydration amongst HCPs whilst at work was examined 
and found that over a third studied were dehydrated at the start of their shift, 
and close to half at the end of the shift. Moreover, a significant proportion of 
staff were oliguric and produced less than 0.5 ml/kg/hour of urine. Subgroup 
analysis revealed that close to one-third of doctors studied were dehydrated 
at the start of their shift and nearly half at the end. In nurses, a different 
pattern emerged with a greater proportion of nurses than doctors dehydrated 
at the start of their shift. However, a similar proportion were dehydrated at 
the end.  
Moreover, a comparison of hydration status during day and night shifts in 
those that participated in the study for two shifts, demonstrated that there 
were greater rates of dehydration at the start of the day shifts compared with 
night shifts. Again, a significantly greater proportion of nurses, who start work 
up to two hours before doctors, were dehydrated at the start of their day 
shift. This study also demonstrated interesting patterns when comparing the 
hydration status of HCP’s working on medical and surgical wards. On surgical 
wards, nurses consumed the greatest volume of fluid and had the lowest 
prevalence of dehydration at the start and end of their shift, and none were 
dehydrated both at the start and end of their shift. Conversely, on medical 
wards, nurses consumed significantly less fluid than their surgical 
counterparts and had the highest prevalence of dehydration.  
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Nurses often have protected break times; however, the ability to have an 
undisturbed break may be influenced by the location of the staff room. 
Interestingly in this study, the staff room where medical nurses often took 
their break was located on the ward whereas for surgical nurses, this was off 
the ward. This set up may have supported surgical nurses in maintaining 
undisturbed breaks and therefore allowing adequate fluid consumption 
during break times.  
A different pattern emerged in doctors. Although the vast majority of the 
doctors were euhydrated at the start of their shifts, the prevalence of 
dehydration amongst foundation grade doctors was nearly double that of 
more senior speciality doctors. Moreover, at the end of the shift, three-
quarters of the speciality doctors were euhydrated, however, most of the 
foundation doctors were dehydrated. These patterns may be related to 
knowledge and awareness of the importance of hydration as previously 
discussed. However, another contributing factor is that senior doctors are 
more likely to have developed the ability to prioritise work and breaks. In this 
study, despite longer breaks, less busy and stressful shifts, a significant 
proportion of junior doctors were dehydrated at the end of their shift, likely a 
consequence of difficulty taking quality breaks and prioritising fluid 
consumption. Unlike nurses, in this study doctors did not have structured 
protected break times or access to on/close ward staff/break rooms. Doctors 
are also often contacted during break periods, particularly during busy on 
calls. This coupled with limited/no access to convenient break areas makes it 
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difficult to prioritise hydration. Moreover, foundation doctors are usually 
more ward-based and are the first point of call for nursing staff so are more 
likely to be disturbed than senior colleagues. 
A key reason for the high prevalence of dehydration is related to inadequate 
fluid consumption, with the mean volume of fluid consumed being 
approximately 30% less in participants who were dehydrated at the end of the 
shift than in those who were euhydrated at the end of the shift when 
comparing all HCPs. Inadequate access to drinking water, the common 
practice of missing or limiting breaks, and restricted access to staff-rooms, are 
therefore likely contributing factors. This, together with the widespread 
practice of dissuading HCPs to consume food or fluids on-wards in order to 
maintain a professional image, are likely to add to this problem. Such 
practices make it difficult for staff to achieve or maintain an optimal, or even 
adequate, hydration status, particularly during busy and stressful shifts, which 
are the norm in most emergency admission’s wards. However, a 
communication (Wade, 2010) in response to a study investigating hydration 
status in ICU staff (Solomon et al., 2010) highlighted that this practice was not 
in keeping with the views of patients and visitors. In this communication 
patients’ visitors and staff from medical and surgical wards were invited to 
answer questions related to the practice of food and fluid consumption in 
view of patients and relatives. Sixty-seven (94%) of the 71 patients and all 18 
of the visitors who responded, did not mind whether HCPs drank in view of 
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patients who could eat and drink, with similar responses from patients who 
were ‘nil by mouth’.  
Another contributing factor to the high prevalence of dehydration amongst 
HCPs is increased fluid loss through excessive sweating. Current UK health and 
safety legislation dictates that the minimum working temperature is 16oC, but 
there is no legislation for maximum working temperatures (Executive, 1992). 
Hospitals are often hot and humid environments, with evidence suggesting 
ambient temperatures reaching up to 30oC and that approximately 90% of UK 
hospital wards are of a design type that makes them susceptible to 
overheating (Change, 2014). Moreover, where air-conditioning is used 
without humidification, the relative humidity of the environment will fall 
which can greatly increase respiratory water loss. Maintenance of optimal 
working environmental temperatures and humidity is therefore likely to help 
reduce fluid loss through sweating given that some HCPs have been reported 
to walk up to five miles during a day shift (Hendrich et al., 2008).  
The high prevalence of dehydration amongst HCPs at the start of the shift in 
this study may be related to early starts as previously reported with other 
shift workers (Brake and Bates, 2003), and may be counteracted by pre-shift 
bolus oral fluid loading. 
Lack of awareness has also been identified as a cause of dehydration in other 
shift workers, and this has been shown to improve with education (Rogers et 
al., 2001). This may also be reflected in the HCPs’ approach to personal fluid 
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management, particularly when faced with a busy and challenging working 
environment. 
The present study demonstrated a small but significant increase in errors 
made during short-term working memory tasks, which was most evident in 
short term functional working memory (Sternberg memory test). Moreover, a 
small but consistent pattern of increased errors associated with other 
cognitive tests were seen, although this was not statistically significant. It is 
important to highlight that although these cognitive changes were small, they 
may be of relevance to clinical practice given the number and complexity of 
tasks performed by HCPs. This may also be of relevance in the context of 
complex surgical procedures, which at times can be lengthy, and performed 
under conditions that predispose to dehydration, whilst requiring a multitude 
of cognitive and psychomotor skills to complete in a safe and efficient manner 
(Kahol et al., 2008).  
Changes related to dehydration draw parallels with the adverse effects of 
sleep deprivation, where psychomotor performance in surgeons performing 
laparoscopy has been shown to be impaired with fatigue (Gaba and Howard, 
2002). Interestingly, the present study revealed that when comparing day and 
night shifts in those who have participated in this study over two shifts, no 
significant differences were demonstrated in the prevalence of dehydration. 
Furthermore, contrary to previous reports of increased cognitive impairment 
associated with night shifts (Dula et al., 2001, Machi et al., 2012(Dula et al., 
2001, Machi et al., 2012), there were no significant differences in cognitive 
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function associated with dehydration during night shifts. However, 
dehydration was associated with a small but significant increase in the 
number of errors made with the Sternberg three-letter short term memory 
tests before and after day shifts. 
This study suggests a link between dehydration and increased subjective 
feelings of thirst and tiredness. Others have also linked mild dehydration with 
headache, anxiety, reduced alertness, fatigue, increased perception of task 
difficulty and reduced ability to concentrate (Ganio et al., 2011, Shirreffs et 
al., 2004, Cian et al., 2000, Armstrong et al., 2012, Wilson and Morley, 2003), 
and have shown improvement with rehydration (Neave et al., 2001).  
Given the link between dehydration and ill health and reports linking stress, 
tiredness and burnout in HCPs to suboptimal patient care (Firth-Cozens and 
Greenhalgh, 1997, Shanafelt et al., 2002), it is therefore prudent to encourage 
and facilitate HCP wellness to help facilitate high standards of clinical care.  
4.6 Limitations 
The present study reports significant findings with potential clinical 
implications, but there are limitations which should be considered when 
interpreting the results. This is a single centre study, although the NHS trust is 
one of the largest in the UK with a work force which is likely to be 
representative of other centres across the UK with similar working conditions. 
HCPs involved in the study were aware of the study aims and objectives and 
this may have influenced their behaviours. However, there was no clear 
  100 
incentive to act differently and the researchers stressed the importance of 
maintaining normal behaviour whilst involved in the study.  
The use of urine osmolality as a measure of hydration status in this study is 
consistent with the opinions of many scientists and clinicians that support 
urine osmolality as one of the most accurate objective measures of hydration 
status (Sawka et al., 1996, Armstrong et al., 2013b, Armstrong et al., 2013a, 
Popowski et al., 2001, Shirreffs, 2003, Shirreffs and Maughan, 1998, 
Armstrong et al., 1994). However, it is important to note that urine osmolality 
is a measure of the osmolality of the pooled urine in the bladder produced 
since the time of the last micturition, which may vary between participants. 
Therefore, hydration status reported in this study is likely to represent the 
hydration over the period of time from the last micturition rather than at a 
specific time point when the urine was collected. Furthermore, it can be 
influenced by recent fluid consumption which may induce diuresis and hypo-
osmolar urine production, which may result in artificial dilution of the urine 
osmolality (Popowski et al., 2001, Shirreffs, 2003, Shirreffs and Maughan, 
1998, Armstrong et al., 1994). However, in the present study, urine osmolality 
is likely to be an accurate representative of hydration status as clear and 
significant relationships between urine osmolality and other markers of 
hydration, including change in weight and urine output, were observed.  
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4.7 Conclusion 
This study highlights for the first time that a significant proportion of HCPs 
were dehydrated at the start and end of medical and surgical shifts, many of 
whom were oliguric. The effects of dehydration on cognitive function were 
inconsistent, and mostly not statistically significant. However, trends were 
observed showing increased error with dehydration. Although widely 
debated, cognitive impairment associated with dehydration is important to 
highlight as it may affect decision making and potentially influence patient 
outcome. There is little disagreement regarding the challenges and difficulties 
frontline HCP’s face, and thus knowing the prevalence of dehydration may 
allow for low-cost intervention strategies which could help improve working 
conditions and may enhance patient safety.  
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 Hydration and 5.
Outcome in Older 
Patients admitted 
to hospital: The 
HOOP prospective 
cohort study 
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5.1 Introduction 
Older adults are susceptible to dehydration due to age related 
pathophysiological changes (El-Sharkawy et al., 2014). These changes often 
result in a hyperosmolar state, which can lead to alterations in cell 
metabolism and function, mediated by changes in cell volume (Lang, 2007, 
Haussinger et al., 1993, Manz and Wentz, 2005).  
Hyperosmolar dehydration (HD) is a state of water depletion and occurs when 
water loss is greater than salt loss. It is considered the most common form of 
dehydration in older adults and has been linked with increased morbidity and 
mortality (Stookey et al., 2005, Gorelick et al., 1993, Warren et al., 1994). 
Studies have demonstrated associations between serum hyperosmolarity and 
poor outcome in patients admitted to hospital with stroke and critical illness, 
as well as those with acute coronary syndrome receiving percutaneous 
coronary intervention (Rohla et al., 2014, Holtfreter et al., 2006, Manz and 
Wentz, 2005, Bhalla et al., 2000). However, few studies have adequately 
assessed the prevalence of dehydration in hospitalised older adults and the 
impact on outcome, with many failing to adjust for key confounding factors 
associated with mortality such as comorbidities.  
This study aimed to investigate the prevalence of HD in hospitalised adults 
aged ≥65 years, admitted as emergencies to a large UK teaching hospital and 
to assess its impact on short and long-term outcomes.  
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5.2 Hypothesis 
We hypothesised that HD would be prevalent in hospitalised older adults and 
would be associated with poor outcome. The prevalence of HD may be 
significantly greater than clinically reported dehydration due to limitations of 
clinical features of dehydration in older adults.  
5.3 Methodology 
This prospective cohort study, conducted between 31st August 2012 and 30th 
April 2014, was designed to include patients aged ≥65 years admitted as an 
emergency to hospital. Patients who were moribund, with terminal illness and 
a predicted life expectancy of < 3 months as well as those on end of life 
pathways were excluded, in line with the research ethics committee approval 
(Figure 14).  
Data collected from the participants, medical notes and/or relatives included 
demographics and cause of hospital admission as well as comorbidities. These 
were used to calculate the Charlson Comorbidity Index (CCI) (Charlson et al., 
1994, Charlson et al., 1987). Bedside observations were used to calculate the 
National Early Warning Score (NEWS), a validated measure of illness severity 
(Smith et al., 2013). The participant’s ability to perform daily activities 
necessary to independent living was assessed using the Barthel Activity of 
Daily Living index (ADL) score, with a potential score of 0-20 with higher 
scores indicating a better ability to perform the ADL (Wade and Collin, 1988). 
Cognitive function was assessed using the Mini Mental State Examination 
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(MMSE), with a potential score between 0 and 30, where lower scores suggest 
cognitive impairment (Folstein et al., 1975). The Confusion Assessment 
Method (CAM) was also used to assess for evidence of delirium (Ely et al., 
2001). Frailty was assessed using the seven point Canadian Study of Health 
and Ageing clinical frailty scale (CSHA), with higher scores indicating increased 
frailty (Rockwood et al., 2005). Participants were also screened for 
malnutrition using the Nutrition Risk Screening tool (NRS) 2002 (Kyle et al., 
2006, Kondrup et al., 2003). Data were also collected on typical fluid 
consumption habits by asking participants to estimate the average number of 
cups of beverages consumed on a typical day. If participants were unable to 
recall this, efforts were made to obtain the information from relatives or 
carers. Study participants also marked a 100 mm visual analogue scale to 
indicate subjective feelings of symptoms associated with dehydration: this 
questionnaire was previously used to assess the relationship between 
dehydration and subjective feelings (Shirreffs et al., 2004). The tools used for 
data collection are presented in the appendix section. 
Most patients admitted acutely to hospital undergo routine venous blood 
sampling. Where possible, this sample was used to measure serum osmolality 
(by freezing point depression) as well as serum concentrations of sodium, 
potassium, urea and creatinine, eGFR and a full blood count. In addition, a 5 
ml urine sample was collected where possible. HD was defined as serum 
osmolality >300 mOsmol/kg and impending HD as 295-300 mOsmol/kg 
(Thomas et al., 2008, Armstrong, 2007, Armstrong, 2005).  
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Pulse rate, blood pressure, respiratory rate, temperature and body weight 
were also measured. Participants who were still in hospital 48 hours after 
admission were reviewed and the same measurements were repeated. 
Participants who had been discharged were not reviewed at this point. 
Following discharge, length of hospital stay excluding mortality (LOS), 
discharge destination and mortality were recorded. All the study participants 
were followed up using the hospital’s electronic records which were reviewed 
at 30 and 90 days as well as 12 months post admission.  
 
 
Figure 14: Screening and recruitment of participants for the hydration and 
outcome in older adults study. 
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5.4 Result 
Two-hundred participants were recruited to the study (Figure 14). Blood 
samples were obtained from all 200 participants, of whom 187 had serum 
osmolality measured. One hundred and sixteen of the participants were 
reviewed at 48 hours after admission: 110 of these underwent venous blood 
sampling, and 95 had serum osmolality measured. Admission and 48 hour 
serum osmolality measures were available for 92 participants. Table 18a and 
18b summarises participant characteristics at admission and at 48 hours after 
admission. 
Table 18a: Descriptive statistics of participants recruited to the study at 
admission and those still in hospital 48 hours after admission. 
 All at 
admission 
(n=200) 
At 48 
hours after 
admission 
(n=116) 
Age (years): mean (SD) 81 (8) 83 (7) 
Gender Male: n (%) 107 (53.5) 62 (53.4) 
Female: n (%) 93 (46.5) 54 (45.6) 
Canadian study of health and aging (CSHA) 
scale: median (Q1,Q3) 
4 (3,5) 4 (3,6) 
Charlson Comorbidity Index : median (Q1, Q3) 4 (3, 5) 4 (3,5) 
Barthel activities of daily living index: median 
(Q1, Q3) 
17 (11, 20) 16 (10, 20) 
Cognitive assessment (MMSE)a: mean (SD) 24.6 (6.0) 22.2 (10.0) 
Confusion Assessment Method (CAM) score % 
with delirium: n (%) 
70 (35.0) 31 (26.7) 
 
a) MMSE – Mini Mental State Examination. Results available in 159 
study participants at admission and 59 at 48 hours after admission. 
Serum osmolality was measured in 187 (94%) patients. One hundred and 
sixteen (58%) participants were reviewed at 48 hours after admission: 110 
(95%) of these underwent venous blood sampling and 95 (86%) had serum 
osmolality measured. Admission and 48 hour serum osmolality measures 
were available for 92 (46%) participants. 
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Table 18b: Descriptive statistics of participants recruited to the study at 
admission and those still in hospital 48 hours after admission. 
 
 
 All at 
admission 
(n=200) 
At 48 
hours after 
admission 
(n=116) 
Nutritional assessments (NRS 2002)a : median 
(Q1,Q3) 
1 (1, 4) 1 (1, 4) 
Nutritional assessments (NRS 2002)a - % at risk 
of malnutrition: n (%) 
70 (38.0) 40 (36.4) 
Weight (kg)b: mean (SD) 71.0 (17.4) 72.6 (18.5) 
Height (cm)b: mean (SD) 165.2 
(12.6) 
166.5 
(12.7) 
Body mass index (BMI)b – mean (SD) 26.8 (6.6) 26.4 (7.1) 
Approximate average daily fluid consumption 
(ml)c: mean (SD) 
1379 (544) 1343 (547) 
Fluid consumption in 
past 48 hoursc 
Unchanged: n (%) 106 (60.2) 25 (29.1) 
Increased: n (%) 8 (4.5) 25 (29.1) 
Decreased: n (%) 62 (35.2) 36 (41.9) 
Source of admission Emergency 
department: n (%) 
173 (86.5) 100 (86.2) 
General practitioner 
referral: n (%) 
27 (13.5) 16 (13.7) 
Residence prior to 
admission 
Home: n (%) 173 (86.5) 99 (85.3) 
Community care: n (%) 27 (13.5) 17 (14.7) 
 
 
a) NRS 2002 – Nutrition Risk Screening tool 2002. Results available in 184 
study participants at admission and 110 at 48 hours after admission. 
b) Weight, height and BMI measurements available in 161 study 
participants at admission and 93 at 48 hours after admission. 
c) Average fluid consumption based on assumption that each cup of fluid 
consumed amounts to approximately 200 ml of fluid. Data available in 
176 study participants at admission and 86 at 48 hours after 
admission. 
Serum osmolality was measured in 187 (94%) patients. One hundred and 
sixteen (58%) participants were reviewed at 48 hours after admission: 110 
(95%) of these underwent venous blood sampling and 95 (86%) had serum 
osmolality measured. Admission and 48 hour serum osmolality measures 
were available for 92 (46%) participants. 
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 Prevalence of dehydration 5.4.1
Sixty-nine (37%) participants were found to have a serum osmolality >300 
mOsmol/kg and were classified as having HD at admission to hospital. A 
further 40 (21%) participants had impending dehydration (serum osmolality 
295-300 mOsmol/kg). Of those with HD at admission, 44 (64%) were reviewed 
again at 48 hours and 36 (82%) had a repeat serum osmolality measure. 
Twenty-two of these 36 (61%) also had HD at 48 hours after admission. Of the 
92 participants in whom serum osmolality was measured at admission and 48 
hours later, 14 (15%) had HD at 48 hours but were euhydrated at admission 
and 22 (20%) had HD on both occasions. However, on review of the medical 
notes, dehydration was clinically reported by the medical team in only 15 (8%) 
and acute kidney injury (AKI) in 24 (12%) of all the cases.  
The prevalence of HD increased with age and comorbidity. Sixteen (23%) 
participants aged 65-74 years had HD whereas 27 (36%) of those >84 years 
had HD at admission. Similarly, 17% of participants with mild comorbidities 
(CCI 1-2) had HD at admission vs. 43% of those with severe comorbidities (CCI 
≥5). However, there were no significant differences in the age, gender, 
comorbidities, nutritional status or MMSE scores between those euhydrated 
and those with HD at admission to hospital (Table 19a and 19b). There were 
also no statistically significant differences in pulse rate, blood pressure, 
temperature or subjective feelings (data not shown). However, biochemical 
differences were demonstrated (Table 20) between those euhydrated and 
those dehydrated at admission to hospital. 
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Table 19a: Descriptive statistics of patients recruited to the study at 
admission comparing euhydrated (serum osmolality ≤300 mOsmol/kg) and 
dehydrated patients (serum osmolality >300 mOsmol/kg) 
 
Euhydrated 
(n = 118) 
Dehydrated 
(n=69) 
P value 
Age: mean (SD) 82 (7) 81 (8) 0.86 
Gender 
Male: n (%) 66 (55.9) 34 (49.3) 
0.38 
Female: n (%) 52 (44.1) 35 (50.7) 
Canadian study of health and aging 
(CSHA) scale: median (Q1,Q3) 
4 (3,5) 4 (3,6) 0.29 
Charlson Comorbidity Index: median 
(Q1, Q3) 
4 (2,5) 4 (3,5) 0.22 
National Early Warning Score (NEWS): 
median (Q1, Q3) 
1 (0, 2) 1 (1, 2) 0.658 
Barthel activities of daily living index: 
mean (SD) 
15.2 (5.2) 14.7 (5.7) 0.63 
Cognitive assessment (MMSE)a: mean 
(SD) 
24.5 (5.9) 24.4 (6.6) 0.93 
Cognitive assessment (MMSE)a: % 
with delirium: n (%) 
29 (29.3) 14 (28.0) 0.87 
Confusion Assessment Method (CAM) 
score % with delirium: n (%) 
38 (32.2) 27 (39.1) 0.34 
Nutritional assessments (NRS 2002)b, 
median (Q1,Q3) 
1 (1, 4) 1 (1, 4) 0.578 
Nutritional assessments (NRS 2002)b, 
% at risk of malnutrition: n (%) 
38 (35.8) 27 (41.5) 0.457 
Weight (kg)c: mean (SD) 68.4 (17.3) 75.3 (15.6) 0.02 
Height (cm) c: mean (SD) 165 (12.6) 165 (13.9) 0.76 
Body mass index (BMI): c mean (SD) 25.4 (6.1) 27.1 (7.3) 0.06 
Dehydrated refers to hyperosmolar dehydration (serum osmolality >300 mOsmol/kg), 
187 (94%) had serum osmolality measured. One hundred and sixteen (58%) participants 
were reviewed at 48 hours after admission: 110 (95%) of these underwent venous blood 
sampling and 95 (86%) had serum osmolality measured. Admission and 48 hour serum 
osmolality measures were available for 92 (46%) participants. Acute kidney injury 
includes all stages  
a. MMSE – Mini Mental State Examination. Results available in 159 study 
participants at admission 99 euhydrated and 50 dehydrated  
b. NRS 2002 – Nutrition Risk Screening tool 2002. Results available in 184 study 
participants at admission 110 euhydrated and 62 dehydrated 
c. Weight, height and BMI measurements available in 161 study participants at 
admission 100 euhydrated and 51 dehydrated 
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Table 19b: Descriptive statistics of patients recruited to the study at 
admission comparing euhydrated (serum osmolality ≤300 mOsmol/kg) and 
dehydrated patients (serum osmolality >300 mOsmol/kg). 
 
Euhydrated 
(n = 118) 
Dehydrated 
(n=69) 
P value 
Approximate average daily fluid 
consumption (ml)a: mean (SD) 
1406 (558) 1326 (540) 0.40 
Fluid 
consumption 
in past 48 
hours b 
Unchanged: n (%) 59 (55.7) 39 (67.2) 
0.22 
Increased: n (%) 7 (6.6) 1 (1.7) 
Decreased: n (%) 40 (37.7) 18 (31.0) 
Source of 
admission 
Emergency 
department: n (%) 
102 (86.4) 61 (88.4) 
0.70 
General practitioner 
referral: n (%) 
16 (13.6) 8 (11.6) 
Residence 
prior to 
admission 
Home: n (%) 103 (87.3) 59 (85.5) 
0.73 
Community care: n (%) 15 (12.7) 10 (14.5) 
Clinical 
diagnosis 
Dehydration: n (%) 9 (7.6) 6 (8.9) 0.33 
Acute kidney injuryc: n 
(%) 
6 (5.1) 15 (21.7) <0.001 
Dehydrated refers to hyperosmolar dehydration (serum osmolality >300 mOsmol/kg), 
187 (94%) had serum osmolality measured. One hundred and sixteen (58%) participants 
were reviewed at 48 hours after admission: 110 (95%) of these underwent venous blood 
sampling and 95 (86%) had serum osmolality measured. Admission and 48 hour serum 
osmolality measures were available for 92 (46%) participants. Acute kidney injury 
includes all stages  
a) Weight, height and BMI measurements available in 161 study participants at 
admission 100 euhydrated and 51 dehydrated 
b) Average fluid consumption based on assumption that each cup of fluid consumed 
amounts to approximately 200 ml of fluid. Data available in 176 study 
participants at admission 106 euhydrated and 58 dehydrated. 
c) Acute kidney injury includes all stages of the condition  
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Table 190: Blood and urine results at admission and 48 hours after admission 
comparing those dehydrated to euhydrated. 
 
 Admission 48 hours after admission 
 Euhydrated 
(n = 118) 
Dehydrated 
(n = 69) 
P value 
Euhydrated 
(n = 59) 
Dehydrated 
(n = 33) 
P value 
Haemoglobin 
(g/l): mean 
(SD) 
12.7 
(2.1) 
12.5 
(2.3) 
0.48 
13.0 
(10.5) 
11.6 
(2.4) 
0.45 
Platelets  
(X109/l ): 
mean (SD) 
267.9 
(120.3) 
234.1 (88.7) 0.05 
248.3 
(84.6) 
212.1 
(88.1) 
0.05 
White cell 
count 
(X109/l): mean 
(SD) 
11.0 
(6.7) 
11.0 
(5.5) 
0.95 
8.2 
(3.3) 
8.4 
(3.6) 
0.74 
Haematocrit 
(L/l): mean 
(SD) 
0.38 
(0.06) 
0.39 
(0.07) 
0.95 
0.36 
(0.58) 
0.36 
(0.67) 
0.7 
Sodium 
(mmol/l): 
mean (SD) 
136.2 
(5.9) 
141.3 
(6.5) 
<0.001 
136.6 
(4.1) 
142.4 
(4.9) 
<0.001 
Potassium 
(mmol/l): 
mean (SD) 
4.3 
(0.5) 
4.4 
(0.6) 
0.14 
4.2 
(0.5) 
4.6 
(0.3) 
0.28 
Urea 
(mmol/l): 
mean (SD) 
7.6 
(3.2) 
8.1 
(1.8) 
<0.001 
7.1 
(2.6) 
11.3 
(6.0) 
<0.001 
Creatinine 
(mmol/l): 
mean (SD) 
85.1 
(31.4) 
133.5 
(62.2) 
<0.001 
96.1 
(27.8) 
120.2 
(51.7) 
0.02 
eGFR 
(ml/min): 
mean (SD) 
62.8 
(18.8) 
46.1 
(19.5) 
<0.001 
59.7 
(16.7) 
51.6 
(18.0) 
0.03 
Serum 
Osmolality 
mOmsol/kg: 
mean (SD) 
288.6 
(12.4) 
312.4 
(16.5) 
<0.001 
291.0 
(8.3) 
309.4 
(7.9) 
<0.001 
Urine 
Osmolality* 
mOmsol/kg: 
mean (SD) 
523.1 
(214.2) 
505.1 
(166.3) 
0.76 
5401.1 
(168.0) 
551.3 
(162.7) 
0.89 
*Results available in 42 study participants at admission 26 euhydrated and 16 dehydrated at 
admission and 23 cases at 48 hours, 15 euhydrated and 8 dehydrated. 
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 Hydration status and outcome 5.4.2
Overall, 14 (7%) participants died in-hospital, 11 (79%) of whom were 
dehydrated at admission (P=0.001). The 30-day mortality was greater in those 
dehydrated at admission than in those who were euhydrated [11 (16%) vs. 5 
(4%) respectively (P=0.01)]. Numerically higher mortality rates were also seen 
with HD at 90 days and one year after admission but these were not 
statistically significant (Table 21). Comparable patterns were demonstrated 
when comparing changes in hydration status over 48 hours, (Table 17). Cox 
regression survival analysis adjusted for age, gender, comorbidity, NEWS, 
frailty and nutritional status demonstrated that participants dehydrated at 
admission to hospital were at greater risk of mortality in-hospital than those 
euhydrated at admission (Table 21).  
The median (Q1, Q3) length of hospital stay between those euhydrated and 
those dehydrated at admission was 4 (1, 11) vs. 5 (1, 11) days, P=0.73. 
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Table 201: Hydration status and mortality in hospitalised older adults.  
Mortality a 
Euhydrated 
(n=118) 
Dehydrated 
(n=69) 
P 
value 
Unadjusted 
HR (95%CI) 
P 
value+ 
Adjusted 
HR 
(95%CI) b 
P 
value+ 
Euhydrated 
to 
euhydrated 
(n=46) 
Euhydrated 
to  
Dehydrated 
(n=14) 
Dehydrated 
to 
euhydrated 
(n=12) 
Dehydrated 
to 
dehydrated 
(n=20) 
P 
value 
In-hospital: 
n (%) 
3 (3) 11 (16) 0.001 
6.76 (1.89 
to 24.23) 
0.003 
6.04(1.64 
to 22.25) 
0.007 2 (4) 1 (7) 0 (0) 5 (25) 0.03 
30 day: 
n (%) 
5 (4) 11 (16) 0.01 
4.07 (1.41 
to 11.41) 
0.009 
3.52 
(1.19 to 
10.41) 
0.024 3 (7) 1 (7) 0 (0) 5 (25) 0.07 
90 day: 
n (%) 
16 (14) 16 (23) 0.09 
1.91 (0.95 
to 3.82) 
0.068 
1.82 
(0.90 to 
3.65) 
0.095 7 (15) 3 (21) 2 (17) 8 (40) 0.15 
One year: 
n (%) 
28 (24) 19 (28) 0.57 
1.20 (0.67 
to 2.13) 
0.542 
1.14  
(0.64 to 
2.03) 
0.655 13 (28) 4 (29) 3 (25) 9 (45) 0.53 
a Mortality rate after admission to hospital. b Model adjusted for age, gender, illness severity- National Early Warning Score (NEWS), Comorbidities-Charlson 
Comorbidity Index (CCI), Frailty- Canadian Study of Health and Aging (CSHA) and nutrition- Nutrition Risk Screening (NRS) 2002.+Comparing with those 
euhydrated at admission. Dehydrated refers to hyperosmolar dehydration (serum osmolality >300 mOsmol/kg). 
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5.5 Discussion 
This study has demonstrated that when using serum osmolality as a marker of 
hydration, HD appeared to be present in over a third of older adults admitted 
to hospital as medical emergencies. This may be a result of late presentation 
resulting from delayed recognition/detection of HD in the community setting 
by the participants, carers or HCPs. This study also reports for the first time, 
the prevalence of HD at 48 hours after admission, which was similar to that at 
admission.  
The prevalence of HD increased with age suggesting that older adults are 
more vulnerable to dehydration during their hospital admission. This may be a 
consequence of age-related pathophysiological changes that render older 
adults susceptible to salt and water imbalance or a result of increased 
comorbidities and associated polypharmacy which further impairs 
homeostatic mechanisms (El-Sharkawy et al., 2014).  
This study also highlights the poor outcome associated with HD in hospitalised 
older adults. Overall, participants diagnosed with HD at admission were 
shown to be six times more likely to die in hospital compared with those 
without HD, independent of key confounders such as age, gender, CCI 
(includes cause of admission), NEWS and risk of malnutrition. These findings 
are in keeping with a previously published US study where the authors 
reported a 17% 30-day mortality and a 48% one-year mortality in participants 
admitted with dehydration diagnosed clinically, without adjustment for 
confounders (Warren et al., 1994).  
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The causes of this are likely to be multifactorial, with undiagnosed HD possibly 
being a major contributing factor, given that nearly a quarter of those with HD 
at admission were also diagnosed with AKI by the medical team during the 
hospital stay. These findings also suggest that AKI may be a strong 
contributing factor to mortality in the HD group, as was reported by the 2009 
UK National Confidential Enquiry into Patient Death which highlighted that as 
many as 12,000 deaths could be prevented annually within the NHS by 
treating the ‘avoidable’ causes of AKI such as dehydration (National 
Confidential Enquiry into Patient Outcome and Death, 2009, Ftouh and 
Thomas, 2013).  
No significant differences in LOS were observed between the two groups, 
however, this is probably a consequence of the complex and often lengthy 
process (including non-medical issues) of discharge of the older adult from 
hospital.  
One of the challenges facing HCP is the difficulty in diagnosing dehydration in 
older adults given the complex nature of this condition and its associated 
clinical manifestations. This study demonstrated that in this setting there 
were significant differences between groups in some of the biomarkers of 
hydration including, urea, creatinine and sodium. However, there were few 
differences in some of the clinical features typically associated with 
dehydration.  
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5.6 Limitations 
Some limitations should be considered when interpreting these results. This 
was a single centre study, although the hospital is one of the largest in the UK 
serving a diverse population that represents the wider UK population.  
Many scientists and clinicians support serum osmolality as one of the most 
accurate objective measures of hydration status. Hyperosmolality, however, 
does not represent all forms of dehydration but rather only that associated 
with hypertonicity. Dehydration associated with excess salt and water loss 
may present with hypoosmolality (Sawka et al., 1996, Thomas et al., 2008, 
Armstrong et al., 2013b). Moreover, salt-free oral fluid consumption or 
intravenous administration may also result in hypoosmolality, highlighting the 
need to consider salt and water balance when using serum osmolality to 
assess hydration status (Lobo et al., 2001b, Kenney et al., 1990).  
It is also important to consider that the use of serum osmolality to assess 
hydration status does not necessarily represent the overall 24-hour fluid 
balance, but rather the hydration status at the time of blood sampling given 
that serum osmolality is tightly regulated (Armstrong et al., 2013a). Moreover, 
using serum osmolality of >300 mOsmol/kg to define HD may denote a state 
of severe HD of approximately 4-5% of body weight and may therefore have 
underestimated the prevalence of HD in this study (Armstrong et al., 1997, 
Cheuvront et al., 2013).  
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HD may be a manifestation of disease severity, and an increase in mortality 
would therefore be expected, although attempts were made to account for 
confounders including age, gender, frailty, nutritional status and cause of 
admission and comorbidities using the CCI as well as illness severity (NEWS). 
However, although validated and widely used, the CCI does not account for all 
comorbidities. 
This study included a relatively small sample of patients although likely to be 
representative of the wider population. However, further work is required to 
clarify the prevalence of HD and indeed clinically diagnosed dehydration in a 
larger population and assess the impact on outcome. 
  
5.7 Conclusion 
This study highlights a high prevalence of HD in older adults admitted to 
hospital as a medical emergency, and shows that a significant proportion 
remained dehydrated 48 hours after admission. Despite accounting for 
confounding variables, HD was associated with increased risk of death.  
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6.1 Introduction 
Maintenance of fluid and electrolyte balance is essential to normal 
physiological function and older adults are susceptible to fluid and electrolyte 
imbalance due to numerous factors associated with ageing. (El-Sharkawy et 
al., 2014) Cognitive impairment can inhibit the recognition of dehydration-
related symptoms, physical disability may restrict access to water, (Gaspar, 
1999) and embarrassment associated with urinary urgency and incontinence 
may force older adults to restrict their fluid intake. 
Studies have reported an association between acute and chronic dehydration 
and several other conditions including urinary tract infections, urolithiasis, 
delirium as well as respiratory, gastrointestinal and cardiovascular disorders. 
(El-Sharkawy et al., 2015a, Manz and Wentz, 2005)   
Dehydration has also been linked with mortality (Warren et al., 1994, El-
Sharkawy et al., 2015b). A pilot study was conducted (Chapter 5) to 
investigate the prevalence of dehydration at admission in 200 older adults 
and reported that HD (serum osmolality >300 mOsmol/kg) was associated 
with a six-fold increase in the in-hospital mortality, independent of age, 
gender, nutritional status, frailty, comorbidities (CCI) and illness severity 
(NEWS) (El-Sharkawy et al., 2015b). Moreover, it showed that the prevalence 
of HD was significantly greater than clinically reported dehydration (El-
Sharkawy et al., 2015b). Furthermore, a study from the US also reported low 
prevalence of clinically diagnosed dehydration which was associated with a 
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17% 30 day mortality (Warren et al., 1994). However, it is unclear whether the 
findings from the US studies reflect the prevalence of dehydration and impact 
on outcome in UK centres.  
This study aimed to measure the prevalence of dehydration diagnosed 
clinically during hospital admission in older adults. This study also aimed to 
assess the effects of dehydration diagnosed clinically on mortality and LOS.  
 
6.2 Hypothesis 
We hypothesised that the prevalence of clinically reported dehydration would 
be low, consistent with previous findings from the US and those reported in 
Chapter 5. Clinically reported dehydration would be associated with increased 
mortality independent of confounders as was reported in Chapter 5. 
Moreover, dehydration would also likely be associated with increased hospital 
stay given the association with increased age and comorbidity (Warren et al., 
1994, El-Sharkawy et al., 2015b)  
 
6.3 Methodology 
This retrospective cohort study in older adult patients aged ≥ 65 years was 
conducted using data from a large UK university teaching hospital NHS Trust. 
The diagnosis of dehydration (ICD-10 E86.X) was recorded by the hospital’s 
coders where hospital clinicians diagnosed patients to be in a state of severe 
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dehydration or dehydration treated with IV solutions and excludes other 
diagnoses of hypovolaemia consistent with national coding protocols. 
 Sub group analysis 6.3.1
The principal diagnoses corresponding to each admission were grouped into 
disease categories according to ICD-10 chapters to allow for sub-group 
analysis of conditions that commonly cause hospital admission in older adults. 
This included cardiovascular, respiratory and gastrointestinal conditions. 
Covariates calculated above were used in this analysis. However, the CCI did 
not include the primary cause of hospital admission for this analysis. Details of 
the methods used are listed in Chapter 3. 
 
6.4 Results 
 Prevalence of dehydration 6.4.1
A total of 42,553 unique patient records were identified between 1 April 2011 
and 31 October 2013, of which 32,980 (77.5%) patients were admitted to 
medical specialties. Figure 15 describes cohort selection methods and Table 
22 lists the summary of the patient characteristics.  
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Figure 15: Data selection methods to investigate the prevalence of clinically 
diagnosed dehydration amongst hospitalised older adults: *
 
First admission 
episode selected. 
# 
Dehydrated patient episodes selected over non-dehydrated 
episodes.  
 
 
Patients admitted to medical specialties 
(n=32,980) 
Dehydration as primary 
cause of admission (PD) 
(n=227) 
Dehydration SD  
(n=3,022) 
All older adults admitted to hospital acutely between 1
st
 April 2011 and 31
st
 October 2013 
(n=80,591) 
Dehydration PD & SD 
(n=2,924)  
Dehydration as 
secondary diagnosis (SD)  
(n=3,254) 
No dehydration in 
any diagnosis 
category  
(n=77,110) 
Dehydration PD 
(n=220) 
No dehydration  
 (n=41,470)  
Duplicates*  
(n= 7) 
Duplicates *  
(n= 232) 
Duplicates *  
(n= 35,640) 
Duplicates
 #
  
(n= 318) 
Duplicates
 #
 (n= 1841) 
Surgical admissions  (n= 9,573) 
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Table 22: Demographics and characteristics of the study cohort. Comparing 
those with and without dehydration during hospitalisation. 
 
All patients 
(n=32980) 
Without 
dehydration 
(n=30048) 
With 
dehydration 
(n=2932) 
P 
value* 
Age (years): 
n (%) 
65 - 75 1386 (4.2) 1338 (4.5) 48 (1.6) 
<0.001 
76 - 85 23651 (71.7) 21790 (72.5) 1861 (63.5) 
86 - 95 7338 (22.3) 6405 (21.3) 933 (31.8) 
>95 605 (1.8) 515 (1.7) 90 (3.1) 
Gender: n 
(%) 
Female 17670 (53.6) 16102 (53.6) 1568 (53.5) 
<0.001 
Male 15310 (46.4) 13946 (46.4) 1364 (46.5) 
Charlson 
Comorbidity 
Index: n (%) 
None 8100 (24.6) 7717 (25.7) 383 (13.1) 
<0.001 
Mild 15172 (46.1) 14015 (46.6) 1157 (39.5) 
Moderate 5665 (17.2) 4993 (16.6) 672 (22.9) 
Severe 4043 (12.3) 3323 (11.1) 720 (24.6) 
Admission 
Method: n 
(%) 
ED 20860 (63.3) 19272 (64.1) 1588 (54.2) 
<0.001 GP 9886 (30.0) 8738 (29.1) 1148 (39.2) 
other 2234 (6.8) 2038 (6.8) 196 (6.7) 
*P value comparing patients with and without dehydration. ED-Emergency department. 
GP- General Practice  
 
 
Dehydration was noted in 2,932 (8.9%) patients and was the primary cause of 
admission in 190 (0.6%). Patients with dehydration had greater mean (SD) 
age, 81.4 vs. 78.6 years, and higher median CCI score, 2 (1, 4) vs. 1 (0, 3) 
P<0.001. The prevalence of dehydration was also shown to increase with age 
and comorbidity (Figure 16). 
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Figure 16: (Top) Prevalence of dehydration with increased age. (Bottom) 
Prevalence of dehydration with Charlson Comorbidity Index unadjusted for 
age. ‘None’ (no comorbidity, 0 points), ‘Mild’ (mild comorbidity, 1-2 points), 
‘Moderate’ (moderate comorbidity, 3-4 points) and ‘Severe’ (severe 
comorbidity, ≥5 points) 
 Dehydration and acute kidney injury 6.4.2
AKI was reported in 1,399 (47.7%) patients with dehydration, compared with 
4,768 (15.9%) patients without dehydration, P<0.001. Moreover, a greater 
proportion of those with dehydration had stage 3 AKI, compared with those 
without dehydration, 22.2% vs. 12.3%, respectively, P<0.001. Delirium, 
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dementia and urinary tract infections (UTI) were also more prevalent in those 
with dehydration (Table 23). 
Table 213: Hydration status and associated conditions. 
 
 Dehydration and mortality  6.4.3
Mortality rates at all time points were consistently higher in patients 
diagnosed with dehydration (Table 20). Kaplan Meier survival plots 
demonstrated a significant reduction in survival in those diagnosed with 
dehydration, and whilst the rate of death in those with dehydration reduced 
with time, the difference in mortality was maintained one year after 
admission, P<0.001 (Figure 17). Cox regression analysis adjusted for age, 
gender and comorbidity (CCI) demonstrated that those with primary or 
secondary diagnoses of dehydration were twice as likely to die in-hospital, HR 
2.11 (1.92 to 2.32), P<0.001. Table 24 lists the unadjusted and adjusted HR for 
 
Without 
dehydration 
(n=30048) 
With 
dehydration 
(n=2932) 
P value 
Acute kidney injury: n (%) 4768 (15.9) 1399 (47.7) <0.001 
Acute kidney 
injury stage: n (%) 
Stage 1 3249 (68.1) 713 (51.0) 
<0.001 Stage 2 933 (19.6) 375 (26.8) 
Stage 3 586 (12.3) 311 (22.2) 
Urinary tract infection: n (%) 1026 (3.4) 222 (7.6) <0.001 
Dementia: n (%) 2541 (8.5) 581 (19.8) <0.001 
Delirium: n (%) 599 (2.0) 187 (6.4) <0.001 
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the 30- and 90-day mortality as well as one-year post admission mortality. 
Sub-group analysis revealed similar trends associated with dehydration that 
were independent of the primary cause of hospital admission for patients 
admitted with principal diagnoses (ICD-10) of cardiovascular, respiratory or 
gastrointestinal disease (Table 25a, 25b and Figure 18a and 18b).  
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Figure 17: Kaplan Meier survival plot demonstrating differences in mortality 
for dehydration as a primary diagnosis (top), and as a secondary diagnosis 
(bottom). 
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Table 22: Dehydration and outcome in older adults admitted to hospital, comparing those with and without clinically reported dehydration 
using Cox and linear regression analysis. 
  
In-hospital 
mortality 
P value 
30-day 
mortality 
P value 
90-day 
mortality 
P 
value 
one year 
mortality 
P value 
Without 
Dehydration 
(n=30048) 
n (%) 2133 (7.1) - 2526 (8.4) - 416 (13.8) - 7422 (24.7) - 
Dehydration 
recorded in any 
diagnosis 
category 
(n=2932) 
n (%) 580 (19.8) <0.001 700 (23.9) <0.001 1076 (36.7) <0.001 1545 (52.7) <0.001 
Unadjusted 
2.96 (2.70 to 
3.24) 
<0.001 
3.015 (2.77 to 
3.278) 
<0.001 
3.02 (2.82 to 
3.22) 
<0.001 
2.68 (2.54 to 
2.83) 
<0.001 
Adjusted* 
2.12 (1.92 to 
2.32) 
<0.001 
2.16 (1.98 to 
2.35) 
<0.001 
2.127 (1.984 to 
2.280) 
<0.001 
1.91 (1.8 to 
2.02) 
<0.001 
Dehydration 
(PD) (n=190) 
n (%) 19 (10.0) 0.37 32 (16.8) 0.001 56 (29.5) <0.001 84 (44.2) <0.001 
Unadjusted 
1.24 (0.97 to 
2.40) 
0.348 
1.755 (1.239 
to 2.487) 
<0.002 
1.982 (1.523 to 
2.579) 
<0.001 
1.83 (1.48 to 
2.27) 
<0.001 
Adjusted* 
0.92 (0.59 to 
1.44) 
0.712 
1.304 (0.922 
to 1.846) 
0.133 
1.44 (1.10 to 
1.89) 
0.003 
1.34 (1.07 to 
1.68) 
<0.001 
Dehydration 
(SD) (n=2744) 
n (%) 561 (20.4) <0.001 668 (24.3) <0.001 1020 (37.2) <0.001 1461 (53.2) <0.001 
Unadjusted 
3.07 (2.80 to 
3.37) 
<0.001 
3.052 (2.845 
to 3.268) 
<0.001 
3.05 (2.85 to 
3.27) 
<0.001 
2.72 (2.57 to 
2.872) 
<0.001 
Adjusted* 
2.19 (2.0 to 
2.41) 
<0.001 
2.15 (2.0 to 
2.31) 
<0.001 
2.15 (2.01 to 
2.310) 
<0.001 
1.934 (1.821 to 
2.052) 
<0.001 
*Adjusted for Age, gender and Charlson Comorbidity Index. PD primary cause of admission. SD, secondary diagnosis. The data demonstrates a 
significant reduction in survival in those diagnosed with dehydration as PD, SD or in any diagnosis category, and whilst the rate of death in those with 
dehydration reduced with time, the difference in mortality was maintained one year after admission even after adjusting for key confounders P<0.001. 
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Table 235a: Dehydration and outcome in older adults admitted to hospital, comparing those with and without clinically reported dehydration 
using univariate and multivariate Cox regression analysis. 
Primary diagnosis
+
 
 
In-hospital 
mortality 
P value 
30-day 
mortality 
P value 
90-day 
mortality 
P value 
One year 
mortality 
P value 
Length of 
hospital 
stay*: 
Median (Q1, 
Q3) 
P value 
Cardiovascular 
disease 
Without 
dehydration: n(%) 
535 (8.81) 
<0.001 
587 (9.67) 
<0.001 
809 (13.33) 
<0.001 
6070 (21.6) 
<0.001 
3 (1, 8) 
<0.001 
With dehydration: 
n(%) 
40 (25.97) 44 (28.57) 69 (44.81) 88 (57.14) 15 (5, 19) 
Unadjusted HR 
3.15 (2.28 to 
4.34) 
<0.001 
3.13 (2.31 to 
4.25) 
<0.001 
3.817 (2.99 to 
4.88) 
<0.001 
3.44 (2.77 to 
4.27) 
<0.001 - - 
Adjusted HR
#
 
2.14 (1.55 to 
2.95) 
<0.001 
2.13 (1.56 to 
2.90) 
<0.001 
2.53 (1.98 to 
3.22) 
<0.001 
2.15 (1.70 to 
2.72) 
<0.001 - - 
Respiratory disease 
Without 
dehydration: n(%) 
519 (13.59) 
<0.001 
601 (15.74) 
<0.001 
800 (20.95) 
<0.001 
1226 (32.11) 
<0.001 
4 (1,8) 
<0.001 
With dehydration: 
n(%) 
110 (30.64) 132 (36.77) 179 (49.86) 233 (64.9) 9 (5, 17) 
Unadjusted HR 
2.41 (1.96 to 
2.96) 
<0.001 
2.52 (2.08 to 
3.04) 
<0.001 
2.75 (2.34 to 
3.24) 
<0.001 
2.71 (2.35 to 
3.11) 
<0.001 - - 
Adjusted HR
# 1.77 (1.44 to 
2.18) 
<0.001 
1.90 (1.57 to 
2.30) 
<0.001 
2.02 (1.71 to 
2.38) 
<0.001 
2.01 (1.74 to 
2.32) 
<0.001 - - 
+
Three most common admission diagnosis categories. 
#
Adjusted for Age, gender and Charlson Comorbidity Index.* length of hospital stay excluding in-hospital mortality. 
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Table 25b: Dehydration and outcome in older adults admitted to hospital, comparing those with and without clinically reported dehydration 
using univariate and multivariate Cox regression analysis. 
Primary diagnosis
+
 
 
In-hospital 
mortality 
P value 
30-day 
mortality 
P value 
90-day 
mortality 
P value 
One year 
mortality 
P value 
Length of 
hospital 
stay*: 
Median (Q1, 
Q3) 
P value 
Gastrointestinal 
disease 
Without 
dehydration: n(%) 
113 (7.99) 
<0.001 
124 (8.77) 
<0.001 
188 (13.3) 
<0.001 
341 (24.12) 
<0.001 
2 (1, 5) 
<0.001 
With dehydration: 
n(%) 
40 (19.32) 40 (19.32) 69 (33.33) 102 (49.28) 6 (3,15) 
Unadjusted HR 
2.52 (1.76 to 
3.62) 
<0.001 
2.28 (1.60 to 
3.26) 
<0.001 
2.74 (2.076 to 
3.61) 
<0.001 
2.39 (1.92 to 
2.99) 
<0.001 - - 
Adjusted HR
#
 
1.88 (1.31 to 
2.69) 
<0.001 
1.67 (1.16 to 
2.40) 
<0.001 
2.03 (1.54 to 
2.67) 
<0.001 
1.83 (1.45 to 
2.29) 
<0.001 - - 
+
Three most common admission diagnosis categories. 
#
Adjusted for Age, gender and Charlson Comorbidity Index.* length of hospital stay excluding in-hospital mortality. Sub-group analysis 
revealed significant reduction in survival in those diagnosed with dehydration as a secondary diagnosis. This increased mortality was independent of the primary cause of hospital admission 
for patients admitted with principal diagnoses (ICD-10) of cardiovascular, respiratory or gastrointestinal disease as well as key confounders (CCI).  
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Figure 18a: Kaplan Meier survival plot demonstrating differences in mortality 
between patients with and without dehydration for patients admitted with a 
primary diagnosis of (a) cardiovascular and  (b) respiratory conditions 
categorised according to ICD-10. 
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Figure 18b: Kaplan Meier survival plot demonstrating differences in mortality 
between patients with and without dehydration for patients admitted with a 
primary diagnosis of (a) gastrointestinal conditions categorised according to 
ICD-10. 
 
 Dehydration and length of hospital stay 6.4.4
The median (Q1, Q3) LOS (excluding in-hospital deaths) in the 190 patients 
admitted with a primary diagnosis of dehydration was 4 (1, 9) days. Patients 
diagnosed with dehydration during their hospital admission (n=2,932) had a 
median (Q1, Q3) LOS of 8 (4, 19) days compared with 3 (1, 8) days for patients 
without the condition, P<0.001. The greatest difference was seen in patients 
admitted with acute cardiovascular conditions where the median LOS was 13 
(5, 19) days for patients diagnosed with dehydration compared with 3 (1, 8) 
days for patients without the diagnosis, P<0.001. 
  
a 
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 Data validation  6.4.5
Two hundred medical records were identified randomly and audited by the 
study team: 169 (85%) were diagnosed with dehydration, 73 (43%) of these 
were diagnosed by an experienced clinician (specialist registrar or consultant). 
A second investigator also audited 164 of the selected notes independently 
and both agreed that in 124 (76%) cases that the diagnosis of dehydration was 
appropriate, with ‘substantial agreement’, Kappa statistic 0.754, P<0.001. 
Biochemical validation was conducted for 6,155 patient admissions that had 
the required serum biochemistry measures for the equation by Krahn and 
Khajuria, 2006. Patients diagnosed clinically with dehydration had a mean (SD) 
osmolarity of 301 (22) vs.294 (12) for patients without dehydration, P<0.001. 
6.5 Discussion 
The present study highlights that clinically diagnosed dehydration was 
reported in nearly 10% of hospitalised older adults. Half of these patients 
were also diagnosed with AKI, using a validated automatic detection algorithm 
incorporating internationally accepted criteria (based on rise in serum 
creatinine, SCr). Dehydration was associated with a significant increase in LOS 
and the risk of death in older adults diagnosed with dehydration was twice 
that of patients without the diagnosis, independent of age, gender and 
comorbidities. 
The findings of the present UK study are consistent with a previous report 
from the US which also used clinical coding criteria. (Warren et al., 1994) 
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Warren et al., 1994 reported that 1.4% of the 10 million older adult 
admissions reviewed were diagnosed with dehydration as the principal cause 
of hospitalisation and 6.7% as a secondary diagnosis. However, the prevalence 
of dehydration reported clinically was significantly lower than estimates based 
on biochemical measures of dehydration. (Stookey et al., 2005, Bennett et al., 
2004, El-Sharkawy et al., 2015b). Stookey et al, 2005 used the 1992 
Established Populations for Epidemiologic Studies of the Elderly to classify 
1,737 older adult participants according to multiple dehydration indices and 
reported that up to 60% of community-dwelling older adults were 
dehydrated. Others have demonstrated that up to 48% of older adults were 
dehydrated at admission to hospital, although significant variations have been 
reported depending on the method used to assess for the condition. (Stookey 
et al., 2005, Bennett et al., 2004). The significant disparity in the prevalence of 
dehydration between biochemical and clinically-diagnosed dehydration is 
likely to be multifactorial. Firstly, in the present study, only patients with 
severe dehydration or dehydration requiring IV fluid therapy were captured 
by the coders. Secondly, there are significant challenges with diagnosing 
dehydration in older adults due to the lack of specific clinical features which 
are often erroneously attributed to other causes. This, together with the 
current absence of validated hydration assessment tools compounds the 
problem and results in undiagnosed and therefore underreported 
dehydration in the clinical settings.  
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The present study highlights several key conditions associated with 
dehydration including dementia, delirium and UTI, although it is difficult to 
determine whether these conditions were present as a consequence of 
dehydration or have resulted in dehydration. However, several healthy 
volunteer studies have previously linked dehydration with cognitive 
impairment and morphological brain changes (increased ventricular size 
proportional to body weight loss). (Kempton et al., 2009, Dickson et al., 2005) 
Direct inverse associations between dehydration and delirium have also been 
reported in residents of nursing homes. (Seymour et al., 1980, Voyer et al., 
2009) In the case of UTI, animal models have demonstrated that increased 
urinary volume and flow reduces the antimicrobial load and the associated 
reduced urine osmolality provides a favourable environment for immune cell 
activity. (Beetz, 2003) Clinical studies have also shown that increased fluid 
consumption may prevent UTI recurrence. (Beetz, 2003) 
Dehydration as a primary or secondary diagnosis was shown to be associated 
with poor outcome in hospitalised older adults. Patients admitted to hospital 
with a primary diagnosis of dehydration had a 16.8%, 30 day and 44.2%, one-
year mortality. Moreover, patients diagnosed with dehydration in any 
diagnosis category during their hospital admission were twice as likely to die 
in hospital compared with those without the diagnosis, independent of age, 
gender and comorbidity (CCI).  
This relationship continued after stratifying for common causes of hospital 
admissions categorised in accordance with ICD-10. Patients admitted with 
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cardiovascular, respiratory or gastrointestinal conditions and diagnosed with 
dehydration during their hospital episode had a two-fold increase in the risk 
of in-hospital mortality compared with those admitted with the same 
diagnosis category but not reported to be dehydrated clinically. This was also 
independent of age, gender and comorbidities (CCI). These finding are 
supported by studies linking serum hyperosmolality with poor outcome 
following acute coronary syndrome and stroke. (Bhalla et al., 2000, Rohla et 
al., 2014) 
One potential explanation for this increased mortality rate associated with 
dehydration is late clinical detection given that nearly half of those with 
dehydration had a concomitant diagnosis of AKI, which is associated with high 
mortality. (Lewington and Kanagasundaram, 2011). The relationship between 
dehydration and AKI is complicated by the fact that modern definitions of AKI 
are based on rises in SCr. Some definitions suggest that dehydration should be 
excluded as a cause of rise in SCr before a diagnosis of AKI is given. In practice 
this is difficult, particularly with increasing use of AKI e-alerts. (Porter et al., 
2014) These findings also highlight the importance of early diagnosis of 
dehydration.  
Significantly greater LOS was demonstrated in patients diagnosed with 
dehydration compared with those without. The median LOS for patients 
admitted with a primary diagnosis of dehydration was 4 days. In the case of 
dehydration as a secondary diagnosis, the LOS was nearly three-times that of 
those without dehydration (8 days vs. 3 days respectively). If this increase in 
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LOS was a direct consequence of dehydration, it would equate to substantial 
avoidable costs. It is important to note however, that any cost implications 
related to dehydration are difficult to fully quantify given that dehydration is 
underreported using current methods.  
6.6 Limitations 
This study reports significant findings with potential clinical implications, 
however, there are some limitations that need to be considered when 
interpreting the results. Firstly, dehydration may be a manifestation of disease 
severity and therefore, increased LOS and mortality would be expected. 
However, the regression modelling demonstrated that dehydration was 
associated with poor outcome independent of age, gender and comorbidities.  
Secondly, this was a single centre study and may not be representative of 
other UK centres, although numerous publications from hospital and 
community settings suggest that fluid mismanagement may be more 
widespread. (Powell and Paterson-Brown, 2011, 2009, Leach et al., 2013) 
Finally, this was a retrospective study that was dependent on accuracy of 
coding for the diagnosis. Diagnosing dehydration is difficult in older adults and 
therefore the prevalence may have been underestimated. However, the 
accuracy of entry of data was validated by auditing case notes. Moreover, 
local and independent audits demonstrated that the diagnosis was both 
appropriate and accurate in the majority of cases. Furthermore, serum 
osmolarity was used as an objective measure of dehydration to support the 
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accuracy of the data. However, further work is required using objective 
measures to assess the prevalence of dehydration and the relationship with 
AKI and outcome.  
6.7 Conclusions 
This study highlights that a small but significant proportion of hospitalised 
older adults are diagnosed with severe dehydration which is associated with a 
substantial increase in LOS and mortality, independent of age, gender and 
comorbidities. Despite the limitations reported, the implications of this study 
are serious and require further investigation to help prevent avoidable 
morbidity and mortality as well as reduce costs. 
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 An analysis of 7.
equations to 
calculate 
osmolarity and 
predict 
hyperosmolar 
dehydration in 
hospitalised older 
adults 
  
  141 
7.2 Introduction 
Dehydration indicates a loss of body water resulting in a state of 
hypohydration, and depending on the corresponding amounts of electrolyte 
loss in addition to water, may be classified as isotonic, hypotonic or 
hypertonic. A diagnosis of dehydration should therefore be considered in the 
context of changes in serum electrolyte concentrations as well as tonicity 
(serum osmolality). Iso-osmolar dehydration occurs when salt loss is 
proportional to water loss. Hypoosmolar dehydration occurs in approximately 
2.8% of community-dwelling older adults and results from greater salt than 
water loss (Stookey et al., 2004). Conversely, hyperosmolar dehydration 
results from greater water than solute loss and is thought to be the most 
common form of dehydration in older adults, reported in up to 60% of “well” 
community-dwelling older adults (Stookey et al., 2004, Stookey et al., 2005).  
Current clinical methods of assessing and monitoring hydration status are 
unreliable in older adults Schols et al., 2009, Shimizu et al., 2012b, Shimizu et 
al., 2012a, Fortes et al., 2014, Eaton et al., 1994, Fletcher et al., 1999, McGee 
et al., 1999, Weinberg and Minaker, 1995). Serum osmolality (mOsmol/kg) is a 
measure of solute concentration as measured by freezing point depression. It 
is widely seen as the most reliable objective measure of hydration status 
(Bhalla et al., 2000, Sollanek et al., 2011, Cheuvront et al., 2013, Cheuvront et 
al., 2010, Stookey et al., 2005). Although widely used in human physiological 
research settings, it has not been fully adopted in clinical practice. This may be 
due to a combination of limited awareness and financial constraints. There is 
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also a lack of evidence supporting serum osmolality as an effective clinical tool 
to aid the assessment of hydration status or as a predictor of kidney injury or 
outcome in patients.      
For a given solution such as plasma or other body fluid, osmolality 
(mOsmol/kg), is the number of osmotically active solutes per kilogram 
contributing to the solution’s osmotic pressure.  
 Osmolarity (mOsmol/l or mmol/l) is less than osmolality, because the total 
solvent mass used in the expression of osmolarity excludes the mass of any 
solutes present.  
At physiological solute concentrations, the mass of the solute is small relative 
to the mass of the solvent, but the solutes do not behave as perfect osmolytes 
so the differences between calculated osmolarity and the measured 
osmolality are likely to be small with little clinical significance. Therefore, in 
the present clinical study, mOsmol/kg is equivalent to mOsmol/l. Moreover, 
differences in equations were measured in mmol/l; equivalent to mOsmol/l, 
given that one mmol/l of osmotically active solute equates to an osmolarity of 
one mOsmol/l. 
Several equations have been published that use routinely measured 
biochemical parameters to calculate serum osmolarity or to estimate serum 
osmolality. Osmolarity was originally used in clinical practice to estimate the 
osmolar gap, the difference between measured serum osmolality and 
calculated osmolarity used to guide clinical treatment of unmeasured 
  143 
osmotically active substances such as ethanol and methanol (Glasser et al., 
1973, Lynd et al., 2008).  
The accuracy of 36 published equations for the estimation of serum 
osmolarity or osmolality was assessed in a population that included acutely ill 
hospital patients (n = 195) as well as adults attending outpatient clinics (n = 
41) (Fazekas et al., 2013). The authors reported that mean differences upto 35 
mmol/l were observed between measured and calculated osmolality using 
some published formulae, but the mean difference could be as little as 0.5 
mmol/l depending on the equation used (Fazekas et al., 2013). Nonetheless, 
even when there was good agreement between measured and predicted 
mean values, a large error was observed in individual values: even the “best” 
equation gave a 95% confidence interval of -6.5 to 7.5 mmol/l. Siervo et al., 
2014 investigated the accuracy of osmolarity equations in community-
dwelling older adults and demonstrated that some can be 97% sensitive at 
predicting HD (serum osmolality >300 mOsmol/kg). However, to our 
knowledge no studies have assessed the accuracy of these equations in 
hospitalised older adults in diagnosing hyperosmolar dehydration. Such 
equations are not only useful in research settings but may also allow use in 
clinical practice to assess and monitor hydration status.  
This study aimed to assess the accuracy of 35 published equations (Fazekas et 
al., 2013, Siervo et al., 2014) in estimating measured serum osmolality and 
diagnosing hyperosmolar dehydration. 
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7.3 Methodology 
An electronic database from a large UK university teaching hospitals NHS trust 
was searched by a specialist data analyst who retrieved data relating to 
patients aged ≥ 65 years admitted to medical specialties as an emergency 
between the 1 April 2011 and 31 October 2013. The methods used to select 
the cohort are summarised in Figure 19. HD was defined as measured serum 
osmolality >300 mOsmol/kg, measured by freezing point depression (Thomas 
et al., 2008, Armstrong, 2007, Armstrong, 2005).  
7.4 Osmolarity estimate  
With the widespread use of bedside glucose monitoring, laboratory blood 
glucose measurements are no longer performed routinely. Therefore, in order 
to investigate the suitability of the equations to estimate serum osmolality 
and thus diagnose HD, the two most accurate osmolarity equations were 
adapted by replacing the blood glucose concentration with a constant value. 
The constant values were derived from median/mean population values, 
stratified by diabetes status. The results were compared with 35 equations 
published previously (Edelman et al., 1958, Holmes, 1962, Jackson and 
Forman, 1966, Gerich et al., 1971, Jetter, 1969, Mahon et al., 1968, Boyd and 
Baker, 1971, Dorwart, 1973, Glasser et al., 1973, Ross and Christie, 1969, 
Stevenson and Bowyer, 1970, Wilson, 1973, Bhagat et al., 1984, Dorwart and 
Chalmers, 1975, Jenkins and Larmore, 1974, Snyder et al., 1992, Hoffman et 
al., 1993, Koga et al., 2004, Rasouli and Kalantari, 2005, Wojtysiak et al., 1999, 
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Khajuria and Krahn, 2005, Bianchi et al., 2009) and complied in two 
publications (Fazekas et al., 2013), (Siervo et al., 2014).  
7.5 Statistical analysis 
Statistical analysis was performed as outlined in Chapter 3. In addition, to 
assess whether estimated osmolality differed systematically from measured 
osmolality, mean (SD/95% CI) differences between the two values were 
calculated for each of the equations and differences of <2 mmol/l were 
considered to be meaningful. The Bland-Altman method (Dewitte et al., 2002, 
Connelly, 2008) was used to assess whether differences depended on the 
magnitude of the osmolality values. Regression analysis was performed on the 
mean and differences between osmolality and osmolarity to investigate 
further the effects relating to the magnitude of the values. Sensitivity and 
specificity analyses were performed using area under the curve (AUC) and 
receiver operating characteristic (ROC) analysis (Zweig and Campbell, 1993). 
To compare the findings of this study with those of Siervo et al., 2014, their 
online supplementary table containing mean of the difference and SD was 
used. SD was converted to 95% CI.  
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All serum osmolality 
measurements between  
1
st
 April 2011 and  
31
st
 October 2014  
n=5228 
Patients admitted to 
medical specialties  
n=5012 
Patients with all the relevant 
serum biochemistry  
n=565 
Exclusions: 
• Alcohol related 
admission: n=69 
• Patents diagnosed with 
GI bleed: n=147 
Biochemistry unavailable  
• Na: n=215 
• K: n=508 
• Urea: n=48 
• Glucose: n=3676 
Patients with all 
biochemistry results 
n=217 
*Duplicates removed 
n=348  
Figure 19: Cohort selection methods. All serum osmolality measurements were 
identified together with the biochemistry performed on the same sample.  Patients 
who did not have a reported serum sodium, potassium, urea and glucose were 
excluded. In addition, patients admitted with methanol poisoning or any alcohol 
related conditions including alcohol intoxication were excluded to reduce the risk of an 
artificially high osmolar gap. Patients admitted with hypovolaemia resulting from blood 
loss including those with gastrointestinal bleeding, were also excluded to minimise the 
effects of non-water loss hypovolaemia. In cases where more than one serum 
osmolality was measured during the same admission, only the first measurement was 
selected. *duplicates indicate multiple serum osmolality measurements from the same 
patient, first value was preferentially selected. K-Potassium, Na-Sodium. 
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7.6 Results  
 Cohort description  7.6.1
Of the 5228 measurements of serum osmolality made, 217 unique older adult 
patient records were identified who had serum osmolality, sodium, 
potassium, urea and glucose, all measured from the same blood sample 
(Figure 19). HD was present in 51 (23%) patients, of which, 28 (55%) had 
diabetes. Table 26 lists the patient demographics and summarises the 
measured serum biochemistry for the cohort.  
 
Table 246: Cohort demographics and serum biochemistry, comparing patients 
with and without diabetes.   
  
All patients 
(n=217) 
Patients 
without 
diabetes 
(n=155) 
Patients 
with 
diabetes 
(n=62) 
P value 
Age (years): mean (SD) 78.4 (8.2) 77.9 (8.2) 79.2 (7.1) 0.288 
Charlson Comorbidity 
Index : median (Q1,Q3) 
1 (1,3) 1 (0, 2) 3 (2, 5) <0.001 
Gender:  
n (%) 
Female 126 (58) 90 (58.1) 36 (58.1) 
0.996 
Male 91 (52) 65 (41.9) 26 (41.9) 
Serum Osmolality 
(mOsmol/kg): mean (SD) 
284.5 
(26.22) 
278.9 
(21.4) 
298.5  
(31.4) 
<0.001 
Sodium (mmol/l):  
mean (SD) 
131.3 (9.7) 130.8 (8.9) 132.7 (11.5) 0.194 
Potassium (mmol/l): 
mean (SD) 
4.2 (0.8) 4.1 (0.7) 4.5 (0.9) <0.001 
Glucose (mmol/l):  
median (Q1,Q3)) 
6.6  
(5.4, 9.7) 
5.9  
(5.1, 7.3) 
14.1  
(8.0, 22.2) 
<0.001 
Urea (mmol/l):  
median (Q1,Q3) 
6.5  
(4.6, 9.8) 
6  
(4.3, 8.5) 
7.5  
(5.2, 12) 
0.003 
eGFR*: median (Q1,Q3) 
72  
(52, 90) 
78  
(60, 90) 
54  
(38, 83) 
0.001 
*Estimated glomerular filtration rate.   Comparison of cohort demographic and 
serum biochemistry, comparing patients with and without diabetes. 
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 Mean of the difference between osmolality and osmolarity 7.6.2
The mean (95% CI) of the difference between serum osmolality and the 
calculated osmolarity using the equations was consistently and significantly 
greater in equations that did not account for blood glucose concentration 
(Tables 27a to 27e). All the equations within a clinically acceptable overall 
deviation from the measured value (<2 mmol/l) included glucose and urea 
concentrations. The lowest overall mean (95% CI) of the difference was 
observed with equation 33 (Bianchi et al., 2009), 0.2 (-0.7 to 1.2) mmol/l. 
When stratified by diabetes status, the mean (95% CI) of the difference was 
greater in patients with diabetes. However, equation 32 (Khajuria and Krahn, 
2005) demonstrated the greatest overall consistency and when stratified by 
diabetes, with an overall mean (95% CI) of the difference of -1.1 (-2.0 to -0.1) 
mmol/l, -1.0 (-1.8 to -0.1) mmol/l in patients with diabetes and -1.1 (-2.0 to -
0.1) mmol/l in patients without diabetes.  
Using the two most accurate equations 32 (Khajuria and Krahn, 2005) and 33 
(Bianchi et al., 2009), glucose was replaced with the median population 
glucose concentration, 8.5 mmol/l for patients with diabetes and 6.4 mmol/l 
for patients without diabetes (equations 32a and 33a respectively). The lowest 
mean (95% CI) of the difference was -0.1 (-1.4 to 1.1) mmol/l, seen in patients 
without diabetes using equation 33a and increased in patients with diabetes 
to 11.3 (9.3 to 13.3) mmol/l. Equation 32a demonstrated similar results in 
patients with diabetes -0.8 (-2.8 to -2.0) mmol/l and in patients without 
diabetes 9.8 (7.8 to 17.6) mmol/l.   
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Table 257a: Mean (95% CI) of the difference between measured serum osmolality and calculated osmolarity using published equations, 
mmol/l. 
Equation no. Equation description 
All patients 
(n=217) 
Patients without 
diabetes  
(n=155) 
Patients with 
diabetes  
(n=62) 
Equation 1 1.75 × Na+ + glucose + 0.5 × urea + 10.1 
30.7 (29.5 to 31.8) 29.5 (28.3 to 30.6) 33.5 (32.3 to 34.6) 
Equation 2 2.63 × Na+ − 65.4 
4.6 (2.5 to 6.7) 0.4 (-1.1 to 1.9) 15.0 (12.2 to 17.7) 
Equation 3 1.86 × Na+ + glucose + 0.5 × urea 
26.3 (25.1 to 27.4) 25.3 (24.1 to 26.4) 29.0 (27.9 to 30.0) 
Equation 4 2 × (Na++K+) + glucose + 0.5 × urea 
-0.5 (-1.5 to 0.6) -1.2 (-2.2 to -0.1) 1.4 (0.4 to 2.4) 
Equation 5 2 × Na+  
21.9 (19.8 to 23.9) 17.3 (15.9 to 18.7) 33.2 (30.5 to 35.8) 
Equation 6 2 × Na+ + glucose + 0.5 × urea 
7.9 (6.8 to 9.0) 7.0 (5.9 to 8.1) 10.4 (9.34 to 11.4) 
Equation 7 2 × Na+ + 7 
14.9 (12.8 to 16.9) 10.3 (8.9 to 11.7) 26.2 (23.5 to 28.8) 
Equation 8 2 × Na+ + 10 
11.9 (9.8 to 13.9) 7.3 (5.9 to 8.7) 23.2 (20.5 to 25.8) 
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Table 27b: Mean (95% CI) of the difference between measured serum osmolality and calculated osmolarity using published equations, mmol/l. 
Equation no. Equation description 
All patients 
(n=217) 
Patients without 
diabetes  
(n=155) 
Patients with 
diabetes  
(n=62) 
Equation 9 2 × Na+ + glucose 
12.1 (10.7 to 13.4) 10.7 (9.4 to 12.0) 15.3 (13.9 to 16.6) 
Equation 10 2.1 × Na+ 
8.7 (6.63 to 10.7) 4.3 (2.9 to 5.7) 19.9 (17.2 to 22.5) 
Equation 11 2 × Na+ + glucose + 0.93 × 0.5 × urea 
8.2 (7.1 to 9.3) 7.2 (6.1 to 8.3) 10.8 (9.7 to 11.8) 
Equation 12 (2 × (Na+ + K+) + glucose + 0.5 × urea) × 0.985 
3.8 (2.7 to 4.9) 3.0 (1.9 to 4.1) 5.8 (4.8 to 6.8) 
Equation 13 1.86 × Na+ + glucose + 0.5 × urea + 5 
25.8 (24.6 to 26.9) 24.8 (23.6 to 25.9) 28.5 (27.4 to 29.5) 
Equation 14 2 × Na+ + 0.9 × glucose + 0.93 × urea × 0.5 
9.2 (8.05 to 10.3) 7.9 (6.8 to 9.0) 12.7 (11.5 to 13.8) 
Equation 15 2 × Na+ + 0.5 × urea 
17.8 (15.9 to 19.6) 13.6 (12.4 to 14.8) 28.3 (25.8 to 30.7) 
Equation 16 (1.86 × Na+ + glucose + 0.5 × urea)/0.93 
6.9 (5.8 to 8.0) 6.2 (5.1 to 7.3) 8.7 (7.7 to 9.7) 
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Table 27c: Mean (95% CI) of the difference between measured serum osmolality and calculated osmolarity using published equations, mmol/l. 
Equation no. Equation description 
All patients 
(n=217) 
Patients without 
diabetes  
(n=155) 
Patients with 
diabetes  
(n=62) 
Equation 17 1.9 × (Na+ + K+) + glucose + 0.5 × urea 
13.1 (12.0 to 14.1) 12.3 (11.2 to 13.4) 15.1 (14.0 to 16.1) 
Equation 18 1.85 × Na+ + glucose + 0.5 × urea + 8.55 
19.1 (17.9 to 20.2) 18 (16.8 to 19.1) 21.8 (20.7 to 22.8) 
Equation 19 1.86 × Na+ + glucose + 0.5 × urea + 9 
17.3 (16.1 to 18.4) 16.3 (15.1 to 17.4) 20.0 (18.9 to 21.0) 
Equation 20 1.86 × Na+ + glucose + urea + 9 
13.2 (12.2 to 14.1) 12.5 (11.5 to 13.5) 15.1 (14.2 to 15.9) 
Equation 21 2 × (Na+ + K+) + glucose + 0.93 × 0.5 × urea 
-0.2 (-1.2 to 0.9) -1.0 (-2.0 to 0.1) 1.7 (0.7 to 2.7) 
Equation 22 1.89 × Na+ + 1.38 × K++ 1.08 × glucose + 1.03 × 
urea + 7.47 
4.0 (3.1 to 5.0) 3.7 (2.7 to 4.7) 4.7 (3.9 to 5.5) 
Equation 23 1.86 × (Na+ + K+) + glucose + urea + 10 
4.4 (3.4 to 5.4) 3.9 (2.9 to 4.9) 5.7 (4.8 to 6.6) 
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Table 27d: Mean (95% CI) of the difference between measured serum osmolality and calculated osmolarity using published equations, mmol/l. 
Equation no. Equation description 
All patients 
(n=217) 
Patients without 
diabetes  
(n=155) 
Patients with 
diabetes  
(n=62) 
Equation 24 2 × Na+ + 0.9 × glucose + 0.93 × 0.5 × urea + 8 
1.2 (0.1 to 2.3) -0.1 (-1.2 to 1.0) 4.6 (3.4 to 5.8) 
Equation 25 1.86 × Na+ + 1.03 × glucose + 1.28 × 0.5 × urea 
24.9 (23.8 to 25.9) 24.0 (22.9 to 25.1) 27.1 (26.1 to 28.0) 
Equation 25a, (1.86 × Na+ + 1.03 × glucose + 1.28 × 0.5 × urea) 
× 0.985 
28.8 (27.7 to 29.8) 27.8 (26.7 to 28.9) 31.2 (30.1 to 32.2) 
Equation 26 1.36 × Na+ + 1.6 × glucose + 0.45 × urea + 91.75 
-5.3 (-6.7 to -3.8) -4.7 (-6.0 to -3.3) -6.6 (-8.0 to -5.1) 
Equation 27 2 × Na+ + glucose + urea + 35.2 
-31.4 (-32. to -30.) -32 (-32. to -31.0) -29.7 (-30.9 to -28.3) 
Equation 27a (2 × Na+ + glucose + urea + 35.2) × 0.985 
-26.6 (-27.2 to -25.3) -27.4 (-28.0 to -26.4) -24.7 (-25.0 to -23.0) 
Equation 28 1.897 × Na+ + glucose + urea × 0.5 + 13.5 
8.0 (6.9 to 9.1) 6.9 (5.8 to 8.0) 10.6 (9.5 to 11.6) 
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Table 27e: Mean (95% CI) of the difference between measured serum osmolality and calculated osmolarity using published equations, mmol/l. 
Equation no. Equation description 
All patients 
(n=217) 
Patients without 
diabetes  
(n=155) 
Patients with 
diabetes  
(n=62) 
Equation 29 1.9 × (Na+ + K+) + glucose + urea × 0.5 + 5 
8.1 (7.0 to 9.2) 7.3 (6.2 to 8.4) 10.1 (9.1 to 11.1) 
Equation 30 1.86 × (Na+ + K+) + glucose + urea 
14.4 (13.4 to 15.3) 13.9 (12.9 to 14.9) 15.7 (14.8 to 16.5) 
Equation 31 2 × Na+ + 1.15 × glucose + urea 
2.4 (1.5 to 3.3) 2.2 (1.2 to 3.2) 2.9 (2.1 to 3.7) 
Equation 32 1.86 × (Na+ + K+) + 1.15 × glucose + urea + 14 
-1.1 (-2.0 to -0.1) -1.1 (-2.0 to -0.1) -1.0 (-1.8 to -0.1) 
Equation 33 1.09 × 1.86 × Na+ + glucose + urea 
0.2 (-0.7 to 1.2) -0.4 (-1.3 to 0.6) 1.9 (1.02 to 2.8) 
List and description of equations used in the study, with mean (95% CI) of the difference between measured serum osmolality and calculated 
osmolarity in all study patients and stratified by diabetes status. This data shows that the mean (95% CI) of the difference between serum osmolality 
and the calculated osmolarity using the equations was consistently and significantly greater in equations that did not account for blood glucose 
concentration. Moreover, increase accuracy was seen in patients without diabetes.  
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 Bland-Altman analysis 7.6.3
Equations that demonstrated an overall mean of the difference of <2 mmol/l 
and maintained this after stratification by diabetes status, were further 
analysed for agreement using Bland-Altman methods (Dewitte et al., 2002, 
Connelly, 2008). These were equations 4 (Gerich et al., 1971, Jackson and 
Forman, 1966), 21 (Jenkins and Larmore, 1974), 32 (Khajuria and Krahn, 2005) 
and 33 (Bianchi et al., 2009) (Tables 27a to 27e). Equation 32 (Khajuria and 
Krahn, 2005) and 33 (Bianchi et al., 2009) demonstrated greatest agreement 
and consistency when stratified by diabetes status (Figure 20). This trend was 
also seen for equations 32a and 33a but only in the cohort without diabetes 
(Figure 21).  
  155 
  
Mean +1.96 SD
Mean -1.96 SD
-3
0
-2
0
-1
0
0
1
0
2
0
D
iff
e
re
n
ce
 b
e
tw
e
e
n
 O
sm
o
la
lit
y 
&
 O
sm
o
la
lr
ity
200 250 300 350 400
Mean (Osmolality & Osmolarity)
b 
Mean +1.96 SD
Mean -1.96 SD
-3
0
-2
0
-1
0
0
10
20
D
iff
er
e
nc
e
 b
et
w
e
en
 O
sm
o
la
lit
y 
&
 O
sm
ol
ar
ity
200 250 300 350 400
Mean (Osmolality & Osmolarity)
d 
Mean -1.96 SD
Mean +1.96 SD
-3
0
-2
0
-1
0
0
10
20
D
iff
er
e
nc
e
 b
ew
tw
ee
n 
O
sm
ol
al
ity
 &
 O
sm
o
la
rit
y
200 250 300 350 400
Mean (Osmolality & Osmolarity)
a 
Mean +1.96 SD
Mean -1.96 SD
-3
0
-2
0
-1
0
0
10
20
D
iff
er
en
ce
 b
et
w
ee
n 
O
sm
ol
al
ity
 &
 O
sm
ol
ar
ity
200 250 300 350 400
Mean (Osmolality & Osmolarity)
c 
  156 
  
Figure 20 (above): Bland-Altman plots demonstrating the relationship between measured serum osmolality and 
calculated osmolarity for equations with the lowest and most consistent mean of difference between osmolality 
and osmolarity. Regression coefficient and R2 for these plots are listed below. 
 Whole cohort Without Diabetes With Diabetes 
 
R2 
Regress coefficient  
 (95% CI) 
R2 
Regress coefficient  
 (95% CI) 
R2 
Regress coefficient  
 (95% CI) 
Equation 4 (a) 
0.15 
-1.20 
(-1.58 to -0.82) 
0.11 
-0.83 
(-1.19 to -0.46) 
0.19 
-1.82 
(-2.74 to -0.89) 
Equation 21 (b) 
0.16 
-1.207 
(-1.19 to -0.47) 
0.20 
-0.83 
(-1.19 to -0.47) 
0.20 
-1.81 
(-2.72 to -0.90) 
Equation 32 (c) 
0.08 
-1.01 
(-1.46 to -0.57) 
0.12 
-0.913 
(-1.31 to -0.52) 
0.06 
-1.23 
(-2.54 to -0.14) 
Equation 33 (d) 
0.05 
-0.775 
(-1.23 to -0.32) 
0.03 
-0.513 
(-0.95 to -0.08) 
0.03 
-0.94 
(-2.10 to 0.23) 
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Figure 21: (above): Bland-Altman plots demonstrating the relationship between measured serum osmolality and 
calculated osmolarity for equations with the lowest and most consistent mean of difference between osmolality 
and osmolarity. Regression coefficient and R2 for these plots are listed below. 
 Whole cohort (a) Without Diabetes (b) With Diabetes (c) 
 
R2 
Regress coefficient  
 (95% CI) 
R2 
Regress coefficient  
 (95% CI) 
R2 
Regress coefficient  
 (95% CI) 
Equation 32a 
0.25 
-0.93 
(-1.16 to -0.72) 
0.12 
-0.95 
(-1.31 to -0.58) 
0.25 
-0.81 
(-1.16 to -0.46) 
Equation 33a 
0.13 
-0.69 
(-0.93 to -0.45) 
0.04 
-0.53 
(-0.93 to -0.13) 
0.13 
-0.60 
(-0.99 to -0.22) 
Equation 32a and 33a indicate glucose replaced with median population glucose of 8.5 mmol/l for patients with 
and mean population glucose of 6.4 mmol/l in patients without diabetes. 
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 Diagnostic accuracy 7.6.4
Equations 32 (Khajuria and Krahn, 2005) and 33 (Bianchi et al., 2009) 
demonstrated the greatest consistency and accuracy at diagnosing HD (Table 
30). Overall, equation 32 had the greatest diagnostic accuracy at 300 mmol/l; 
with a sensitivity (95% CI) of 90% (86% to 94%) and specificity (95% CI) of 
97.0% (95% to 99%) and positive and negative likelihood ratios of 30 and 0.1, 
respectively. Equation 32a demonstrated sensitivity (95% CI) of 80% (74% to 
86%) and specificity of 95% (92% to 98%) at 297 mmol/l in patients without 
diabetes (Table 28).  
 Comparison with other published data 7.6.5
The absolute difference between measured and calculated osmolality in the 
present study was compared with those previously published by Siervo et al., 
2014 and Fazekas et al., 2013 (Tables 29a to 29h). The present study 
demonstrates that equations 32 and 33 were likely the most 
accurate/consistent equations. The mean of the difference (95% CI) for 
equations 32 was -1.1 (-2.0 to -0.1) mmol/l and 0.2 (-0.7 to 1.2) mmol/l for 
equations 33. Siervo et al., 2014 demonstrated comparable results with a 
mean (95% CI) of the difference of -0.4 (-1.0 to 0.2) mOsmol/kg for equation 
32 and -0.5 (-1.1 to 0.1) mOsmol/kg for equation 33. However, the findings of 
Fazekas et al., 2013 differed significantly, with a mean of the difference (95% 
CI) of -7.3 (-15.2 to 0.6) mOsmol/kg for equation 32 and -8.7 (-17.0 to -0.3) 
mOsmol/kg for equation 33.  
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Table 28: Sensitivity and specificity of equations at diagnosing hyperosmolar dehydration, serum osmolality >300 mOsmol/kg  
 
  
 Whole cohort Without diabetes With diabetes 
Equation 
no. 
Osmolarity 
(mmol/l) 
Sensitivity 
(95 % CI): % 
Specificity 
(95 % CI): % 
Osmolarity 
(mmol/l) 
Sensitivity 
(95 % CI): % 
Specificity 
(95 % CI): % 
Osmolarity 
(mmol/l) 
Sensitivity 
(95 % CI): % 
Specificity 
(95 % CI): % 
4 295 
83 
(78 to 88) 
94 
(91 to 97) 
295 
83 
(77 to 89) 
94 
(91 to 97) 
297 
96 
(92 to 100) 
91 
(87 to 95) 
21 297 
88 
(84 to 92) 
96 
(94 to 99) 
294 
83 
(77 to 89) 
92 
(89 to 96) 
297 
96 
(92 to 100) 
94 
(91 to 97) 
32 300 
90 
(86 to 94) 
97 
(95 to 99) 
296 
87 
(82 to 92) 
97 
(95 to 99) 
301 
96 
(92 to 100) 
97 
(95 to 99) 
33 297 
88 
(84 to 92) 
95 
(92 to 98) 
301 
83 
(77 to 89) 
99 
(97 to 100) 
299 
93 
(87 to 99) 
97 
(95 to 99) 
32a 297 
69 
(63 to 75) 
94 
(91 to 97) 
297 
80 
(74 to 86) 
95 
(92 to 98) 
297 
59 
(47 to 71) 
93 
(89 to 96) 
33a 296 
66 
(59 to 72) 
92 
(88 to 96) 
299 
70 
(63 to 77) 
95 
(92 to 98) 
294 
62 
(50 to 74) 
91 
(87 to 95) 
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Table 29a: Previously published work comparing the mean of the difference between measured serum osmolality and calculated osmolarity. 
 
Fazekas et al, 2013  Siervo et al, 2014+ 
 
All the cohort All the cohort Without diabetes With diabetes 
Equations 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI) 
mmol/l 
 
Absolute 
difference: 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
1 
23.1 
(12.8 to 33.5) 
7.6 
30.9 
(30.3 to 31.5) 
0.2 
30.6 
(23. to 31.3) 
1.1 
32.3 
(31.6 to 33.0) 
1.2 
2 
-15.1 
(-30.5 to 0.2) 
10.4 
-4.0 
(-5.0 to -3.0) 
0.6 
−5.6 
(-3.2 to -
0.8)) 
5.2 
3.0 
(1.9 to 4.1) 
12 
3 
17.7 
(7.3 to 28.1) 
8.6 
25.9 
(25.3 to 26.5) 
0.4 
25.5 
(24.9 to 
26.1) 
0.2 
27.5 
(26.9 to 28.1) 
1.5 
4 
-9.2 
(-19.1 to 0.7) 
8.7 
-1.7 
(-2.1 to -1.1) 
1.2 
−2.0 
(-3.0 to -0.6) 
1 
-0.2 
(-0.8 to 0.4) 
1.2 
5 
7.8 
(-6.3 to 21.8) 
14.1 
17.1 
(16.2 to 18.0) 
4.8 
15.7 
(15 to 16.4) 
1.6 
23.4 
(22.4 to 24.4) 
9.8 
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Table 29b: Previously published work comparing the mean of the difference between measured serum osmolality and calculated osmolarity. 
 
Fazekas et al, 2013  Siervo et al, 2014+ 
 
All the cohort All the cohort Without diabetes With diabetes 
Equations 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI) 
mmol/l 
 
Absolute 
difference: 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
6 
-1.4 
(-11.3 to 8.4) 
6.5 
6.7 
(6.0 to 7.4) 
1.2 
6.3 
(5.6 to 7.0) 
0.7 
8.4 
(7.8 to 9.0) 
2 
7 
1.1 
(-12.5 to 14.8) 
13.8 
10.1 
(9.2 to 11.0) 
4.8 
8.7 
(8.0 to 9.4) 
1.6 
16.4 
(15.4 to 17.4) 
9.8 
8 
-1.7 
(-15.4 to 11.9) 
10.2 
7.1 
(6.2 to 8.0) 
4.8 
5.7 
(5.0 to 6.4) 
1.6 
13.4 
(12.4 to 14.4) 
9.8 
9 
1.9 
(-11.1 to 14.9) 
10.2 
10.2 
(9.5 to 10.9) 
1.9 
9.6 
(8.9 to 10.3) 
1.1 
12.6 
(11.9 to 13.3) 
2.7 
10 
-5.7 
(-19.5 to 8.2) 
3 
3.3 
(2.4 to 4.2) 
5.4 
2.0 
(1.3 to 2.7) 
2.3 
9.8 
(8.8 to 10.8) 
10.1 
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Table 29c: Previously published work comparing the mean of the difference between measured serum osmolality and calculated osmolarity. 
 
Fazekas et al, 2013  Siervo et al, 2014+ 
 
All the cohort All the cohort Without diabetes With diabetes 
Equations 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI) 
mmol/l 
 
Absolute 
difference
: mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
11 
-1.2 
(-11.2 to 8.9) 
7 
6.9 
(6.2 to 7.6) 
1.3 
6.5 
(5.8 to 7.2) 
0.7 
8.7 
(8.1 to 9.3) 
2.1 
12 
-4.8 
(-14.4 to 4.8) 
1 
-2.6 
(-3.2 to -2.0) 
1.2 
−2.3 
(-3.5 to -1.1) 
0.7 
-4.3 
(-4.9 to -3.7) 
1.5 
13 
12.7 
(2.3 to 23.0) 
13.1 
20.9 
(20.3 to 21.5) 
4.9 
20.5 
(19.9 to 21.1) 
4.3 
22.5 
(21.9 to 23.1) 
6.0 
14 
-0.6 
(-10.6 to 9.4) 
8.6 
7.6 
(6.9 to 8.3) 
1.6 
7.1 
(6.4 to 7.8) 
0.8 
9.8 
(9.2 to 10.4) 
2.9 
15 
4.3 
(-6.6 to 15.1) 
13.5 
13.6 
(12.8 to 14.4) 
4.2 
12.4 
(11.7 to 13.1) 
1.2 
19.3 
(18.4 to 20.2) 
9.0 
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Table 29d: Previously published work comparing the mean of the difference between measured serum osmolality and calculated osmolarity. 
 
Fazekas et al, 2013  Siervo et al, 2014+ 
 
All the cohort All the cohort Without diabetes With diabetes 
Equations 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI) 
mmol/l 
 
Absolute 
difference
: mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
16 
-2.2 
(-11.8 to 7.4) 
4.7 
5.9 
(5.3 to 6.5) 
1 
5.6 
(5.0 to 6.2) 
0.6 
7.3 
(6.7 to 7.9) 
1.4 
17 
4.5 
(-5.1 to 14.2) 
8.6 
12.4 
(11.8 to 13.0) 
0.7 
12.0 
(11.4 to 12.6) 
0.3 
13.9 
(13.3 to 14.5) 
1.2 
18 
7.7 
(-2.5 to 18.0) 
11.4 
18.7 
(18.1 to 19.3) 
0.4 
18.4 
(17.7 to 19.0) 
0.4 
20.3 
(19.7 to 20.9) 
1.5 
19 
8.7 
(-1.5 to 19.0) 
8.6 
16.9 
(16.3 to 17.5) 
0.4 
16.5 
(15.9 to 17.1) 
0.2 
18.5 
(17.9 to 19.1) 
 
1.5 
20 
5.2 
(-3.0 to 13.5) 
8 
13.4 
(12.8 to 14.0) 
0.2 
13.2 
(12.6 to 13.8) 
0.7 
14.3 
(13.8 to 14.8) 
0.8 
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Table 29e: Previously published work comparing the mean of the difference between measured serum osmolality and calculated osmolarity. 
 
Fazekas et al, 2013  Siervo et al, 2014+ 
 
All the cohort All the cohort Without diabetes With diabetes 
Equations 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI) 
mmol/l 
 
Absolute 
difference
: mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
21 
-9.0 
(-19.0 to 1.1) 
8.8 
-1.4 
(-2.0 to -0.8) 
1.2 
−1.8 
(-3.0 to -0.6) 
0.8 
0.1 
(-0.5 to 0.7) 
1.6 
22 
-3.1 
(-10.8 to 4.7) 
0.9 
4.2 
(3.6 to 4.8) 
0.2 
4.1 
(3.5 to 4.7) 
0.4 
4.7 
(4.2 to 5.2) 
0.0 
23 
-2.5 
(-10.2 to 5.1) 
1.9 
4.5 
(4.0 to 5.1) 
0.1 
4.4 
(3.8 to 5.0) 
0.5 
5.3 
(4.8 to 5.8) 
0.4 
24 
-8.3 
(-18.8 to 2.2) 
7.1 
-0.4 
(-1.1 to 0.3) 
0.8 
–0.8 
(-2.1 to -0.6) 
0.8 
1.8 
(1.2 to 2.4) 
2.8 
25 
22.0 
(12.3 to 31.7) 
2.9 
24.7 
(24.1 to 25.3) 
0.2 
24.5 
(23.9 to 25.1) 
0.5 
26 
(25.4 to 26.6) 
 
1.1 
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Table 29f: Previously published work comparing the mean of the difference between measured serum osmolality and calculated osmolarity. 
 
Fazekas et al, 2013  Siervo et al, 2014+ 
 
All the cohort All the cohort Without diabetes With diabetes 
Equations 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI) 
mmol/l 
 
Absolute 
difference: 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
25a - - 
28.7 
(28.1 to 29.3) 
0.1 
28.4 
(27.7 to 29.) 
0.6 
30 
(29.4 to 30.6) 
1.2 
26 
-5.8 
(-16.6 to 5.0) 
0.5 
-0.9 
(-1.6 to -0.2) 
4.4 
–0.5 
(-2.0 to -1.0) 
3.5 
-2.5 
(-3.3 to -1.7) 
4.1 
27 
-34.9 
(-43.5 to -26.3) 
2.6 
-32 
(-32.6 to -
31.3) 
0.6 
−32.2  
(-33.9 to -
31.0) 
0.2 
-31 
(-31.5 to -
30.4) 
2.0 
27a - 26 
-27.1 
(-27.6 to -
26.5) 
1.1 
−27.3 
(-28.5 to -
26.1) 
0.3 
-26.1 
(-26.6 to -
25.5) 
2.0 
28 
-0.4 
(-10.1 to 9.2) 
7.6 
7.3 
(6.7 to 7.9) 
0.7 
6.9 
(6.3 to 7.5) 
0 
8.9 
(8.3 to 9.5) 
1.7 
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Table 29g: Previously published work comparing the mean of the difference between measured serum osmolality and calculated osmolarity. 
 
 
 
Fazekas et al, 2013  Siervo et al, 2014+ 
 
All the cohort All the cohort Without diabetes With diabetes 
Equations 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI) 
mmol/l 
 
Absolute 
difference: 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
29 
-0.1 
(-9.4 to 9.3) 
8 
7.4 
(6.8 to 8.0) 
0.7 
7 
(6.4 to 7.6) 
0.3 
8.9 
(8.3 to 9.5) 
1.2 
30 
6.7 
(-1.6 to 15.0) 
7.7 
14.5 
(13.9 to 15.1) 
0.1 
14.4 
(13.8 to 15) 
0.5 
15.3 
(14.8 to 15.8) 
0.4 
31 
-5.8 
(-14.0 to 2.5) 
3.4 
2.1 
(1.5 to 2.7) 
0.3 
2.0 
(1.4 to 2.6) 
0.2 
2.6 
(2.0 to 3.2) 
0.3 
32 
-7.3 
(-15.2 to 0.6) 
6.2 
-0.4 
(-1.0 to 0.2) 
0.7 
–0.4 
(-1.5 to 0.7) 
0.6 
-0.3 
(-0.8 to 0.2) 
0.7 
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Table 29h: Previously published work comparing the mean of the difference between measured serum osmolality and calculated osmolarity. 
 
Fazekas et al, 2013  Siervo et al, 2014+ 
 
All the cohort All the cohort Without diabetes With diabetes 
Equations 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
Mean of 
difference 
(95% CI) 
mmol/l 
 
Absolute 
difference: 
mmol/l* 
Mean of 
difference 
(95% CI): 
mmol/l 
Absolute 
difference 
mmol/l* 
33 
-8.7 
(-17.0 to -0.3) 
8.5 
-0.5 
(-1.1 to 0.1) 
0.3 
–0.8  
(-2.0 to 0.4) 
1.1 
0.5 
(-0.1 to 1.1) 
1.2 
Data published by Fazekas et al., 2013 and Siervo et al., 2014.*Absolute difference between means of the difference published by 
Fazekas et al., 2013 and Siervo et al., 2014 subtracted from the mean of the difference between osmolality and osmolarity from the 
present study. +The online supplementary table published by Siervo et al., 2014 containing mean of the difference and SD was used.  
SD was converted to 95% CI using the following equation [95% CI = mean ± 1.96 x SE], [SE = SD ÷ √n]. 
The present study demonstrates that equations 32 (Khajuria and Krahn, 2005) and 33 (Bianchi et al., 2009) were likely the most 
accurate/consistent equations. 
  169 
7.7 Discussion 
This study investigated the accuracy of previously published equations at 
calculating serum osmolarity in hospitalised older adults and has shown that 
the equation 33 (Bianchi et al., 2009) was the most accurate when considering 
the overall mean of the difference (95% CI) between measured and calculated 
serum osmolality. However, the mean of the difference (95% CI) increased 
after stratification by diabetes status. Equation 32 (Khajuria and Krahn, 2005) 
had a greater overall mean of the difference that is within acceptable limits 
and showed little change after stratification for diabetes status. Moreover, 
equation 32 demonstrated the greatest diagnostic accuracy at predicting HD 
with over 90% sensitivity and 97% specificity at 300 mmol/l. This equation 
(Khajuria and Krahn, 2005) also demonstrated greatest diagnostic accuracy 
after stratification for diabetes status.  
The findings of the present study are consistent with work published by Siervo 
et al., 2014 who investigated the difference between measured serum 
osmolality and calculated osmolarity in community-dwelling older adults. The 
authors reported that equations 32 and 33 were associated with the lowest 
overall mean (SD) of the difference between osmolality and osmolarity. 
Moreover, the absolute difference between findings reported in the present 
study and those reported by Siervo et al., 2014 were constantly low for most 
equations. Furthermore, Siervo et al., 2014 reported similar diagnostic 
accuracy using this equation, with sensitivity of 97% with 76% specificity at 
296 mmol/l. However, Fazekas et al., 2013, reported greater mean of the 
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difference between measured osmolality and osmolarity calculated using 
equation 32 (Khajuria and Krahn, 2005). Although, it is important to note that 
the study by (Fazekas et al., 2013) used serum samples from a relatively 
younger adult population (mean age 58). 
The use of these equations is dependent on the availability of serum 
biochemistry including serum glucose measurements which are not always 
routinely performed. This study showed that equation 32a maintained 
excellent levels of sensitivity (87%) and specificity (95%) at 297 mmol/l at 
diagnosing HD. These findings may be useful in clinical or research settings to 
assess and monitor changes in hydration status where serum glucose 
measurements are not available. This high level of sensitivity and specificity 
with equation 33a is likely due to the tight regulation of serum glucose in non-
diabetic patients. However, in patients with diabetes glycaemic control is less 
predictable where rapid increase in serum glucose concentrations occur in the 
post prandial period or as a result of ill health due to physiological stress. In 
these patients where formal laboratory glucose testing is unavailable, bedside 
glucose tests may prove a useful alternative if performed close to the time of 
blood sampling for biochemistry. Various reports have demonstrated 
excellent sensitivity and specificity of modern bedside glucose testing kits 
which are readily available and routinely used (Bala Raghavendra and Bhat, 
2010). Therefore it may be feasible to use this result as an alternative to 
formal laboratory serum glucose testing. However, the present study did not 
test this hypothesis. 
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Knowing serum osmolality may be useful in the clinical setting to aid the 
assessment and diagnosis of dehydration. It is important to note however, 
that the present study did not investigate the clinical applicability of 
osmolality, further work is required to clarify this.  
 
7.8 Conclusion  
The findings reported in the present study together with previous work 
published by Siervo et al., 2014 support the use of equation 32 (Khajuria and 
Krahn, 2005) as an alternative to serum osmolality, and may be used to screen 
and monitor hydration status in hospitalised older adults where serum 
osmolality is unavailable. 
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 Hyperosmolar 8.
dehydration as a 
predictor of 
kidney injury and 
outcome in 
hospitalised older 
adults  
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8.1 Introduction 
Increased age is associated with diminished physiological reserve and can 
result in physical as well as functional decline. Age-related pathophysiological 
changes (El-Sharkawy et al., 2014) make the older adult increasingly 
vulnerable to fluid and electrolyte disturbance, particularly during periods of 
ill health or physiological stress.  
Serum osmolality is the key regulated variable in fluid balance. Cheuvront et 
al., 2010 demonstrated that serum osmolality of 297 mOsmol/kg had 90% 
sensitivity and 100% specificity in young adults dehydrated in a hot 
environment to between 2% and 7% of TBW. An additional benefit of serum 
osmolality is that it can be used to assess hydration status at a set point as 
well as to monitor hydration over time at any given time interval.  
HD was reported in 37% of older adults at admission to hospital and was 
associated with a six-fold increase in mortality (El-Sharkawy et al., 2015a). 
(Chapter 5) However, in Chapter 6, a review of 32,980 older adult hospital 
admissions demonstrated that 0.6% of patients had clinically reported 
dehydration as the primary cause of admission and 8.9% as a secondary 
diagnosis, associated with a 2.2 fold increase in mortality. However, it is 
unclear which of these findings represent a true reflection of the prevalence 
and impact on outcome. Both studies also reported higher prevalence of AKI 
associated with dehydration. However, the studies did not clarify whether AKI 
was a cause or effect of dehydration. 
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Serum osmolality, widely seen as the most reliable objective measure of 
hydration status (Bhalla et al., 2000, Sollanek et al., 2011, Cheuvront et al., 
2013, Cheuvront et al., 2010, Stookey et al., 2005) is not routinely measured 
in clinical practice. However, equations have been developed to estimate 
osmolality using routinely measured biochemistry including sodium, 
potassium, urea and glucose (Fazekas et al., 2013, Siervo et al., 2014). Some 
of these equations have been shown to be accurate enough to be used as a 
surrogate marker of serum osmolality (Chapter 7) (Fazekas et al., 2013, Siervo 
et al., 2014).  
This study aimed to use the admission records from a large UK university 
teaching hospitals National Health Service (NHS) trust to estimate the 
prevalence of HD using the equation by Khajuria and Krahn, 2005 and to 
assess the impact on AKI, LOS and mortality in hospitalised older adults.  
8.2 Hypothesis 
We hypothesised that the prevalence of HD would be higher than previously 
reported clinical dehydration (Chapter 6) and similar to that reported in 
Chapter 5. Dehydration would be associated with increased LOS and increased 
risk of AKI and mortality.  
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8.3 Methodology 
This retrospective cohort study in adult patients aged ≥ 65 years was 
conducted using data from a large UK university teaching hospitals NHS trust.  
Details of the data selection methods, data validation and analysis are 
outlined in Chapter 3.  
 Osmolality estimate and outcome  8.3.1
Laboratory glucose measurements are not routinely performed on 
hospitalised patients as most patients undergo bedside “finger prick” glucose 
measurements. To investigate the effects of HD on a wider population of 
hospitalised older adults osmolarity was estimated using a constant value 
instead of serum glucose in Krah & Khajuria’s equation for patients without 
diabetes. The constant value was derived from mean population values given 
that serum glucose is tightly regulated in patients without diabetes. All 
patients with serum glucose measurements were identified (n=23,979). 
Where multiple measurements were performed on the same patient during 
admission, the first measurement was selected, with a final sample of 13,673. 
The cohort was then stratified by diabetes status to measure the mean serum 
glucose (6.3 mmol/l) in patients without diabetes (n=9,536). The accuracy of 
this estimation was assessed and the effects on outcome reported in 
supplementary data. A similar approach was not possible in patients with 
diabetes due to the wide variation in serum glucose and thus the limited 
accuracy of this approach. Results from this analysis are listed in Appendix 1. 
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 Inclusion/exclusion criteria 8.3.2
All older adult patients admitted to hospital as a medical emergency were 
included. Patients admitted with any alcohol related condition including 
alcohol intoxication were excluded to reduce the risk of artificially high 
osmolar gap, the difference between measured serum osmolality and 
calculated osmolarity. Patients admitted with bleeding or those admitted to 
surgery were also excluded, Figure 22. Patients who did not have measured 
serum biochemistry required for the equation by Krah and Khajuria, 2005 
within 12 hours of admission were also excluded from the primary analysis. 
HD was defined as serum osmolarity >300 mOsmol/kg calculated using the 
equation by Krahn and Khajuria, 2005 [1.86 x (Na + K) + 1.15 x glucose + urea 
+ 14] for patients with relevant serum results, Figure 22 (Siervo et al., 2014). 
Clinically reported dehydration (ICD-10 code E86.X) indicated severe 
dehydration or dehydration requiring intravenous fluids. 
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8.4 Results 
 Prevalence of dehydration 8.4.1
A total of 6632 patients were admitted between 1st May 2011 and 31st 
October 2013 who had all the serum parameters required for the equation by 
Krah & Khajuria at admission to hospital (Figure 22). Patient characteristics 
are summarised in Table 30.  
Table 30: Demographics and characteristics of the study cohort, comparing 
those with and without hypertonic dehydration. 
  
All Patients 
(n=6632) 
Euhydrated 
(n=4830) 
Dehydrated
#
 
(n=1802) 
P 
value* 
Age 
65 – 75: n (%) 2692 (40.6) 2103 (43.5) 589 (32.7) 
<0.001 
76 - 85: n (%) 2555 (38.5) 1801 (37.3) 754 (41.8) 
86 - 95: n (%) 1286 (19.4) 865 (17.9) 421 (23.4) 
>95: n (%) 99 (1.5) 61 (1.3) 38 (2.1) 
Gender 
Female: n (%) 3469 (52.3) 2596 (53.7) 873 (48.4) 
<0.001 
Male: n (%) 3163 (47.7) 2234 (46.3) 929 (51.6) 
Charlson 
Comorbidity 
Index  
None: n (%) 1135 (17.1) 910 (18.8) 225 (12.5) 
<0.001 
Mild: n (%) 3117 (47.0) 2364 (48.9) 753 (41.8) 
Moderate: n (%) 1265 (19.1) 780 (16.1) 485 (26.9) 
Severe: n (%) 1115 (16.8) 776 (16.1) 339 (18.8) 
Admission 
Method 
Emergency 
Department: n (%) 
2496 (37.6) 1902 (39.4) 594 (33.0) 
<0.001 
General 
Practitioner: n (%) 
3626 (54.7) 2522 (52.2) 1104 (61.3) 
Other: n (%) 510 (7.7) 406 (8.4) 104 (5.8) 
National Early Warning Score**: 
Median (Q1, Q3) 
1 (0, 2) 1 (0, 2) 1 (0, 3) 0.021 
*P value comparing patients with and without dehydration. 
#
Dehydration indicates hypertonic dehydration, serum 
osmolarity >300 mOsmol/l. 
+
Osmolarity calculated using the equation by Krah & Khajuria, 2006 [1.86 x (Na + K) + 
1.15 x glucose + urea + 14].**National Early Warning Score available in only 422 patients, 274 were euhydrated and 
148 were dehydrated. 
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Exclusions 
Alcohol related admission n=1659 
Patients admitted with bleeding n = 1357 
Admitted to surgical speciality n= 7410 
>12 hours post admission (n=2045) 
Biochemistry absent 
Na (n=437) 
K (n=1415) 
Urea (n=261) 
 
Unique patient admissions  
(n=40,439) 
All older adults admitted to hospital acutely between 1
st
 May 2011 and 31
st
 October 
2013 (n=75,696) 
Patients admitted to 
medical specialities with 
all biochemistry  
(n= 25,855) 
Patients with all 
biochemistry results 
including glucose (n=6632) 
Duplicate Admissions 
excluded (n=35,257) 
Patients without diabetes 
and absent serum glucose 
(n=13,524)  
Absent serum glucose 
(n=19,223) 
Patients with 
diabetes 
(n=5,699) 
Figure 22: Data selection methods  # First admission episode selected If a patient was 
admitted multiple times over the study period, the first admission where dehydration 
was diagnosed (ICD-10 code E86.X) was preferentially selected (dehydration as primary 
cause of admission where preferentially selected over secondary diagnosis of 
dehydration). If dehydration was not diagnosed during any of the admissions, the first 
admission was selected.* Dehydrated patient episodes selected over non dehydrated 
episodes and formal laboratory serum glucose measurement with performed on blood 
sampled at the same time as that used for other biochemistry analysis. 
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HD was noted in 1802 (27.2%) patients at admission compared with 676 
(10.2%) with clinically reported dehydration. Of the 1802 patients with HD, 
313 (17.4%) patients were diagnosed with dehydration by the clinical team 
compared with 363 (7.5%) patients in the euhydrated group, P<0.001. The 
mean (SD) osmolarity in patients who were clinically and biochemically 
dehydrated was 319 (22) compared with 308 (12) in those with HD and were 
not clinically diagnosed, P<0.001. The mean (SD) age of dehydrated patients 
was 79.0 (8.3) compared with 77.6 (8.1) in euhydrated patients. Similarly the 
median CCI (Q1, Q3) score were comparable between patients with and 
without hypertonic dehydration, 1 (0, 2) vs. 1 (1, 2) respectively. However, 
stratification by age and CCI revealed that the prevalence of dehydration 
increased with age and comorbidities, Figure 23. Of the 422 patients that had 
data allowing a NEWS calculation, 35% of which in the dehydrated group at 
admission who also had higher median (Q1, Q3) scores compared with the 
euhydrated group, 1 (0, 3) vs. 1 (0, 2), respectively, P=0.021.  
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Figure 23: (top) Prevalence of dehydration with Charlson comorbidity index (age 
unadjusted). ‘None’ (no comorbidity, 0 points), ‘Mild’ (mild comorbidity, 1-2 
points), ‘Moderate’ (moderate comorbidity, 3-4 points) and ‘Severe’ (severe 
comorbidity, ≥5 points). (bottom): Prevalence of dehydration with increased age. 
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 Dehydration and acute kidney injury 8.4.2
AKI was reported in 710 (39.4%) patients with HD, compared with 818 (16.9%) 
patients who were biochemically euhydrated, P<0.001. Moreover, a greater 
proportion of those with HD had severe AKI, compared with those without 
dehydration, AKI stage 2 –160 (8.9) vs. 145 (3.0) and AKI stage 3 - 162 (9.0%) 
vs. 63 (1.3%), respectively, P<0.001. Patients with HD were at increased risk of 
developing AKI within 24 hours of admission, independent of age, gender and 
CCI, HR 4.45 (3.53 to 5.60), P<0.001. The risk of AKI was also independently 
greater 48 and 72 hours post admission in patients with HD compared with 
euhydrated individuals, Table 31a. Further analysis demonstrated that the risk 
of AKI associated with HD was also independent of NEWS, Table 31b. 
 Dehydration and mortality 8.4.3
Mortality rates at all time periods were consistently higher in patents with HD, 
Table 32a. Kaplan Meier survival plot demonstrates a significant drop in 
survival post admission in those diagnosed with HD, Figure 24. Cox regression 
analysis adjusted for age, gender and comorbidity (CCI) demonstrated that 
patients with HD were at higher risk of mortality 30 days post admission 
compared with those euhydrated at admission, HR 1.61 (1.36 to 1.89), 
P<0.001. Further analysis revealed that dehydration related 30-day mortality 
was also independent of NEWS, Table 32b. 
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Table 31a: Hyperosmolar dehydration and acute kidney injury (AKI) in hospitalised older adults – a) Whole cohort 
a- Whole cohort (n=6632) 
AKI  
(hours from 
admission) 
Euhydrated 
(n=4830) 
Dehydrated* (n=1802) P value 
Unadjusted: 
HR (95% CI) 
P value 
Adjusted+: 
HR (95% CI) 
P value 
All AKI 818 (16.9) 710 (39.4) <0.001 - - - - 
12 to 24 119 (2.5) 203 (11.3) <0.001 
4.79  
( 3.82 to 6.01) 
<0.001 
4.45  
(3.53 to 5.60) 
<0.001 
12 to 48 212 (4.4) 266 (14.8) <0.001 
3.59  
(3.00 to 4.30) 
<0.001 
3.28  
(2.73 to 3.94) 
<0.001 
12 to 72 272 (5.6) 303 (16.8) <0.001 
3.22  
(2.73 to 3.79) 
<0.001 
2.93  
(2.48 to 3.46) 
<0.001 
AKI-Acute kidney injury*Dehydration indicated hyperosmolar dehydration, osmolarity >300mOsmolo/l. +Adjusted for age, gender, Charlson Comorbidity 
Index (CCI). ++Adjusted for age, gender, CCI and National Early Warning Score (NEWS). HR-Hazard ratio. Patients with dehydration were at increased risk of 
developing AKI within 24 hours of admission, independent of age, gender and CCI. Patients with dehydration had higher incidence of AKI. Moreover, the risk 
of AKI was also independently greater 48 and 72 hours post admission in patients with dehydration compared with euhydrated individuals. 
  
  183 
Table 31b: Hyperosmolar dehydration and acute kidney injury (AKI) in hospitalised older adults – b) Whole cohort 
b -Patients with National Early Warning Score (n=422) 
AKI  
(hours from 
admission) 
Euhydrated 
(n=274) 
Dehydrated* (n=148) P value 
Unadjusted: HR (95% 
CI) 
P value 
Adjusted++:  
HR (95% CI) 
P value 
All AKI 54 (19.7) 58 (39.2) <0.001 - - - - 
12 to 24 6 (2.2) 16 (10.8) <0.001 
5.13  
(2.01 to 13.12) 
0.001 
5.15 
 (1.8 to 14.64) 
0.002 
12 to 48 15 (5.5) 22 (14.9) 0.001 
2.90 
 (1.50 to 5.58) 
0.001 
2.74 
 (1.32 to 5.70) 
0.007 
12 to 72 22 (8.0) 29 (19.6) 0.001 
2.64 
 (1.52 to 4.60) 
0.001 
2.54 
 (1.38 to 4.64) 
0.003 
AKI-Acute kidney injury. *Dehydration indicated hyperosmolar dehydration, osmolarity >300mOsmolo/l. +Adjusted for age, gender, Charlson Comorbidity 
Index (CCI). ++Adjusted for age, gender, CCI and National Early Warning Score (NEWS). HR-Hazard ratio. Patients with dehydration had higher incidence of 
AKI. Moreover, those with dehydration were at increased risk of developing AKI within 24 hours of admission, independent of age, gender, CCI and NEWS. 
The risk of AKI was also independently greater 48 and 72 hours post admission in patients with dehydration compared with euhydrated individuals. 
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Table 32a: Hyperosmolar status and mortality in hospitalised older adults. a) Whole cohort 
 
 
 
 
 
 
 
 
 
a- Whole cohort (n=6632) 
Mortality 
Euhydrated 
(n=4830) 
Dehydrated* 
(n=1802) 
P 
value 
Unadjusted: 
HR (95% CI) 
P 
value 
Adjusted+: 
HR (95% CI) 
P value 
In-Hospital 381 (6.4) 231 (12.8) <0.001 
2.087 
(1.752 to 2.48) 
<0.001 
1.723 
(1.44 to 2.06) 
<0.001 
30-day 381 (7.9) 265 (14.7) <0.001 
1.929 
(1.645 to 2.26) 
<0.001 
1.606 
(1.36 to 1.89) 
<0.001 
90-day 679 (14.0) 306 (22.5) <0.001 
1.694 
(1.50 to 1.92) 
<0.001 
1.404 
(1.24 to 1.56) 
<0.001 
One-year 1224 (25.3) 629 (34.9) <0.001 
1.494 
(1.36 to 1.65) 
<0.001 
1.231 
(1.11 to 1.36) 
<0.001 
*Dehydration indicated hyperosmolar dehydration, osmolarity >300mOsmolo/l. +Adjusted for age, gender, Charlson Comorbidity Index(CCI) 
. ++Adjusted for age, gender, CCI and National Early Warning Score. HR-Hazard ratio.   Patients with dehydration had increased mortality 
rates and had increased risk of death (HR), independent of age, gender and, CCI. 
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Table 32b: Hyperosmolar status and mortality in hospitalised older adults. b) Patients with National Early Warning Score  
 
 
 
 
 
 
b- Patients with National Early Warning Score (n=422) 
Mortality Euhydrated (n=274) 
Dehydrated* 
(n=148) 
P 
value 
Unadjusted: HR 
(95% CI) 
P 
value 
Adjusted++: 
HR (95% CI) 
P value 
In-Hospital 16 (5.8) 20 (13.5) 0.007 
2.81 
(1.23 to 6.42) 
0.014 
1.817 
(0.94 to 3.56) 
0.077 
30-day 18 (6.6) 22 (14.9) 0.005 
3.40 
(1.62 to 7.14) 
0.001 
1.915 
(1.03 to 3.56) 
0.039 
90-day 26 (9.5) 27 (18.2) 0.009 
4.42 
(2.40 to 8.15) 
<0.001 
1.634 
(0.96 to 2.78) 
0.071 
One-year 56 (20.4) 44 (29.7) 0.028 
3.19 
(1.91 to 5.33) 
<0.001 
1.278 
(0.85 to 1.91) 
0.234 
*Dehydration indicated hyperosmolar dehydration, osmolarity >300mOsmolo/l. +Adjusted for age, gender, Charlson Comorbidity Index 
(CCI). ++Adjusted for age, gender, CCI and National Early Warning Score (NEWS). HR-Hazard ratio. Patients with dehydration had increased 
mortality rates and had increased risk of death (HR), independent of age, gender, CCI and NEWS.  
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Figure 24: Kaplan-Meier survival plot demonstrating the relationship between hydration status and mortality 
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8.5 Discussion 
HD occurred in over a quarter of hospitalised older adults, consistent with 
previously reported results using osmolality as the marker of hydration (El-
Sharkawy et al., 2015b). However, the prevalence of dehydration in the 
present study is significantly greater than clinically reported dehydration in 
Chapter 6 and that previously reported by Warren et al.  (Warren et al., 1994) 
These significant differences between clinically reported dehydration and HD 
are most likely the result of limited sensitivity of the clinical features of 
dehydration in this age group as well as the lack of screening and poor 
documentation. 
The present study also demonstrated increased prevalence of dehydration 
with increased age and comorbidity similar to that shown in Chapters 5 and 6. 
This is a likely consequence of the disease process and polypharmacy, which 
result in physiological vulnerability and homeostatic irregularity as well as 
organ dysfunction. However, given the high prevalence of HD at admission, 
chronic or pre-existing dehydration should also be considered as a 
contributing factor. Studies have demonstrated that up to 60% of seemingly 
“well” community-dwelling older adults may be dehydrated (Stookey et al., 
2005).  
In the present study, 39% of those who had HD also developed AKI and a 
significantly greater proportion had advanced (stage 3) AKI compared with 
those who were euhydrated, 9% vs. 1.3%, P<0.001. Moreover, regression 
 188 
 
analysis revealed patients with HD were nearly five times more likely to be 
in AKI 12 to 24 hours post admission, adjusted HR 5.15 (1.8 to 14.64) 
P<0.001. ), independent of age, gender, comorbidity and illness severity 
(NEWS). It is of course difficult to attribute cause and effect in this 
retrospective study. However, considering the age-related renal changes (El-
Sharkawy et al., 2014, Lindeman et al., 1985, Davies and Shock, 1950, 
Hollenberg et al., 1974, Beck, 2000), recognising and treating dehydration 
may help prevent AKI in some patients (National Confidential Enquiry into 
Patient Outcome and Death, 2009, Ftouh and Thomas, 2013). This is of 
particular relevance where patients are prescribed diuretics and nephrotoxic 
drugs, a common scenario in older adults.  
Adverse events related to diuretics account for up to 25% of all adverse drug 
reactions in older adults mostly due to poor monitoring and difficulties in 
accurately assessing hydration status (Wierenga et al., 2012, Sandhofer et al., 
2002, Klopotowska et al., 2012). Currently many clinicians rely on changes in 
serum urea and creatinine to aid the assessment of hydration status and fluid 
balance. However, these are not sensitive to small changes in hydration 
status, and are features of AKI (Sandhofer et al., 2002, Khwaja, 2012. 
(Sandhofer et al., 2002, Khwaja, 2012) Moreover, there is evidence suggesting 
that changes in creatinine may lag several days behind actual changes in 
glomerular filtration rate (Moran and Myers, 1985, Star, 1998). Therefore, 
serum osmolality may facilitate diagnosis of HD as well as monitor and guide 
the prescription of diuretics and nephrotoxic drugs. This approach may help 
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prevent AKI, which is associated with high morbidity and mortality (Porter et 
al., 2014, National Confidential Enquiry into Patient Outcome and Death, 
2009, Ftouh and Thomas, 2013).  
HD was also found to be associated with mortality. The 30-day mortality in 
the dehydrated group was nearly double that of the euhydrated group, 14.7% 
vs.7.9%, respectively, P<0.001. It was also independently associated with a 
greater risk of 30-day and 90-day mortality. These findings are consistent with 
previous reports (Chapter 5 and 6) and are unlikely to be unique to this cohort 
or this centre which was described by the Care Quality Commission (CQC) as 
“safe, caring, effective and well-led” and had a standardised mortality rate in 
keeping with the national average (Dr. Foster Intelligence, Commission). 
Studies in other centres have also shown that high osmolality at admission 
was associated with increased morbidity and mortality post ischaemic stroke 
and myocardial infarction (Rohla et al., 2013, Villani et al., 1978, Bhalla et al., 
2000). The higher mortality rates may be related to complications of 
dehydration and associated hypovolaemia such as AKI as well as other organ 
dysfunction.  
This present study also demonstrates a significant difference in the median 
LOS by an extra two days in patients with HD and five days in those clinically 
diagnosed with dehydration compared with euhydrated patients, 5 vs. 3 and 8 
vs. 3, respectively. These marked differences will further contribute to 
financial and resource pressures already facing the NHS.  
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8.6 Limitations 
This study reports significant findings with potential clinical implications; 
however, there are clear limitations that need to be considered when 
interpreting the results. HD (serum osmolality >300 mOsmol/kg) is thought to 
be the most common form of dehydration in older adults, equivalent to a 
reduction of between 4 and 5% of body weight (Armstrong et al., 1997, 
Cheuvront et al., 2013). However, this does not represent all forms of 
dehydration and it is therefore important to consider salt and water balance 
when using serum osmolality to assess hydration status (Electrolytes and 
Water, 2005, Eaton et al., 1994, Thomas et al., 2008, Armstrong, 2007, 
Armstrong, 2005).  
Osmolarity calculations have been shown to be comparable to measured 
serum osmolality and were also highly sensitive and specific at predicting HD 
in this cohort as shown in Chapter 7. These findings are also supported by 
Siervo et al., 2014 who also showed this equation to be the most accurate at 
predicting HD in community-dwelling older adults. However, osmolarity is 
only an estimation of hydration status and may be influenced by various 
factors including serum alcohol concentrations. Efforts were made to exclude 
all alcohol related admissions to minimise bias.  
HD may be a manifestation of disease severity, and an increase in LOS and 
mortality would therefore be expected, although attempts were made to 
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account for confounders including age, gender and comorbidities using the 
CCI and NEWS. 
LOS analysis was based on admission and discharge date and not the date the 
patient was medically fit for discharge. The LOS results should therefore be 
interpreted with caution as delayed discharges are common in older adults, a 
result of complex, length discharge processes, which may attenuate or 
exacerbate the differences in LOS reported in this study. However, it may be 
reasonable to assume that the incidence of delayed discharge may be equal 
between dehydrated and euhydrated patients. 
The study findings are based on data obtained from a large university teaching 
hospitals NHS trust, further work is therefore required to assess whether 
these findings are applicable to other hospitals. However, there are numerous 
reports (although less comprehensive) from hospital and community settings 
suggesting that fluid mismanagement may be more widespread. (Powell and 
Paterson-Brown, 2011, Leach et al., 2013) 
8.7 Conclusions 
This study provides compelling evidence adding to the growing body of 
research highlighting limitations with the way hydration status is currently 
assessed and monitored in hospitalised older adults. 
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It is widely accepted that good hydration is essential to healthy living. 
Dehydration has been linked with multiple system disorders including 
cardiovascular, gastrointestinal and urinary disorders (El-Sharkawy et al., 
2015a). Vulnerable groups such as older adults are at increased risk, 
particularly during periods of ill health as a result of age-related 
pathophysiological changes, multiple comorbidities and polypharmacy (El-
Sharkawy et al., 2015b). 
Work done in this thesis demonstrates that healthy younger adult HCPs are 
also at risk. Over a third of the HCPs studied were dehydrated at the start of 
their shift, close to half at the end, and a third were oliguric. Interestingly, 
differences in the work patterns, speciality of work as well as level of 
experience influenced the hydration status of the participants. The reasons 
for this are likely to be multifactorial, with the difficulty in balancing adequate 
food and fluid consumption with the demands of a busy stressful shift in an 
often hot ward environment being significant contributing factors. Limited 
knowledge and awareness are also likely to be key contributors and 
addressing this has been shown to result in significant improvements in the 
hydration status of shift workers (Brake and Bates, 2003).  
Furthermore, it was demonstrated that dehydration can negatively affect the 
way participants feel and may be associated with impaired cognitive function.  
Other work has shown that rehydration can reverse the cognitive impairment 
associated with dehydration, with the degree of improvement related to the 
severity of the thirst perception (Rogers et al., 2001). 
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These findings may be of clinical significance given the relationship between 
subjective feelings and prescribing errors. A report commissioned for the UK 
General Medical Council investigating the prevalence and causes of 
prescribing errors, highlighted that physical and emotional well-being of the 
prescriber were amongst the five most common root causes (Avery et al., 
2012). The authors reported anxiety and tiredness as key factors that 
contribute to this common problem (Avery et al., 2012). Similarly, findings 
from USA investigations into causes of errors, reported thirst, hunger and 
tiredness as leading causes of prescribing errors amongst interns (Coombes et 
al., 2008). Links between poor quality clinical care, serious clinical errors and 
the physician wellbeing of the clinicians have also been described (Firth-
Cozens and Greenhalgh, 1997). These findings emphasise the importance of 
HCPs maintaining a euhydrated state, given that prescribing and administering 
drugs are amongst the most common tasks undertaken in the clinical setting.  
Others have gone further suggesting that employers should facilitate 
adequate hydration and encourage a culture of wellness amongst HCP’s, given 
that the well-being of workers is an indicator of an organisation’s well-being 
(Wallace et al., 2009, Arnetz, 2005). Simple measures such as easy access to 
drinking water are likely to be a cost effective way to improve the health of 
workers, which has been shown to increase productivity (Linzer et al., 2001) 
and may improve patient care. 
It was also demonstrated in this thesis that HD is common in hospitalised 
older adults and is associated with AKI and poor outcome. Moreover, there 
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was a significant disparity between the prevalence of clinically diagnosed and 
biochemically measured dehydration. This may be explained by the challenges 
in assessing fluid status in the older adult. Current clinical methods of 
assessing and monitoring hydration status have been shown to be unreliable 
(Schols et al., 2009, Shimizu et al., 2012, Fortes et al., 2014, Eaton et al., 1994, 
Fletcher et al., 1999, McGee et al., 1999, Weinberg and Minaker, 1995). A 
study investigating the accuracy of seven clinical signs of dehydration against 
objective biochemical assessment using urea: creatinine ratio and serum 
osmolality, reported poor sensitivity and specificity of commonly assessed 
clinical features including increased CRT, dry mucus membranes, sunken eyes, 
dry axilla and reduced skin turgor, with sensitivity ranging from 0 to 44% 
(Fortes et al., 2014). Common clinical features of dehydration are non-
specific; dry skin and reduced skin turgor can occur with the normal ageing 
process and the commonest cause of dry mucus membrane in the older adult 
is mouth breathing. Additional features of dehydration include dizziness, 
postural hypotension, confusion, weakness and apathy, all of which may 
erroneously be attributed to other causes or simply ascribed to the aging 
process, meaning that HD may not be recognised (Schols et al., 2009, Shimizu 
et al., 2012, Fortes et al., 2014).  
Other markers such as acute changes in weight can also be useful, although 
this requires serial measurements, which can be a challenge in dependent 
older adults and requires specialist equipment and training. Furthermore, this 
 196 
 
method is limited to changes over a short time period as weight fluctuates 
over longer time periods. 
Urine parameters such as urine colour and specific gravity have been used to 
assess hydration status, but these lack sensitivity (Fortes et al., 2014). 
However, urine osmolality and output are more sensitive and specific at 
assessing and monitoring hydration status when measured over 24 hours 
(Armstrong, 2007), though obtaining urine samples is often difficult in older 
adults and oliguria is a late feature of dehydration, associated with AKI 
(Lewington and Kanagasundaram, 2011).  
These challenges in assessing hydration status and the absence of validated 
assessment tools results in undiagnosed and therefore underreported 
dehydration (Lobo et al., 2001a). Limited awareness and poor knowledge 
together with the lack of comprehensive guidelines compound the problem.  
Further findings from this thesis demonstrate that HD may be an independent 
risk factor for AKI, with many of the dehydrated patients also diagnosed with 
AKI. Dehydration was also shown to be a contributor to mortality, 
independent of the primary cause of hospitalization as well as age, gender 
and comorbidities. These findings suggest that missed or late diagnosis of 
severe dehydration that results in kidney injury; a likely contributing factor to 
the increased mortality rates reported.  
The results of these studies are unlikely to be unique to this cohort or this 
centre which was described by the Care Quality Commission (CQC) as “safe, 
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caring, effective and well-led” and had a standardised mortality rate in 
keeping with the national average (Dr. Foster Intelligence, CQC 2014). The 
CQC also noted evidence in the acute setting “that staff assessed nutrition and 
hydration needs and that they put in place and followed care plans if specific 
needs were identified, for example, if a patient required assistance at 
mealtimes.”(CQC, 2014) 
Over the last four decades, numerous publications have highlighted the 
significance of hydration status in vulnerable groups particularly in older 
adults. Some reports have highlighted a clear need for improvement and lack 
of compliance with national care guidelines (National Confidential Enquiry 
into Patient Outcome and Death, 2009, Ftouh and Thomas, 2013). The CQC’s 
Essential Standards of Quality and Safety clearly state that the nutrition and 
hydration needs of service users must be met (CQC, 2012), but the Health 
Ombudsman for England reported that there was a lack of access to fresh 
drinking water during her investigations into the care of older people. 
However, it is important to highlight the CQC investigation that reported 45 
out of 100 acute NHS hospitals complied fully with their standards on 
participants’ nutritional needs following unannounced inspections by an 
independent panel of representatives that included patient charities and 
advocates (CQC, 2011).  
The link between AKI and dehydration demonstrated in this thesis are 
supported by the National Confidential Enquiry into Patient Death which 
reported that as many as 12,000 deaths annually could be prevented by 
 198 
 
treating the causes of ‘avoidable’ AKI which include dehydration (National 
Confidential Enquiry into Patient Outcome and Death, 2009, Ftouh and 
Thomas, 2013).  
Given the challenges highlighted in assessing and monitoring hydration status, 
serum osmolality may be a useful adjunct to current clinical care, as it is the 
key regulated variable in fluid balance and is widely seen as the most reliable 
objective measure of hydration status (Bhalla et al., 2000, Sollanek et al., 
2011, Cheuvront et al., 2013, Cheuvront et al., 2010, Stookey et al., 2005). It 
may also be useful to aid prescribing of diuretics and other nephrotoxic drugs 
given that changes in urea and creatinine may not be sensitive to small 
changes in hydration status (Sandhofer et al., 2002, Khwaja, 2012). Therefore 
using serum osmolality in the clinical setting will not only help early detection 
of dehydration, it may also help prevent AKI. However, it is important to note 
a single measurement is unlikely to be useful due to the rapid fluctuation of 
body water through the different fluid compartments (Armstrong, 2007, 
Armstrong et al., 2013b). 
Despite the widespread use of serum osmolality in a variety of human 
physiological research settings, it has not been fully adopted in the clinical 
setting due to limited evidence and resources. However, it has been 
demonstrated that calculated osmolarity may be used as an alternative in 
hospital (Chapter 7) and community setting (Siervo et al., 2014). Studies 
described in this thesis demonstrated that the equation by Khajuria and 
Krahn, 2005, had the greatest diagnostic accuracy at predicting HD with over 
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90% sensitivity and 97% specificity at 300 mmol/l, consistent with work done 
in community-dwelling older adults (Siervo et al., 2014). This equation is a 
simple and cost effective way to allow screening, diagnosing and monitoring 
of patients. It is based on serum biochemistry, which is routinely measured 
when patients present to hospital and in many cases daily during 
hospitalisation. However, there is a clear need for prospective evaluation and 
validation of the clinical applicability of this approach in order to meet the 
basic needs for some of our most vulnerable patients. 
Dehydration in older hospitalised patients is a major concern for patient 
safety and could also contribute to a significant public health burden. In the 
US it has been estimated that dehydration as a primary diagnosis costs the 
healthcare provider $2942 per admission based on 1991 estimates (Warren et 
al., 1994). Furthermore, a study used the 2004 US National Hospital Discharge 
Survey of 518,000 hospitals and reported that dehydration as the primary 
cause of admission, cost $5.5 billion, describing the findings as “avoidable 
healthcare costs” (Kim, 2007). Given the projected increase in the UK older 
adult population, the financial and resource burdens are likely to increase 
significantly (Cracknell, 2010). However, cost implications related to 
dehydration are difficult to quantify and any figure estimating the financial 
implication is unlikely to account for under-reporting or dehydration-related 
conditions such as urolithiasis and AKI (El-Sharkawy et al., 2015a). 
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Given that hydration and nutrition are the hallmarks of compassionate care, 
there is clear room for improvement. Our findings suggest the need for 
further investigations and interventions in both community and hospital 
settings. Our studies have highlighted that dehydration is still a common 
problem both in healthy individuals as well as hospitalised older adults and 
highlights the challenges in assessing, diagnosing and monitoring dehydration 
in older adults. Routine use of serum osmolality to assess and monitor 
hydration status in older adults may help prevent avoidable causes of kidney 
injury and may reduce morbidity and mortality. Knowing hydration status  
serum osmolality will not only facilitate rehydration, but may also help guide 
the prescription of diuretics and other potentially nephrotoxic mediation.  
Work from this thesis highlights the need for further work to prospectively 
assess the use of serum osmolality as a predictor of dehydration, AKI and 
outcomes. Education of both patients and HCP is also needed in order to 
highlight the importance of good hydration. Co-ordinated efforts are 
necessary to develop comprehensive guidelines and hydration assessment 
tools together with methods to implement and monitor a real change in 
culture and attitude towards hydration in hospitalised older adults. Regular 
feedback audits and reviews of practice are likely to encourage 
implementation of guidelines and improvements in care and will help prevent 
avoidable morbidity, reduce mortality and reduce unnecessary costs.  
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The studies outlined in this thesis have highlighted the high prevalence of 
dehydration amongst HCPs and associated cognitive impairment. It has also 
highlighted that a significant proportion of hospitalised older adults are 
dehydrated, with significant discrepancy between clinically diagnosed and 
objectively measured dehydration. As a result, many may go unrecognised 
and if untreated can result in AKI and poor outcome. However, the work 
undertaken thus far also raises many new questions that we hope to address 
in future studies:  
 
1. Whether the prevalence of dehydration reduces during normal 
working hours or with ‘protected’ breaks. 
 
2. Whether better knowledge, awareness and access to fluids would 
reduce the prevalence of dehydration amongst HCPs, improve 
wellbeing scores and reverse cognitive impairment associated with 
dehydration.  
 
3. Whether the prevalence of dehydration in ‘well’ community-dwelling 
older adults is as high as that reported in hospitalised older adults. 
 
4. Whether the prevalence of dehydration amongst older adult patients 
undergoing elective surgery impacts on intraoperative fluid 
administration and postoperative outcome. 
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5. Whether better knowledge, awareness amongst HCPs, relatives and 
patients impacts on the prevalence of dehydration and associated 
adverse events in older adults. 
 
6.  Whether improved monitoring and access to fluids would reduce the 
prevalence of dehydration and improve outcome amongst hospitalised 
older adults. 
 
7.  Whether the use of osmolality as an adjunct to clinical assessment 
tools, to screen and monitor hydration status in older adults would 
reduce the prevalence of severe dehydration, AKI and improve clinical 
outcome. 
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13.1 Appendix 1: Supplementary data analysis from chapter 8 
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Mean of the difference *(95% CI): 0.78 (-0.47 to 2.02) 
Bland-Altman plot, mean difference and accuracy of osmolarity calculations using Krah & 
Khajuria’s16 equation [1.86 x (Na + K) + 1.15 x 6.3 + urea + 14] for patient without glucose. 6.3 a 
constant value obtained from the mean population (n=13,542) glucose of non-diabetic 
patients. 
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Supplementary Table 1: Demographics and characteristics of the study cohort. Comparing 
those with and without hypertonic dehydration during hospitalisation. 
  
All Patients 
(n=13542) 
Euhydrated 
(n=9902) 
Dehydrated# 
(n=3640) 
P 
value* 
Age 
65 - 75 523 (3.9) 427 (4.3) 96 (2.6) 
<0.001 
76 - 85 9295 (68.6) 6,974  (70.4) 2,321 (63.8) 
86 - 95 3433 (25.4) 2,319 (23.4) 1,114 (30.6) 
>95 291 (2.2) 182 (1.8) 109 (3.0) 
Gender 
Female 
7,715 
(57.0) 
5843 (59.0) 1,872 (51.4) 
<0.001 
Male 
5,827  
(43.0) 
4,059 (41.0) 1,768 (48.6) 
Charlson 
Comorbidity 
Index  
None 
4,327 
(32.0) 
3,329 (33.6) 998 (27.4) 
<0.001 
Mild 
6,095 
(45.0) 
4,524 (45.7) 1,571 (43.2) 
Moderate 
1,899 
(24.0) 
1,153 (11.6) 746 (20.5) 
Severe 1,221 (9.0) 896 (9.1) 325 (8.9) 
*P value comparing patients with and without dehydration. 
#
Dehydration indicates hypertonic dehydration, 
osmolarity >300mOsmol/l. 
+
Osmolarity calculated using the equation by Krah & Khajuria’s equation 2005 [1.86 x 
(Na + K) + 1.15 x glucose + urea + 14]. 
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Supplementary Table 3: Prevalence of conditions associated with dehydration. 
 
 (a) Whole cohort (n=13542) (b) Patients with National Early Warning Score (n=2346) 
AKI  
(hours 
from 
admission) 
Euhydrated 
(n=9902) 
Dehydrated* 
(n=3640) 
P 
value 
Unadjusted: 
HR (95% CI) 
P 
value 
Adjusted
+
: 
HR (95% 
CI) 
P 
value 
Euhydrated 
(n=3854) 
Dehydrated* 
(n=1492) 
P 
value 
Unadjusted: 
HR (95% CI) 
P 
value 
Adjusted
++
: 
HR (95% 
CI) 
P 
val
ue 
All AKI 1276 (12.9) 1068 (29.3) <0.001 - - - - 364 (9.4) 316 (21.2) <0.001 - - - - 
12 to 24 143 (1.4) 288 (7.9) <0.001 
2.96 
(2.42 to 
3.62) 
<0.001 
3.05 
(1.48 to 
3.75) 
<0.001 44 (1.4) 93 (6.2) <0.001 
3.12 
(2.18 to 
4.46) 
<0.001 
3.21  
(2.22 to 
4.65) 
<0.
00
1 
12 to 48 313 (3.2) 429 (11.8) <0.001 
2.33 
(2.01 to 
2.69) 
<0.001 
2.34 
(2.01 to 
2.71) 
<0.001 112 (2.9) 155 (10.4) <0.001 
2.43 
(1.9 to 3.10) 
<0.001 
2.47  
(1.92 to 
3.19) 
<0.
00
1 
12 to 72 420 (4.2) 486 (13.4) <0.001 
2.08 
(1.82 to 
2.37) 
<0.001 
2.10 
(1.84 to 
2.40) 
<0.001 152 (3.9) 179 (12,0) <0.001 
2.22 
(1.78 to 
2.76) 
<0.001 
2.27  
(1.81 to 
2.85) 
<0.
00
1 
*Dehydration indicated hyperosmolar dehydration, osmolarity >300mOsmo/l. 
+
Adjusted for age, gender, Charlson Comorbidity Index . 
++
Adjusted for age, gender, Charlson Comorbidity 
Index and National Early Warning Score. 
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Supplementary Table 4: Hydration status and mortality. 
 (a) Whole cohort (n=13542) (b) With NEWS (n=2346) 
Mortality 
Euhydrated 
(n=9902) 
Dehydrated* 
(n=3640) 
P 
value 
Unadjusted:  
HR (95% CI) 
P 
value 
Adjusted
+
:  
HR (95% 
CI) 
P 
value 
Euhydrated 
(n=3854) 
Dehydrated* 
(n=1492) 
P 
value 
Unadjusted: 
HR (95% CI) 
P 
value 
Adjusted
++
:  
HR (95% 
CI) 
P 
value 
In-
Hospital 
586 (5.9) 499 (13.7) <0.001 
2.39  
(2.11 to 
2.70) 
<0.001 
2.08  
(1.83 to 
2.36) 
<0.001 184 (4.8) 164 (11.0) <0.001 
2.34  
(1.88 to 
2.91) 
<0.001 2.11  
(1.69 to 
2.65) 
<0.001 
30-day 724 (7.3) 568 (15.6) <0.001 
2.23  
(1.99 to 
2.50) 
<0.001 
1.95  
(1.74 to 
2.19) 
<0.001 229 (5.9) 191 (12.8) <0.001 
2.23  
(1.83 to 
2.71) 
<0.001 2.02  
(1.65 to 
2.48) 
<0.001 
90-day 1244 (12.6) 820 (22.5) <0.001 
1.91  
(1.75 to 
2.09) 
<0.001 
1.67  
(1.53 to 
1.83) 
<0.001 397 (10.3) 270 (18.1) <0.001 
1.84  
(1.58 to 
2.16) 
<0.001 1.65  
(1.40 to 
1.94) 
<0.001 
One-year 2078 (21.0) 1188(32.6) <0.001 
1.70  
(1.58 to 
1.83) 
<0.001 
1.47  
(1.37 to 
1.58) 
<0.001 681 (17.7) 438 (29.4) <0.001 
1.79  
(1.59 to 
2.02) 
<0.001 1.58  
(1.40 to 
1.80) 
<0.001 
*Dehydration indicated hyperosmolar dehydration, osmolarity >300mOsmo/l. 
+
Adjusted for age, gender, Charlson Comorbidity Index . 
++
Adjusted for age, gender, Charlson Comorbidity 
Index and National Early Warning Score. 
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13.2 Appendix 2: Subjective feelings questionnaire 
10 cm visual analogue scale to measure subjective feelings 
     
Study ID: ____     Initials: ______          Date of Birth: ____________ 
 
How thirsty do you feel now?  
  
Not at all (0)  (10) very 
thirsty  
 
How hungry do you feel now?  
Not at all (0)  (10) very 
hungry  
 
 
How tired do you feel now?  
Not at all (0)  (10) very 
tired  
 
 
How alert do you feel now?  
Not at all (0)  (10) very 
alert 
 
 
How well can you concentrate just now?  
Not at all (0)  (10) very 
well  
 
 
How stressed do you feel now?  
Not at all (0)  (10) very 
stressed  
 
 
How does your head feel now?  
Not at all (0)  (10) very 
sore  
 
 
How refreshed do you feel now?  
Not at all (0)  (10) very 
refreshed  
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13.3 Appendix 3: Charlson Comorbidity Index  
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13.4 Appendix 4: Rockwood Frailty Scale 
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13.5 Appendix 5: Barthel Activities of Daily Living Index 
 Please 
tick one 
1. In the bath or shower, do you:  
Manage on your own?  
Need help?  
Never have a bath or shower?  
2. Do you go up and down stairs:  
Without any help?  
With help (either supervision or assistance)?  
Not at all?  
3. Do you get dressed:  
Without any help (including buttons, zips, laces etc)?  
With help, but can do at least half on your own?  
With help for almost everything?  
4. Do you get about indoors:  
Walking with no-one helping? (with stick or frame)  
Walking with the help or supervision of one person?  
Propelling you with a wheelchair?  
Not at all?  
5. Do you move from bed to chair:                        
On your own?  
With a little help from one person?  
With a lot of help from one or two people?  
Not at all?  
6. Do you feed yourself:  
Without any help?  
With a little help (e.g. cutting up food)?  
With a lot of help?  
7. Do you use the toilet or commode:  
Without any help?  
With a little help (e.g. wiping)?  
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With a lot of help?  
8. Do you wash your face, brush your hair and teeth, (for men, shave):                                                     
Please tick one 
Without help?  
With help?  
9. Are you incontinent of urine (wet your bed or clothes):  
Never?  
Occasional “accident”?  
More often than occasional “accident”?  
Have a catheter which you manage yourself?  
Have a catheter managed by someone else?  
10. Are you incontinent of your bowels (soil yourself):  
Never?  
Occasional “accident”?  
More often than occasional “accident”?  
Need regular enemas?  
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13.6 Appendix 6: Mini Mental State Examination 
(adapted from Folstein et al. ) 
 Section Questions: points score 
   Max 
score 
Patient 
score 
1 Orientation 
a) Can you tell me today’s (date)/ (month)/ (year)? 
    Which (day of the week) is it today? 
     Can you also tell me which (season) it is? 
5 
 
  
b) What city/town are we in? 
    What are the (county)/ (country)? 
    What (building) are we in and on what (floor)? 
5 
 
2 Registration  
I should like to test your memory. 
(name 3 common objects: e.g. “ball, car, man”) 
Can you repeat the words I said? score 1 point for each word 
(repeat up to 6 trials until all three are remembered) 
(record number of trials needed here:              ) 
3 
 
3 
Attention & 
Calculation 
a) From 100 keep subtracting 7 and give each answer: 
    Stop after 5 answers. (93...86…79...72...65).  
Alternatively 
b) Spell the word ‘WORLD’ backwards. (D_L_R_O_W). 
5 
 
4 Recall 
What were the three words I asked you to say earlier? 
(skip this if all three objects were not remembered during 
registration test) 
3 
 
5 
Language 
Naming 
Name these objects (show a watch) (show a pencil) 2  
 Repeating Repeat the following: “no ifs, ands or buts" 1  
6 Reading 
(show card or write “CLOSE YOUR EYES”) - see over 
Read this sentence and do what it says. 
1 
 
 Writing  Now can you write a short sentence for me? 1 
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7 
Three stage 
command 
(Present paper) 
Take this paper in your left (or right) hand, fold it in half, and 
put it on the floor. 
3 
 
8 Construction Will you copy this drawing please? – see below 1 
 
     
 Total Score  
30 
 
 Notes 
Question 6 – Writing 
 
________________________________________________________________
___ 
Question 8 - Construction 
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13.7 Appendix 7: Nutritional Risk Screening Tool 
 
 
 
